






‘Shrink-Wrapping’ Nanoscale Objects 
 







A thesis submitted for the degree of  











Abstract of the Dissertation 
 ‘Shrink-Wrapping’ Nanoscale Objects 
Patrick Louis Higgs 
This thesis describes the ‘structural metamorphosis’ of discrete single-chain polymer 
nanoparticles (SCPNs) – an architecture in which a linear polymer chain is intramolecularly 
crosslinked – into intermolecularly crosslinked polymer films. It was hypothesized that this 
process could be exploited for the ‘shrink-wrapping’ of 3D nanoscale objects, whereby SCPNs 
concentrate themselves onto the surface of the object through complementary non-covalent 
interactions and then spontaneously crosslink with their neighbouring polymer chains to afford 
a covalently crosslinked film. With the ambitious goal of ‘shrink-wrapping’ virus-like particles 
(VLPs) in mind, this thesis developed the concept by ‘wrapping’ nano- and microscale objects 
of increasing complexity. Chapter 1 proposes a definition for ‘structural metamorphosis’ and 
describes how this phenomenon could be exploited to drive ‘shrink-wrapping’ of virus-like 
particles. Chapter 2 explores the ‘shrink-wrapping’ of simian virus 40 and Model System I, 
where the ‘wrapping’ process is driven by simple electrostatic interactions. Chapter 3 
describes Model System II, in which specific carbohydrate-receptor interactions drive the 
‘shrink-wrapping’ of protein-functionalized silica micro- and nanoparticles. The success of 
these investigations is largely owed to the development of a highly hydrophilic aldehyde 
polymer scaffold that was constructed to circumnavigate issues of non-specific binding 
between polymers and the particle surface. Chapter 4 reports progress in the ‘shrink-wrapping’ 
of SV40 viral capsid, describing work towards the synthesis of SCPNs functionalized with the 
oligosaccharide GM1 – the native ligand of SV40.  The ‘shrink-wrapping’ of sensitive 
biomacromolecular targets such as VLPs requires hydrazone exchange chemistry to operate 
on a reasonable timescale at physiological pH. Published work in Chapter 5 investigates rate-
enhancing structural features which lead to rapid hydrazone exchange processes at neutral 
pH. These findings are anticipated to have important consequences on the development of 
structurally adaptive polymers, materials, molecular machines, nanoparticles and surfaces, 
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µg  Micrograms 
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AFM  Atomic Force Microscopy 
AIBN   2,2'-Azobis(2-methylpropionitrile)  
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DLS  Dynamic light scattering 
DMA   N,N-Dimethylacrylamide 
DMAP  4-(Dimethylamino)pyridine  
DMF   Dimethylformamide  
DMSO  Dimethylsulfoxide  
dRI   Differential refractive index  
E. coli  Escherichia coli  
EDC  1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide 
ELISA  Enzyme-linked immunosorbent assay 
ESI-MS  Electrospray ionisation mass spectrometry  
FT-IR   Fourier transform infrared spectroscopy  
GPC   Gel permeation chromatography  
h   Hour  
HEPES  4-(2-Hydroxyethyl)piperazine-1-ethanesulphonic acid  
HRMS   High resolution mass spectrometry  
IEP  Isoelectric point 
Ka   Association constant  
Kd  Dissociation constant 
kf  Forward rate constant 
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MW  Molecular weight 
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NPs  Nanoparticles 
PD  Polymer dose 
PDI   Polydispersity index 
PE  Polyelectrolyte 
PEG  Poly(ethylene) glycol 
ppm  Parts per million 
PS  Polystyrene 
RAFT   Reversible addition-fragmentation chain transfer  
rt  Room temperature 
RT  Retention time (GPC analysis) 
SCPNs  Single chain polymer nanoparticles 
SDS-PAGE Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
sNPs  Sulfonate-functionalized polystyrene nanoparticles 
TEM  Transmission electron microscopy 
TFA  Trifluoroacetic acid 
TR-DLS Time-resolved dynamic light scattering 
TS  Transition state 
UV  Ultraviolet 
UV-Vis  Ultraviolet-visible  
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This chapter explores the concept of ‘structural metamorphosis’ by structurally dynamic 
chemical architectures. Based upon literature examples which showcase this phenomenon at 
play within chemical systems, the process of ‘structural metamorphosis’ was considered and 
a definition proposed. Literature examples were examined against the proposed definition of 
‘structural metamorphosis’ to verify that it is robust and can be applied consistently. The 
‘structural metamorphosis’ of structurally dynamic polymeric nanoparticles into 
intermolecularly crosslinked polymer films was considered in detail. A strategy to exploit this 























Figure 1: Three examples of metamorphosis from the natural world. (a) Biological metamorphosis of 
the monarch butterfly, Danaus plexippus from its larva (i) to the mature adult form (ii).1 Image by Steve 
Greer Photography, copyright 2020. (b) Conformational ‘metamorphosis’ of dengue virus from its 
‘inactive’ conformer (i) to the pathogenically active (ii) species is triggered by acidifying the virus to 
lysosomal conditions, pH ~ 4.5.2 Reproduced with permission of ref. 2. (c) ‘Structural metamorphosis’ of 
the bacterial hydrophobin BslA, a ‘coat’ protein crucial to biofilm formation. Wild-type BslA (i) migrates 
to the water/air interface and the protein spontaneously undergoes a conformational ‘switch’ (ii), which 
drives the irreversible formation of a polymer-like ‘crosslinked’ protein film (iii) upon the droplet 
surface.3,4 Droplet compression experiments (iv) revealed that BslA films are elastic in nature, 
encapsulating the water droplet within a plastic-like layer. Reproduced with permission of ref. 3. 
1.2. Introduction 
Examples of metamorphosis are ubiquitous and displayed on many levels within the natural 
world: The biological transformation of Danaus plexippus, Monarch butterfly larvae (Fig. 1a) 
into their mature adult form,1 the pH-responsive conformational switch of ‘inactive’ dengue 
virus (Fig. 1b)2 into its pathogenically active form, or the ‘structural metamorphosis’ of the 
biofilm-surface layer protein A (BslA)3 (Fig. 1c) into a crosslinked hydrophobic film upon a 
droplet surface.4 Imperatively, structure gives rise to properties in the natural world. Thus, 
metamorphosis is invoked by an abrupt transformation of bonding (connectivity of 
components) at the molecular level – a process that is often accompanied by a marked change 
in function at a macroscopic level. The monarch butterfly is, for example, capable of flight and 
yet the larvae are not. Whilst intriguing to a broad scientific community, these processes of 
transformation have seldom been explored within chemical systems, with chemists to date 
reporting just a handful of examples in which ‘structural metamorphosis’ was investigated at 
the molecular and/or supramolecular levels. This chapter will firstly define what is ‘structural 
metamorphosis’ and then interrogate this definition by review of select literature examples 

















Figure 2: ‘Structural metamorphosis’ amongst reversibly connected building blocks permits a range of 
molecular architectures to be accessed. The ‘structurally adaptive’ nature of such species requires a 
dynamic bond between the assembled components.  
1.2.1. What is ‘Structural Metamorphosis’? 
Metamorphosis is defined5 as the process of changing shape, structure, or form. In the 
highlighted examples (Fig. 1a-c) of metamorphosis, these transformations are all triggered by 
a change in their external environments. Note that in each case, however, all the necessary 
components required to successfully undergo ‘metamorphosis’ are already present within the 
system, with no need for the input of additional external materials. ‘Structural metamorphosis’ 
is defined in this thesis as a transition between two discrete architectures, where components 
are neither added nor taken away, but the interconnectivity (bonding) of building blocks is 
changed (Fig. 2) at the molecular and/or supramolecular level, facilitating a switch from one 
architecture to another. The ‘reshuffling’ of molecular components which occurs during 
‘structural metamorphosis’ requires a dynamic nature to the bonds that connect the building 
blocks within the system. A dynamic bond is defined6 as any class of chemical bond that can 
selectively undergo reversible breaking and reformation, usually under equilibrium conditions. 
These dynamic bonds can be either covalent or non-covalent in their nature, but crucially, it is 
the ability of these interactions to reversibly break and reform that allows for components to 
change their interconnectivities and for ‘structural metamorphosis’ to subsequently occur. 
There is no requirement within the definition proposed above for ‘structural metamorphosis’ to 
















1.2.2. A Supramolecular Example of ‘Structural Metamorphosis’ 
In 2016 Kumar et al. reported7 the ‘structural metamorphosis’ of PDDA/FMOC-AA coacervate 
droplets (Fig. 3a i) into branched star-like architectures (ii) displaying long outward-reaching 
appendages (Fig. 3c v). This pH-triggered ‘metamorphosis’ of coacervate droplets, was 
triggered by the addition of D-glucono-𝛿-lactone lactone (GDL), the hydrolysis (Fig. 3b) of which 
acidifies the solution, affording the protonation of carboxylate groups within FMOC-AA. When 
protonated, the FMOC-AA embedded within the PDDA/FMOC-AA coacervate rapidly 
aggregates to form long fibres (Fig. 3c ii), which entangle to form a weak hydrogel. Figure 3c 
shows confocal fluorescence microscope images of the coacervate droplet before (iii) and 10 
min after (iv) the addition of GDL. Further experiments revealed that addition of 10 mM sodium 
hydroxide affords rapid collapse (Fig. 3c vi) of the star-like architecture back to its coacervate 
core (vi, 40s), thus demonstrating the pH-responsive nature of these delicate architectures. 
Figure 3:  (a) ‘Structural metamorphosis’ of an PDDA/FMOC-AA coacervate droplet (i) into a branched 
star-like architecture (ii) upon addition of GDL. The entanglement the outward-reaching arm-like 
appendages affords the formation of hydrogel (iii). (b) Chemical structures of FMOC-AA, PDDA, GDL 
and GA. (c) Confocal fluorescence microscope (i, iii, iv, vi) and AFM micrographs (ii, v) characterizing 
the transition of PDDA/FMOC-AA coacervate droplets into branched star-like architecture. 
Fluorescence microscope images of PDDA/FMOC-AA coacervate before (iii) and after (iv) addition of 
GDL. (vi) A series of time-resolved fluorescence microscope images monitoring the rapid collapse of 
star-like architecture induced by the addition of sodium hydroxide. Reproduced with permission from 




This study demonstrates that rudimentary aspects of ‘structural metamorphosis’ can be 
integrated into these coacervate-based ‘protocells’, by incorporation of a pH-responsive 
FMOC-AA dipeptide building block. The ‘metamorphosis’ of coacervate droplets (Fig. 3c i, iii) 
into distinct star-like architectures (Fig. 3c ii, iv-v) was shown to be a quasi-reversible process. 
It was not, however, possible to continuously cycle between coacervate (Fig. 3a i) and star-like 
assembly (Fig. 3a ii). If repeated, the outward growth (Fig. 3c iii-iv) and subsequent pH-
triggered collapse (Fig. 3c vi) of the arm-like tendrils would result in the depletion of 
PDDA/FMOC-AA material from the coacervate core, thus precluding an entirely reversible 
‘metamorphosis’ between coacervate (Fig. 3a i) and star-like architectures (Fig. 3a ii). 
Nevertheless, this study is an excellent example of ‘structural metamorphosis’, where the 
transformation is triggered by adjusting protonation state of the pH-responsive building block 
FMOC-AA. This example clearly fits the above definition of structural metamorphosis, as the 
system traverses between two well-defined architectures (Fig. 3a), from the coacervate droplet 
(i) to the star-like structure (ii) without requiring the addition of further components. 
1.2.3. A Dynamic Covalent Example of ‘Structural Metamorphosis’ 
Research from the laboratory of Sijbren Otto has demonstrated8 that shaking a dynamic 
combinatorial library (DCL) (Fig. 4a-b) made from thiol building block 1 gives rise to ‘stacks’ of 
disulfilde macrocycles 16 (c) which were covalently captured by photoirradiation at 365 nm to 
produce polymers of 1 (d). Elongation of macrocycles 16 into fibres/polymers (c) was shown to 
be a mechanosensitive process,9 driven by the formation of weak β-sheet interactions between 
short peptide sidechains (b) located upon building block 1. Fibre growth occurs spontaneously 
in aqueous solution. However, in the absence of mechanical agitation the DCL composition is 
dominated by macrocycles which do not aggregate into polymers; thus, fibre growth is slow 
and cannot reach completion. Shaking the DCL by was shown favour the formation of hexamer 
(16) fibres, which elongate via a chain-growth polymerization process. Shaking breaks the 
growing fibres into fragments, a process which produces new growing ends and accelerates 
the formation of hexamer fibres.9 Fibre growth thus drives the amplification of macrocycle 16 at 
the expense of the other library members, which leads to the complete consumption of 
thiol 1 via re-equilibration of the DCL. Hexamer fibre growth was monitored by cryo-TEM (g) 
and SDS-PAGE (f), revealing that the emergence of polymers of 16 correlated with a change 
in the bulk material properties, observed as a distinct sol-to-gel transition (e). In this elegantly 
designed system, the ‘structural metamorphosis’ of thiol 1 (e) into long fibres (d) relies upon a 
union of weak supramolecular (β-sheet) interactions and stable dynamic covalent (disulfide) 
bonds, between which a powerful synergy exists. In the absence of either of these interactions, 




This system crucially achieves ‘structural metamorphosis’ by exploiting two key phenomena in 
unison: (i) Concentration (b-c) of molecular building blocks (stacking of macrocycles) through 
non-covalent interactions, followed by (ii) covalent crosslinking (c-d) of the stacked macrocycle 
building blocks. Importantly, note that stacked macrocycle oligomers (c) contain intramolecular 
disulfide bonds, whereas after covalent ‘trapping’ by irradiation with UV light (d) these 
oligomers become intermolecularly crosslinked, with disulfide bonds running between 
neighbouring macrocycles in the oligomer assembly. Covalent ‘trapping’ of intramolecularly 
crosslinked macrocycles (c) into intermolecularly crosslinked (d) polymers of thiol building 
block 1 was thus of crucial importance in obtaining mechanically stable oligomer species. 
These features are also shared by the polymer-based ‘structural metamorphosis’ observed by 



















Figure 4: Shaking the dynamic combinatorial library (b) made from dithiol building block 1 (a) in 
aqueous borate buffer (50 mM, pH 8.1) gives rise to stacks of disulfide macrocycles 16 (c), which are 
covalently captured upon photoirradiation (365 nm) to produce polymers of 1 (d). Photographs (e) of 
samples containing predominantly 16 prior to (left) and after (right) 3 days of photoirradiation. (f) SDS-
PAGE analysis of sample of 16 prior to photoirradiation (lane B) and after 1 day (lane C), 2 days (lane 
D) and 3 days (lane E). Lane A shows the standard molecular weight ladder. (g) Cryo-TEM image of a 
sample containing predominantly 16 after 3 days photoirradiation. Reproduced with permission from ref. 




Figure 5: Structurally dynamic polymers (a) and (b) can undergo ‘macroscopic metamorphosis’
through diene displacement reactions (i-v), permitting their transformation between a structurally 
diverse array of different polymer architectures (a-g): Amphiphilic block copolymer (a), segmented 
hyperbranched polymer (b), comb polymer (c, g), hydrophobic block polymer (d, f) and star polymer
(e). Process of ‘macroscopic metamorphosis’ are driven by the difference in thermodynamic stability of 
DA adducts X and Y. Reproduced with permission from ref. 10, copyright of Nature Chemistry 2017. 
1.2.4. Towards ‘Structural Metamorphosis’ within a Polymeric System 
Brent Sumerlin and co-workers first coined the term ‘macromolecular metamorphosis’ in 2017, 
describing10 an intriguing system in which structurally dynamic polymeric building blocks (Fig. 
5a-b) undergo structural reconfiguration through Diels-Alder (DA) type diene displacement 
reactions (Fig. 5, i-v). These reactions facilitate the interconversion of macromolecular building 
blocks between an array of structurally diverse polymer architectures (a-g), in a process which 
is termed ‘macroscopic metamorphosis’. This study exploits a well-established difference in 
the thermodynamic stabilities of diene/dienophile [4+2] cycloaddition adducts11 (Fig. 5, X-Y) to 
induce transformations in the interconnectivity of polymeric building blocks. Anthracene-
maleimide (Anth-Mal) DA cycloaddition adducts (Y) are much more thermodynamically stable 
than the analogous furan-maleimide (Fur-Mal) adducts (X), thus formation of stable Anth-Mal 
adducts provides the driving force for ‘macroscopic metamorphosis’ of polymeric building 
blocks. Addition of anthracene-functionalized polymer building blocks (i-iii) with a range of 
topologies was thus envisaged to induce structural transformation of the amphiphilic block 
copolymer precursor (a) into comb polymer (c), hydrophobic block copolymer (d) or star 
polymer (e) architectures. Similarly, segmented hyperbranched polymer (b) was transformed 


















Diels-Alder adducts can be considered as a dynamic covalent bonds (DCBs),12 thus and have 
been utilized to construct recyclable networks,13 self-healing materials14 and complex polymer 
architectures.15 However, the conditions for formation and cleavage of this ‘reversible’ linkage 
are harsh, with temperatures in excess of 100 °C typically required. Whilst the disassembly of 
architectures c-g should in principle be possible by inducing the retro-DA reaction to 
disconnect the polymer building blocks at very high temperatures, or under mechanochemical 
stress, this reaction was reported to be essentially irreversible on account of the highly stable 
anthracene-maleimide linkage (Y). The ‘macroscopic metamorphoses’ presented in Figure. 5 
are therefore essentially irreversible processes, with no scope to traverse back and forth 
between the various polymer architectures (a-g). Whilst reversibility is not a specific 
requirement for ‘metamorphosis’ (as defined in this thesis), the potential applications of this 
work are restricted by the irreversible nature of the DA chemistry employed, which precludes 
the macroscopic building blocks from being ‘re-processed’ into an array of polymer 
architectures (a-g). Redesigning the existing system such that the building blocks are instead 
connected by dynamic bonds – which can be readily broken or exchanged under ambient 
conditions – would thus address this deficiency. Utilization of dynamic covalent imine, acyl 
hydrazone or oxime bonds, for example, would permit scope for further modification to the 
polymer morphologies by component exchange processes. Moreover, the hydrolysis of acyl 
hydrazone or imine bonds – a processes which is readily achieved under acidic conditions – 
would permit the disassembly of polymer architectures, such that the constituent building 
blocks can be recovered and possibly recycled. 
Whilst Summerlin et al. demonstrated an impressive level of control over the connectivity of 
macroscopic building blocks, the observed changes in polymer topology are not strictly an 
example of ‘structural metamorphosis’ as defined in this thesis, which demands that all 
components necessary for ‘metamorphosis’ are incorporated within the system prior to the 
transformation. The work reported by Summerlin et al. required the addition of external 
anthracene-functionalized polymer components to induce changes in polymer architecture, 
and thus should be considered as a synthetic modification of the existing polymer structure, 
rather than a ‘metamorphosis’. A more elegant system design might be envisaged by 
incorporating all the key components for ‘metamorphosis’ within the polymer scaffolds. In this 
regard, the Fulton research group have recently reported several examples of ‘structural 
metamorphosis’ in polymeric systems that are entirely consistent with this approach, which will 






1.2.5. ‘Structural Metamorphosis’ of Polymeric Nanoparticles 
The transformation of discrete polymeric nanoparticles (Fig. 6, a) into covalently crosslinked 
polymer films (b) was first reported16 by Murray et al., a process that can be considered as a 
‘structural metamorphosis’. In dilute aqueous solution (a) the single-chain polymer 
nanoparticles (SCPNs) feature intramolecular crosslinks (red) which are dynamic covalent acyl 
hydrazone linkages (c). The concentration of SCPNs (i) drives their ‘structural metamorphosis’ 
into a covalently interlocked polymer film (b) in which adjacent chains are now intermolecularly 
crosslinked (purple) with one another. Thus, the ‘structural metamorphosis’ of SCPNs (a) into 
an intermolecularly crosslinked polymer film (b) is a concentration-crosslinking phenomenon 
which in this example, was driven simply by the evaporation of solvent. It has, however, also 
been demonstrated that other strategies for concentrating the dynamic covalent SCPNs, such 
as weak non-covalent interactions between the polymer chains and a complementary surface 








Figure 6: The transformation of discrete polymeric nanoparticles (a) into a covalently crosslinked 
polymer film (b) can be considered as a ‘structural metamorphosis’. The intramolecular crosslinks (red) 
embedded within single chain polymer nanoparticles (SCPNs) (a) are dynamic covalent hydrazone 
linkages (c). Concentration (i) of these SCPNs from dilute aqueous solution, drives the structural re-
arrangement of crosslinks (ii) which in turn leads to the formation of polymer films (b) featuring 




1.2.6. Component Exchange of Hydrazone Crosslinks 
In the above example, ‘structural metamorphosis’ of SCPNs depends crucially upon the 
dynamic nature of the acyl hydrazone linkages embedded within the polymer chains to facilitate 
the transition from intra- to intermolecularly crosslinked polymer architectures. Crucially, acyl 
hydrazone bonds undergo component exchange processes (Fig. 7a) which facilitate the 
‘structural metamorphosis’ of crosslinker residues embedded within the polymer chains. 
Although any dynamic covalent bond could, in principle, have been utilized to facilitate 
‘structural metamorphosis’, the venerable acyl hydrazone linkage was employed on account of 
its proven track record of reliably facilitating component exchange reactions.12a Figure 7b 
illustrates the hydrazone exchange process, within the context of a hypothetical crosslinked 
polymer system, whereby the reaction of Chain A with Chain B leads to the formation of an 
intermolecularly crosslinked polymer aggregate, Complex A/B. Continuation of this exchange 
process leads to the formation of an intermolecularly crosslinked polymer film, in which each 
polymer chain is covalently linked to its neighbours. 
Figure 7: The process of ‘structural metamorphosis’ relies upon the component exchange of acyl
hydrazone crosslinks, a reaction which displays optimal kinetics at pH 4.5. (a) A component exchange 
reaction in which one reaction partner (blue hexagon) displaces another (red triangle) to afford a new 
product species. These reactions are often entirely reversible and at equilibrium are governed by the 
relative thermodynamic stabilities of the products. (b) Chain A and Chain B – each contain a single 
intramolecular crosslink, however hydrazone exchange facilitates the formation of intermolecularly 




1.2.7. Thermally Induced ‘Metamorphosis’ of Polymeric Nanoparticles 
To explore further the concept of ‘structural metamorphosis’ within polymeric systems, 
Whitaker et al. fabricated a novel class of ‘structurally-dynamic’ polymer nanoparticles (NP1-
NP4) (Fig. 9b) which exhibited reversible sol-to-gel transitions (Fig. 9b-c) triggered by adjusting 
their temperature in aqueous solutions.30a The single-chain polymer nanoparticles (NP1-NP4) 
were prepared (Fig. 9a-b) by addition of crosslinker (SD) (i) to linear copolymer scaffolds (P1-
P4) at pH 4.5, thus yielding SCPNs (NP1-NP4) which feature intramolecular dynamic covalent 
acyl hydrazone linkages. The SCPNs (NP1-NP4) were thermo-responsive in nature, and when 
heated above their lower critical solution temperatures (LCSTs), they precipitated from 
aqueous solution (Fig. 9d). 
Figure 8: Collapse of an individual polymer chain into a single-chain polymer nanoparticle (SCPN) 
via various intramolecular crosslinking chemistries: (i) Covalent, (ii) dynamic covalent or (iii) 
supramolecular interactions. Reproduced with permission from ref. 29, copyright of the Chinese 





In this example, the ‘structural metamorphosis’ of SCPNs (NP1 – NP4) into a crosslinked 
hydrogel network was triggered by raising the temperature of the nanoparticle solutions above 
Figure 9: Thermally induced ‘structural metamorphosis’ of single-chain polymer nanoparticles 
(SCPNs) into an intermolecularly crosslinked hydrogel network. (a) Conjugation of polymer chains P1 
– P4 with crosslinker SD to form intramolecularly crosslinked SCPNs (NP1 – NP4) (b) and their 
subsequent reversible transformation into an intermolecularly crosslinked hydrogel (c). (d) In aqueous 





their LCST* (Fig. 9d) at pH 4.5. As anticipated, heating SCPNs above their LCST afforded a 
white precipitate and after 5 min an opaque solid material formed. Vial inversion tests indicated 
that this material possessed hydrogel-like characteristics, which suggests the reorganisation 
of the polymer chains within the nanoparticles from intra- to intermolecularly crosslinked 
architectures. SCPNs are stable for > 24 h in aqueous solution, however beyond this timescale 
evidence of aggregation was observed. Two distinct arguments can be made to rationalize the 
observed transformation of SCPNs (Fig. 9b) into crosslinked hydrogel (c): 
(1) Kinetic Control: The transformation of SCPNs into crosslinked hydrogel is a 
thermodynamically favourable process, but kinetically disfavoured process (Fig. 10a) as the 
intra-to-inter transformation of acyl hydrazone crosslinks does not readily occur in dilute 
aqueous solution. Initially, SCPNs are in dilute aqueous solution and remain ‘trapped’ in a meta-
stable state by a kinetic barrier (i). Heating NP1-NP4 above their LCST affords the precipitation 
of polymer chains, thus concentrating the SCPNs (ii) from aqueous solution and significantly 
lowering the kinetic barrier (iii) for gel formation. The lowering of this kinetic barrier by 
concentration of polymer chains is a crucial step in allowing SCPNs to undergo ‘structural 
metamorphosis’ into crosslinked hydrogel, a more thermodynamically stable state.  
(2) Thermodynamic Control: The relative energies of SCPNs versus the crosslinked 
hydrogel state are directly influenced by the concentration of polymer chains within the 
aqueous solution (Fig. 10b).† In dilute aqueous solution (T < LCST) SCPNs are the most 
thermodynamically favourable state (Fig. 1b, S1), however, heating of polymer solutions above 
their LCST (i) drives the concentration of polymer chains and thus destabilizes SCPNs (S2) 
relative to the hydrogel state (S3). Conversely, cooling of the sample to below the LCST permits 
swelling followed by steady dissolution of the gel (ii), which raises the energy of the hydrogel 
(S4) state relative to that of SCPNs, thus ‘encouraging’ return to the initial state (S1). Such 
processes of reversible phase-separation/polymer dissolution are well known in the literature, 
and with many thermo-responsive polymer systems displaying this behaviour,30b-g it can be 
readily explained within the framework of Flory-Huggins solution theory.30h-j  
Intriguingly, the gelation process was observed to be entirely reversible. Cooling the gel to 
below the LCST regenerated aqueous solutions of NP1-NP4, which indicates that the system 
is likely operating under thermodynamic control (Fig. 10b). The timescale of the reverse 
process, however, was significantly slower than gel formation, with the solid material requiring 
 
* At T < LCST many weak attractive (enthalpically favourable) interactions arise between water and hydrophobic moieties displayed 
upon the polymer scaffold. Heating the system above its LCST provides sufficient thermal energy to break these weak interactions, 
and thus polymer chains are dehydrated through the entropically favoured displacement of water molecules into the bulk solution. 
 
† This argument operates on the assumption that the system is under thermodynamic control, where population of SCPNs 





several days to several months to become fully re-dissolved in aqueous solution, depending 
upon the density of crosslinker units embedded within the polymer scaffold. These 
observations suggest that dissolution of the hydrogel material is limited by slow 
hydrolysis/exchange processes, which are required to break the intermolecular acyl hydrazone 
linkages on the way to re-forming intramolecularly crosslinked SCPNs. The low temperatures 
(T < LCST) required to facilitate gel-to-SCPN transition will also likely contribute to the long 
dissolution times, as low temperatures provide less thermal energy to drive bond-breaking and 
disentanglement of polymer chains from the hydrogel network. 
Figure 10: (a) SCPNs are ‘trapped’ in dilute aqueous solution by a kinetic barrier (i). Concentrating 
SCPNs (ii) from dilute solution, as accomplished in this example by heating polymer solutions above 
their LCST, lowers this kinetic barrier (iii) allowing SCPNs to undergo ‘structural metamorphosis’ into a 
crosslinked hydrogel, a more thermodynamically stable state. (b) The relative thermodynamic stabilities 
of SCPNs versus the hydrogel state are directly influenced by heating/cooling of the sample. Heating of 
polymer solutions to above their LCST drives the concentration of polymer chains and thus destabilizes 
SCPNs relative to the hydrogel state. Conversely, cooling to below the LCST permits swelling followed 





1.2.8. ‘Shrink-Wrapping’ of 2D Surfaces Displaying Carbohydrate Receptors  
Research by the Fulton group has demonstrated16,30 that ‘structural metamorphosis’ of SCPNs 
is triggered by the concentration of polymer chains, either by evaporation of solvent or by 
thermally-induced precipitation of thermo-responsive polymer chains. However, it was 
hypothesized that SCPNs (Fig. 11a) might also be concentrated onto 2D surfaces (b) through 
weak non-covalent interactions (i), thus providing an additional approach to ‘shrink-wrap’ the 
surface within an intermolecularly crosslinked polymer film (d). Work by Mahon et al. recently 
confirmed this hypothesis, demonstrating31 that carbohydrate-decorated glyco-SCPNs 
possess the ability to concentrate themselves through specific molecular-recognition events at 
protein-functionalized surfaces (Fig. 11c), and thus spontaneously crosslink to form an 
intermolecularly crosslinked polymer film (Fig. 11d). 
In order to facilitate the formation of polymer films through specific molecular-recognition 
events two types of glyco-SCPNs were prepared: (i) MAN-SCPNs, whose intramolecularly 
crosslinked polymer backbone is decorated with  mannosyl hydrazide (MAN) residues and (ii) 
GAL-SCPNs, which display galactosyl hydrazide (GAL) residues. Each of the glyco-SCPNs 
was shown to display a high binding affinity for surfaces functionalized with the complementary 
carbohydrate-binding protein (lectin). Surfaces functionalized with the mannose-binding 
protein Concanavalin A (Con. A) (Fig. 12a) were shown bound selectively to MAN-SCPNs, 
whereas surfaces displaying galactose-binding Heat Labile Toxin (LBT) bound selectively to 
GAL-SCPNs. AFM micrographs revealed that exposure of the protein-functionalized surfaces 
to their complementary glyco-SCPNs afforded a dramatic change in surface roughness arising 
on account of polymer film formation (Fig. 13). AFM was employed to monitor film formation 
Figure 11: Addition of carbohydrate ’decorated’ SCPNs (a) to a surface displaying the complementary 
carbohydrate receptor (b) concentrates the SCPNs onto the surface through specific molecular 
recognition events (i). An increase in the localized concentration of SCPNs triggers a structural 
reorganisation (ii) of dynamic covalent crosslinks to form an intermolecularly crosslinked polymer film 
(d) covering the protein-functionalized surface. The ‘structural metamorphosis’ of SCPNs into 





as a function of time, indicating the steady build-up of a glycopolymer film over a 24 h period. 
Control experiments were performed using the non-complementary pairing of (Fig. 12a) MAN-
SCPNs + LBT surface and (Fig. 12b) GAL-SCPNs + Con A surface. In both cases, however, 
formation of the glycopolymer film was not observed, indicating that ‘shrink-wrapping’ of the 
2D surface may only occur when glyco-SCPNs are concentrated through complementary 
molecular recognition events. Further control experiments also revealed that the ‘shrink-
wrapping’ phenomenon was not observed unless the crosslinkers embedded within the glyco-
SCPNs were dynamic covalent in nature. When ‘fixed’ glyco-SCPNs, containing non-dynamic 
(static) crosslinkers were employed, ‘shrink-wrapping’ of the complementary protein-
functionalized surfaces was not observed, emphasizing the importance of hydrazone exchange 
in the ‘shrink-wrapping’ process.  
Figure 12: ‘Shrink-wrapping’ of 2D lectin-functionalized surfaces. (a) Heat labile toxin (LTB) shown with 
five associated galactose residues (blue). (b) Concanavalin A (Con A) shown in its tetrameric form with 
four associated mannose residues (red). LTB- (a, c-d) and Con A-functionalized (b, e-f) surfaces are 
‘wrapped’ by GAL-SCPNs (i) and MAN-SCPNs (ii), respectively. SCPNs possessing intramolecular 
dynamic covalent crosslinks and carbohydrate residues (GAL or MAN) are stable in dilute solution. 
However, a combination of specific molecular recognition events (c and e) and rearrangement of 
dynamic covalent bonds (d and f) allows SCNPs to crosslink into polymer films. Polymer chains bind to 
lectin-functionalized surfaces through specific recognition events (c and e), leading to the concentration 
of SCPNs upon the surface.  Surface-bound SCPNs become spatially closer to one another, thus their 
dynamic covalent intra-molecular crosslinkers undergo component exchange to form inter-chain 
crosslinks. This process is termed ‘shrink-wrapping’ and results in the formation of intermolecularly 




AFM studies (Fig. 13, g-h) revealed that glycopolymer films can be readily removed by addition 
of hydroxylamine solution, which was hypothesized to cleave the inter-chain acyl hydrazone 
crosslinks by formation of the more stable32 oxime-functionalized polymer. Most importantly, 
the results from this investigation constitute firm evidence that the intra-to-intermolecular 
switch in crosslinking is a real phenomenon, which can be exploited to ‘shrink-wrap’ two-
dimensional surfaces. In a natural progression of this work, the chemistry of ‘shrink-wrapping’ 
2D immobilized protein surfaces should now be extended to the encapsulation of three-
dimensional nano-assemblies, such as virus-like particles.  
 
Figure 13: AFM images of 15 x 15 µm regions of streptavidin-coated polystyrene surfaces (a)(d) prior 
to any modification; (b) after functionalization with Con A via biotin-streptavidin linkage; (c) after 
functionalization with Con A and incubation in a solution of SCPN-MAN for 18 h at 5 °C; (e) after 
functionalization with LTB via biotin-streptavidin linkage; (f) after functionalization with LTB and 
incubation in a solution of SCPN-GAL for 18 h at 5 °C. (g-j) AFM images of 15 × 15 µm regions of 
surfaces displaying: (g) polymer film produced by exposure of MAN-SCPNs to a Con A-functionalised 
surface; (h) the same surface after exposure to hydroxylamine; (i) polymer film produced by exposure 
of MAN-SCPNs to a Con A-functionalised surface; (j) the same surface after exposure to methyl α-




1.2.9. ‘Shrink-Wrapping’ of Viruses and Virus-Like Particles 
Viruses, by their very nature, are designed to selectively target and infiltrate host cells with 
efficacies which have been fine-tuned through millions of years of evolution.33 The first step in 
the infection pathway is attachment of the virus to the cell membrane,34 a process which is 
facilitated by specific recognition events between cell-surface glycans and complementary 
carbohydrate receptors displayed on the periphery of the virus. Researchers are, however, still 
working to elucidate the intricate mechanisms by which viruses manage to evade the immune 
defences and facilitate cell entry.35 A significant barrier to understanding these mechanisms 
and designing effective therapies to combat viral pathogens, however, is that the structure and 
composition of viral surfaces are in a constant state of flux. Viral surfaces evolve rapidly, with 
adjustments of their receptor compositions closely mirroring the changes in the glycans 
displayed upon the surface host cell surface that they are known to target. The development 
of technologies for ‘neutralizing’ such dynamic pathogens must therefore be equally as 
‘intelligent’ if they are to have long-term success. One such strategy would be to interface viral 
targets with ‘structurally adaptive’ SCPNs (Fig. 14a) which, upon their binding to receptors 
located upon the viral surface (b), undergo ‘structural metamorphosis’ into an intermolecularly 
crosslinked polymer film (c). This strategy was envisaged to ‘shrink-wrap’ viral capsids within 
a ‘protective’ layer of glycopolymer film (Fig. 14), analogous to capturing the virus in a 
‘molecular net’. It is anticipated that ‘unwrapping’ (iii) of viral capsid could be triggered by the 
application of a specific stimulus, such as a drop in pH or addition of hydroxylamine, to afford 
displacement of acyl hydrazone crosslinks. 
Figure 14: The 'shrink-wrapping' of a viral capsid within an intermolecularly crosslinked polymer film.  
In step (i) single-chain polymer nanoparticles (SCPNs) decorated with carbohydrate residues bind 
selectively to receptors situated on the periphery of the capsid. This process 'concentrates' the SCPNs, 
allowing their dynamic covalent crosslinkers to undergo intra- to inter-chain reorganisation in step (ii), 
resulting in the shrink-wrapping of the capsid within a layer of intermolecularly crosslinked polymer 
chains.  In step (iii) the application of a stimuli such as a drop in pH or increase in redox potential is 




It is hypothesized that ‘shrink-wrapping’ (Fig. 14) will proceed by the selective recognition of 
receptors (i) located upon the viral surface by SCPNs decorated with residues of the 
complementary carbohydrate, followed by the ‘structural metamorphosis’ of dynamic covalent 
crosslinks (ii) amongst neighbouring polymer chains. Initially, progress of the ‘shrink-wrapping’ 
process would be dependent on the formation of specific carbohydrate-virus recognition 
events. These weak supramolecular interactions concentrate SCPNs onto the periphery of the 
capsid, leading to a concentration-crosslinking phenomenon that drives ‘structural 
metamorphosis’ of SCPNs into covalently crosslinked polymer films.  
In summary, the above description highlights that ‘shrink-wrapping’ is indeed a union of 
supramolecular (i) and dynamic covalent (ii) chemistry, both of which are essential to the 
‘wrapping’ process. These two classes of dynamic bond can be judiciously combined and 
embedded within a single polymer chain to afford a class of ‘structurally dynamic’ SCPNs with 
the capacity to undergo ‘structural metamorphosis’. It is hypothesized that ‘metamorphosis’ of 
carbohydrate-decorated SCPNs would facilitate the ‘shrink-wrapping’ of virus-like particles 
displaying the complementary carbohydrate receptor. Initial inspiration for the ‘shrink-
wrapping’ of virus-like particles came from research published by the group of Professor 
George Whitesides,36 which demonstrated the ability of carbohydrate-functionalized 
poly(acrylamides) to inhibit viral surfaces with impressive selectivity (Fig. 15a-c). 
1.2.10.  Inspiration for the ‘Encapsulation’ of Viral Targets 
During the early 1990s the laboratory of Professor George Whitesides investigated the 
inhibition of virus-cell binding by sialic acid (SA) decorated polyacrylamides (Fig. 15a). Their 
work36d identified that the multivalent expression of carbohydrate residues upon a 
glycopolymer scaffold (Fig. 15e) drastically improves the efficacy of the inhibitor compared to 
that of monovalent carbohydrate ligands (Fig. 15d), thus presenting a useful strategy for 
interrupting virus-cell binding to prevent invasion of host cells by influenza virus (Fig. 15a-b). 
The multivalent inhibition (Fig. 15e) of virus-cell interactions by α-sialyl bearing polyacrylamide 
scaffolds arises from two effects: (i) multivalent capping or (ii) steric blocking of the viral surface 
by polymer. A series of carefully designed and rigorously conducted control experiments 
delineated the individual contributions of these two effects, revealing that multivalent capping 
(i) was predominantly responsible for inhibiting carbohydrate receptors displayed on the 
periphery of influenza virus. An ELISA-type assay (Fig. 17a) was developed to quantify the 
strength of the inhibitory effect by measuring the strength of polymer-virus binding. Binding 
was assessed with a comprehensive library of acrylamide-based glycopolymers displaying a 
range of carbohydrate types, carbohydrate densities and molecular weights were explored to 




been reported37 in 1995 that multivalence (cluster glycoside) effects play an important role in 
the strength of virus-cell binding, chemists at the time were only just beginning to realize the 
instrumental importance of multivalency effects, which are now known to have a multitude of 
biological consequences.38 Seminal work by the Whitesides research group demonstrated that 
that multivalent effects can be exploited to disrupt virus-cell interactions, thus inhibiting entry 
of the virus into cell. 
 
 
Figure 15: Possible explanations for the inhibition of attachment of influenza virus particles to sialic acid 
(SA) residues upon the cell surface by SA-polyacrylamide. Influenza virus (a) binds sialic acid residues 
displayed on the surface of cells (b) to induce cell entry (c) and invade the host organism. Inhibition of 
virus-cell interactions prevent influenza from binding the cell surface, thus preventing invasion of the 
host cell. Strategies for inhibiting virus-cell binding: monovalent capping (d) with a small molecule 




In 1996, Whitesides et al. demonstrated36d that carbohydrate-functionalized polyacrylamides 
(Fig. 16a) displaying multiple copies of α-sialoside (SA) bind strongly to the periphery of 
influenza virus (strain A/X-31, H3N2), directly inhibiting the pathogens ability to agglutinate 
Erythrocytes. The efficacy of SA-glycopolymers in inhibiting influenza-erythrocte adhesion was 
related directly to the binding affinity of glycopolymer for the virus surface. Kd values for SA-
functionalized glycopolymers were determined by ELISA sandwich assay (Fig. 17a) and ranged 
from 40 to 4000 nM. ELISA Kd values were shown to reduce upon increasing the molecular 
weight of SA-glycopolymers, thus it was concluded that the strength of polymer-virus binding 
depends critically on (i) the number and (ii) the density of SA residues displayed upon the 
polymer scaffold. The approximate polymer-capsid binding stoichiometries were determined 
accurately by a modified ELISA experiment in which SA-glycopolymers were labelled with 
fluorescein dye. Remarkably, ELISA revealed that only a very low number of glycopolymer 
chains were required to inhibit the hemagglutination caused by the viral capsid. A polymer with 
a chain length of 1000 monomer units (MW ≈ 140 kDa), required only 30 polymer chains per 
viral particle to display inhibition. It was also demonstrated that the mass of polymer bound to 
the virus surface was independent of the chain length, once a critical number of carbohydrate 
residues were displayed by the polymer chain. These observations confirm that glycopolymers 
displaying the appropriate carbohydrate residues may concentrate themselves onto viral 
capsids through specific molecular recognition events. It is thus hypothesized that ‘shrink-
wrapping’ with carbohydrate-bearing SCPNs may present a viable strategy for the 
encapsulation of viral substrates. 
Figure 16: (a) Preparation of α-sialyl-functionalized polyacrylamide, a polyvalent inhibitor of influenza 
virus A/X-31 (H3N2). (b) Volume restriction and loss of water (W) from a sterically stabilized viral particle 
on approach of a red blood cell. Both changes are associated with unfavourable energy terms due to 
losses of both conformational entropy and favourable water-polymer interactions. Reproduced with 




Lying at the vanguard of viral surface engineering and neoglycoconjugate chemistry, these 
seminal studies directly supported the hypothesis that multi-valency effects are crucial in 
mediating strong carbohydrate-protein recognition events between glycopolymers and 
receptors displayed upon the periphery of the virus. Of crucial importance to these 
investigations were: (i) The development of an ELISA assay (Fig. 17a) which estimated the 
affinity of SA-functionalized glycopolymer to the viral surface, and (ii) the utility of TEM imaging 
(Fig. 17b) to visualize the attachment of glycopolymers to the viral surface (Fig. 17b). In 
combination these two techniques provided a strong characterization handle with which the 
nature of virus-polymer interactions could be thoroughly interrogated. 
 
Figure 17: (a) ELISA-type assay for measuring the binding of biotin-labelled polymer-bearing sialic 
acid (SA) groups to the influenza virus. (b) Colloidal gold-labelled SA-functionalized polyacrylamide 
binding to influenza virus. (c-e) TEM micrographs showing gold-labelled polymer adhered to the 
periphery of influenza virus. Polymer-bound virus was labelled with streptavidin-coated colloidal gold
and dark spots were observed around the periphery of the viral particles. Adsorbed polymer-virus 
complexes were stained with uranyl acetate negative stain prior to TEM. Scale bars all indicate 100 nm.




1.2.11.  Catching a Virus in a Molecular Net 
Virus-like particles have played an important role in vacine development.39a,b However, viral 
capsids are often susceptible to degradation upon exposure to elevated temperatures or 
dehydrating conditions.39c Recent advances in virus engineering have demonstrated that virus-
like particles can be protected from their external environment by covalent modification of the 
capsid exterior. In 2016, Delalande et al. reported39d the capture of brome mosaic virus (BMV) 
within a ‘molecular net’ (Fig. 18, a). The metal-organic net was constructed around BMV, a 
small non-enveloped icosahedral virus, by the coordination of tannic acid (TA) with iron (III) 
(Fig. 18, b-c) to determine whether the net could act as a transport barrier for water. It was 
anticipated that the thin virus-bound  layer of Fe3+/TA coordination polymer would maintain a 
hydrated environment around the virus, thus stabilizing BMV against disassembly in physically 
or chemically challenging environments. Reported characterization was consistent with a thin 
virus-adsorbed layer of TA/Fe3+, which was obtained by treating BMV with FeCl3 (Fig. 18a, i), 
removing the non-surface-bound Fe3+ ions, then adding TA crosslinker (ii) to obtain the 
molecular net architecture. This modified protocol was necessary to ensure that Fe3+/TA 
coordination was localized to the virus surface and did not occur in the bulk solution, which 
was shown to lead to large crosslinked aggregates containing multiple virus particles buried 
within a thick layer of Fe3+/TA.  
AFM analysis and negative-stain TEM images revealed that TA/Fe3+ coated virus (Coated 
BMV) featured remarkable stability against capsid disassembly in aqueous buffer (Fig. 19a, c) 
or by exposure to dehydrating conditions (Fig. 19b-c) and thus negligible size decreases were 
Figure 18: Catching a virus in a molecular net. (a) Overview of ‘coating’ BMV capsid with a crosslinked 
layer of tannic acid/Fe3+ coordination polymer. Structures of tannic acid, TA (b) and TA/Fe3+ 





observed by AFM (Fig. 19, h-i), whereas the unmodified virus (Naked BMV) was readily 
denatured, as evidenced by a collapse in the particle height by AFM (Fig. 19, g, k). Further 
experiments demonstrated that Coated BMV was stable for up to four weeks at pH 4.6 and 
low salt concentrations, as was evidenced by the negligible change in its electrophoretic 
mobility from one week to another. AFM analysis revealed that after storing Coated BMV in air 
for one year the virus remained remarkably intact, suggesting that the virus-adsorbed TA/Fe3+ 
layer is highly effective in maintaining the native hydration state around the virus, thus 
protecting it against harsh external environments, even over relatively long timescales. Note 
that these studies remain distinct from the concept of ‘shrink-wrapping’, as preparation of the 
virus-adsorbed TA/Fe3+ layer required the addition of external tannic acid crosslinker to obtain 
metal-ligand coordination network around the viral surface. This work highlights, however, the 
considerable potential of chemical approaches in stabilizing viral capsids, preventing their 
degradation, improving their shelf lives, and possibly circumnavigating their requirement for 
cold storage. 
Figure 19: Experimental results demonstrating that a virus-adsorbed layer of TA/Fe3+ protects the 
encapsulated BMV capsids against disassembly in aqueous buffer or by exposure to dehydrating 
conditions. (A) TEM images of: Naked BMV capsids (a), Coated BMV capsids (b) and Coated BMV 
capsids after 48 h incubation in disassembly buffer (c). Representative AFM micrographs (B) and height 
histograms (C) for Coated BMV and Naked BMV in water and in air, after drying. Reproduced with 





Inspired by stimuli-responsive behaviour observed in nature, chemists have sought to 
incorporate rudimentary aspects of intelligence within simple molecular,40 supramolecular,8 
polymer systems10,30,31 and produce ‘smart’ materials7 which adapt to changes in their external 
environment. Review of this literature revealed surprisingly few examples of ‘structural 
metamorphosis’, an intriguing process in which ‘structurally adaptive’ systems traverse from 
one discrete molecular, macromolecular, or supramolecular architecture to another. This 
thesis was inspired by the emergence of this novel phenomenon and reports a strategy by 
which ‘structural metamorphosis’ of SCPNs might be exploited to drive the ‘shrink-wrapping’ 
of virus-like particles and other biologically relevant targets. Whilst ‘metamorphosis’ appears 
to be a thermodynamically favourable process, observations suggest that meta-stable SCPNs 
architectures may remain ‘kinetically trapped’ as discrete polymer chains in dilute aqueous 
solution. Early investigations have demonstrated30,31 that weak supramolecular interactions 
concentrate SCPNs, thereby triggering their ‘metamorphosis’ into polymer films. Furthering 
this work, it is anticipated that carbohydrate-receptor recognition events may drive the ‘shrink-
wrapping’ of virus-like particles by triggering film formation upon the viral surface. It is 
hypothesized that ‘shrink-wrapping’ will protect the virus from its external environment and 
may present a strategy to engineer viral surfaces without requirement for covalent modification 
of the capsid. ‘Shrink-wrapping’ may also be utilized to ‘capture’ and ‘neutralize’ harmful 
pathogens within a polymer ‘net’. Many bacterial and viral pathogens rely upon carbohydrate-
receptor interactions to facilitate cell entry,38 thus the presence of a ‘shrink-wrap’ layer is 
anticipated to mask carbohydrate-receptors displayed upon the antigen surface, thereby 
inhibiting cell entry. Development of the ‘shrink-wrapping’ concept is fundamentally a 
supramolecular chemistry project, in which utility structurally adaptive polymer architectures 
shall be explored. Progress towards the ambitious goal of ‘shrink-wrapping’ viral capsids will 
be incremental, gradually developing this novel concept by ‘wrapping’ biological targets of 











1.4. Proposed Approach 
Research towards the ‘shrink-wrapping’ of complex biological targets such as ‘native’ influenza 
virus or E. Coli will follow a stepwise approach, steadily progressing the ‘shrink-wrapping’ 
concept to systems of increasing complexity (Fig. 20a-d). Investigations in this thesis began 
with Model System I (a) (Chapter 2) where electrostatically charged SCPNs were employed 
to ‘shrink-wrap’ negatively charged polystyrene nano- and microspheres. In these studies, it 
was hypothesized that simple electrostatic interactions drive the concentration aspect of the 
‘shrink-wrapping’ process. In Model System II (b) (Chapter 3) specific molecular recognition 
events drive ‘shrink-wrapping’ by concentrating mannose-decorated glyco-SCPNs onto the 
periphery of protein-functionalized silica microparticles which display the complementary 
mannose receptor. Investigations towards the ‘shrink-wrapping’ of virus-like particles (c) were 
reported in Chapter 4, which details the synthesis of GM1-functionalized glycopolymers for 
binding to Simian Virus 40 (SV40), a small non-enveloped icosahedral viral capsid. Many such 
biomacromolecules display optimum stability at pH 7.4, yet acidic conditions (pH 4.5) are 
required to facilitate successful ‘shrink-wrapping’. To address this limitation and improve 
biocompatibility of the ‘wrapping’ approach, Chapter 5 investigates rate-enhancing structural 
features which facilitate rapid hydrazone exchange at neutral pH (e). Inclusion of these moieties 
upon polymer scaffolds is thus anticipated to yield next-generation polymer ‘wrapping agents’ 
which ‘shrink-wrap’ complex biological targets at physiological pH (f). 
Figure 20: Research strategy for progressing the ‘shrink-wrapping’ concept towards biological targets of 
increasing complexity. (a) Model System I: Electrostatically charged SCPNs were adsorbed onto 
oppositely charged polystyrene nano- or microspheres. Electrostatic interactions drive the ‘shrink-
wrapping’ process. (b) Model System II: Protein-functionalized silica nano- and microspheres displaying 
mannose-binding receptors were ‘shrink-wrapped’ with mannose-decorated SCPNs. (c) Virus-Like 
Particles: Investigations towards the ‘shrink-wrapping’ Simian virus 40 viral capsid. (d) ‘Shrink-wrapping’ 
of ‘native’ viruses such as influenza, or pathogenic bacteria such as E. Coli. (e) Rate-enhancing structural 
features (A) facilitate rapid hydrazine exchange at neutral pH, and thus their inclusion upon polymer 
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2.1.  Abstract 
This chapter explores the ‘shrink-wrapping’ of electrostatically charged 3D nanoscale objects 
within dynamic covalent polyelectrolyte films. The incorporation of acyl hydrazone covalent 
crosslinks within these polyelectrolyte films was anticipated to impart additional stability to the 
adsorbed polymer, beyond that observed for the corresponding non-crosslinked 
polyelectrolyte layer. Experiments began with the ‘shrink-wrapping’ of Simian Virus 40 (SV40), 
a small icosahedral DNA tumour virus which displays a net negative surface charge upon the 
capsid exterior. Single-chain polymer nanoparticles (SCPNs) were engineered to display the 
complementary positively charged quaternary ammonium appendages upon their surfaces. It 
was hypothesized that favourable electrostatic polymer-virus interactions would thus 
concentrate SCPN chains onto the viral surface, and then drive ‘shrink-wrapping of SV40 
capsid. Dynamic light scattering (DLS) and zeta potential measurements were employed to 
monitor the ‘wrapping’ process, and fluorescence titration experiments provided fundamental 
insights regarding the nature of the interaction between polymer and capsid. To further explore 
‘shrink-wrapping’ of electrostatically charged nanoscale objects, ‘wrapping’ experiments were 
conducted with a basic model system (Model System I) based upon sulfonate-functionalized 
polystyrene nanoparticles. Time-resolved DLS experiments were employed to monitor the 
adsorption of polyelectrolyte layers onto the periphery of the colloidal particles, which revealed 
a subtle increase hydrodynamic diameter of 10 – 30 nm, consistent with the formation of thin 
(5 – 15 nm) adsorbed polymer coating. This observation was corroborated by TEM (polymer 
coating  4 nm) and zeta potential measurements, which revealed an increase in positive 
charge at the polystyrene surface that correlated with the administered Polymer Dose (PD). 
Upon addition of excess polycation, a complete surface-charge reversal was achieved, thus 
affording ‘wrapped’ polystyrene nanoparticles with good colloidal stability on account of their 
net positive charge. Control experiments were then undertaken to demonstrate the 
intermolecularly crosslinked nature of surface-bound polymer ‘wrapping’, by attempting to 
displace non-crosslinked polymer layers. These studies revealed that that the adsorption of 
‘hard’ polyelectrolytes onto colloidal particles is an essentially irreversible process, a result 
which posed a significant challenge to experiments designed to demonstrate the 
intermolecularly crosslinked nature of the adsorbed polymer films. To circumnavigate the 
issues of irreversible polymer-particle binding, ‘wrapping’ experiments were conducted with 
‘soft’ polyelectrolytes, the deprotonation of which permitted the displacement of the now 
charge-neutral polymer layer from the particle surface. These experiments produced 
encouraging results which support the hypothesis that nano- and microscale objects were 
successfully ‘shrink-wrapped’, however additional work is needed to adapt this strategy to the 





In recent years, the rapid formulation of novel vaccines has strongly benefitted from the 
development of virus-like particles (VLPs) for use as non-infectious virus alternatives, which 
lack all harmful genetic information but still retain the same protein surface structure and 
identical immunogenic properties to the naturally-occurring infectious virus.1 A great limitation, 
however, is that viral capsids are delicate self-assembled protein structures which may suffer 
severe physical instability when placed in environments outside of physiological conditions.2 
Exposure to high temperatures and dehydrating conditions results in the eventual denaturing 
of proteins, rapidly followed by disassembly of the viral capsid. 2 By constructing a robust 
synthetic polymer ‘wrapping’ it is anticipated that VLPs can be protected from ‘harsh’ external 
environments, which may prevent their degradation and possibly even eliminate the 
requirement for cold transport and storage, two factors which add significant cost to 
vaccination programs in developing nations. Successful ‘shrink-wrapping’ of viral capsid also 
presents exciting opportunities in targeted-drug delivery, where VLPs have become 
increasingly popular vehicles3 for controlled-release on account of their uniform nanoscale 
size, well-defined surface structures, ease of fabrication and accessible chemical modification.4 
Recent literature reports encapsulation of pharmaceutical compounds within the capsid 
(vector) interior, followed by molecular recognition of its outer surface to ‘concentrate’ the 
release of the drug at a target cell.5 ‘Shrink-wrapping’ thus presents a potential strategy to 
engineer viral surfaces, for example to introduce drug-delivery markers onto the capsid 
exterior, without requiring direct covalent modification of the virus proteins. Furthermore, in 
drug-delivery applications the presence of ‘foreign’ capsid within the body often provokes an 
immune-response, resulting in the reduced bioavailability of the drug. It is also hypothesized 
that development of an effective mechanism for on-demand ‘wrapping’ and ‘unwrapping’ of 
the capsid could mask the viral surface from the immune system, thus may offer scope to 
control the rate of cargo release and minimize any undesirable immune-response.6 This 
chapter reports studies on the ‘shrink-wrapping’ of a virus-like particle (Simian Virus 40) and a 
VLP model system (Model System I) based on polystyrene-sulfonate nanoparticles (sNPs), 






2.3. Results and Discussion 
2.3.1.   Synthesis and Characterization of Aldehyde Polymer Scaffold 
Aldehyde acrylamide monomer M1 (Fig. 1a) was synthesized in four steps and isolated as a 
white solid (3.05 g, 43 % overall yield). Monomer M1 was prepared (Fig. 1a) by treatment of 4-
4-carboxybenzaldehyde with trimethylorthoformate in acidic methanol (i) affording the acetal-
protected intermediate 1. The methyl ester of 1 was subjected to aminolysis with a large excess 
of 1,2-ethylenediame (ii) to furnish intermediate 2. Following purification by column 
chromatography, the primary amine group of 2 was acetylated by dropwise addition of acryloyl 
chloride to yield the acrylamide 3. Treatment of 3 with 2 M HCl afforded monomer M1, which 
was isolated by column chromatography. The assigned 1H NMR spectrum of M1 (Fig. 1b) 
matched the expected structure and was enitrely consistent with the literature reports.7  
Figure 1: (a) Synthesis of aldehyde acrylamide monomer M1. Step (i) CH(OMe)3, H2SO4, MeOH, reflux, 
18 h. Step (ii) 1,2-ethylenediamine, reflux, 48 h. Step (iii) acryloyl chloride, Et3N, CH2Cl2, 0 o, 18 h. Step 
(iv) 50:50 Acetone:2M HCl(aq). (b) 1H NMR spectrum (d6-DMSO, 400 MHz) of monomer M1, with 




Aldehyde-functionalized scaffold (P1) was prepared (Fig. 2a) by reversible addition-
fragmentation chain-transfer (RAFT)8 copolymerization of aldehyde monomer M1 with N, N-
dimethylacrylamide (DMA), a comonomer selected to impart aqueous solubility to the resulting 
polymer scaffold. Copolymer P1 was shown by 1H NMR spectroscopy (Fig. 2b) to have a 
degree of polymerization (Dp) of 89, containing approximately 21 aldehyde units (n) and 68 
DMA (m) units, as determined by 1H NMR end group analysis (Fig. 2d). Gel permeation 
chromatography (GPC) analysis of P1* (Fig. 2c) revealed a monomodal distribution of polymers 
with a low PDI of 1.15, indicative of a well-controlled polymerization. 
 
* Molecular weight (MW) of polymer samples were determined by calibration of the GPC instrument with a set of 
near-monodisperse poly(methylmethacrylate) (pMMA) standards. A calibration plot of MW versus retention time 
(RT) was obtained from pMMA standards. Comparison of the retention time at the polymer peak maximum (RTmax) 
to the RT versus MW calibration plot allowed for the MW of the polymer sample to be deduced. Whilst this is method 
Figure 2: Synthesis and characterization of aldehyde-functionalized polymer scaffold P1 (a) RAFT 
copolymerization of aldehyde monomer M1 and N,N-dimethylacrylamide (DMA) affording aldehyde 
copolymer P1. (b-c) Characterization of aldehyde scaffold P1 by 1H NMR (CDCl3, 300 MHz) spectroscopy 
(b) and GPC analysis (c). (d) Table of characterization data of P1 by 1H NMR spectroscopy (i) and GPC 




2.3.2.   Synthesis of Hydrazide Residues 
Hydrazide residues R2-R5 were prepared according Scheme 1, and hydrazide R1 (Girard’s 
Reagent T) is commercially available. Dansyl hydrazide R3 was synthesized by Dr Clare 
Mahon.9a See experiment section for full synthetic protocols, characterization and 1H NMR data. 
Sulfonate residue R2 was prepared as previously reported,9a whilst morpholine hydrazide (R5) 
was prepared9b (Scheme 1, step vii) by hydrazinolysis of ethyl ester 8 and isolated in an 89 % 
yield. After workup R5 was characterized by 1H NMR spectroscopy and used without further 
purification. Ferrocene hydrazide R4 was prepared by a modified literature protocol,10 as it 
could not be prepared by hydrazinolysis of the corresponding methyl ester (see page 87). 
 
of analysis yields only an approximate molecular weight, these values were entirely consistent with MWs deduced 
by 1H NMR end group analysis, indicating a good level of accuracy in MW determination 
Scheme 1: Synthesis of hydrazide residues (R2 - R5) used for the preparation of polyelectrolyte 
scaffolds. Step (i) K2SO3, H2O, reflux, 8 h. Step (ii) N2H4.H2O, MeOH, reflux 16 h. Step (iii) Et3N, CH2Cl2, 
rt, 24 h. (iv) NH2NH2.H2O, MeOH, rt, 18 h. Step (v) tert-Butylcarbazate, EDC, CH2Cl2, rt, 18 h. Step (vi) 




2.3.3.   Preparation of Dynamic Covalent Polyelectrolytes 
‘Hard’ polyelectrolytes† (P2 - P3) were prepared (Fig. 3) by grafting hydrazide residues (R1/R2) 
onto aldehyde scaffold P1. Aldehyde groups displayed along P1 were ‘decorated’ with 
sulfonate residue (R2) (Fig. 3a) and Girard’s reagent T (R1) (Fig. 3b), to afford linear polyanion 
P2 and linear polycation P3, respectively.‡ ‘Unbound’ hydrazide residues and other non-solvent 
contaminants were removed from the ‘decorated’ polymer scaffolds by dialysis against water. 
Subsequent lyophilization afforded the charged polymers (P2 - P3) as low-density solids which 
were characterized by 1H NMR spectroscopy (Fig. 4a-b).  
 
† A polyelectrolyte is defined as a polymer chain which displays multiple electrostatic charges. ‘Hard’ 
polyelectrolytes are polymers which display multiple electrostatically charged groups which cannot be readily 
neutralized by protonation or deprotonation. Sulfonate (SO3-)-functionalized polymers (P2) are thus ‘hard’ 
polyanions and quaternary ammonium (NMe3+)-functionalized polymers (P3 - P5) are ‘hard’ polycations. 
 
‡ Condensation reaction between polyaldehyde scaffold P1 and hydrazides (R1 - R2) was quantitative in aqueous 
solution, with formation of the thermodynamically stable hydrazone bond (Fig. 3c) being fast under mildly acidic 
conditions. 
 
Figure 3: Preparation of ‘hard’ polyelectrolytes (P2-P5). (a-b) Decoration of aldehyde scaffold P1 with 
hydrazide residues (R1-R2) to afforded hydrazone-functionalized polymers (P2/P3) with pendant 
charged groups (c). Cationic polyelectrolyte P3 (b) was further labelled (d) with dansyl hydrazide (R3) 
and ferrocene hydrazide (R4) (e) to afford P4/P5, which could be visualized by fluorescence microscopy 




1H NMR spectra (Fig. 4a-b) of polyanion P2 and polycation P3 revealed complete 
disappearance of the aldehyde signal (δ 10.04 ppm) and the concomitant emergence of 
hydrazone C-H signals (orange) at δ 8 – 10 ppm. Multiple resonances were observed for the 
hydrazone C-H environment on account of hindered rotation about the amide bond, giving rise 
to syn/anti isomerization, consistent with previous literature reports.11 These observations 
demonstrate aldehyde scaffold P1 was completely ‘decorated’ with hydrazides R1/R2 to afford 
the corresponding hydrazone-functionalized polyelectrolytes P2/P3, which display 21 sulfonate 
and quaternary ammonium residues, respectively. 1H NMR spectra obtained after purification 
of P2/P3 by dialysis, confirmed that these polyelectrolytes were essentially free of small 
molecule impurities. 
Figure 4: Assigned 1H NMR spectra (400 MHz, D2O) of linear polyanion P2 (a) and linear polycation P3 




2.3.4.   Synthesis and Characterization of ‘Soft’ Polycation 
‘Soft’ polycation P7§ bearing pendant morpholine moieties was prepared by ‘decoration’ of 
aldehyde scaffold P6 with morpholine hydrazide R5 (Fig. 5a). Aldehyde-functionalized scaffold 
P6 (Fig. 5b) is a highly water-soluble poly(ethylene glycol)acrylate-based polymer, the 
synthesis and characterization of which is discussed in Chapter 3.  
1H NMR spectroscopy (Fig. 5c) was employed to monitor the reaction of morpholine hydrazide 
R5 with aldehyde scaffold P6, with complete disappearance of the ‘diagnostic’ aldehyde signal 
at ~ 10 ppm (Fig. 5c, iii) revealing complete ‘decoration’ of all 29 aldehyde moieties upon P6 
with R5. Figure 5c, iii shows the 1H NMR spectrum of P7 after its purification by dialysis. 
 
 
§ P7 is classed as a ‘soft’ polycation, as the electrostatically charged morpholine appendages can be readily 
protonated/deprotonated by adjusting the pH of solution. 
Figure 5: (a) Preparation of morpholine-functionalized ‘soft’ polyelectrolyte (P7) by grafting of 
morpholine hydrazide (R5) onto aldehyde scaffold P6. P6 (b) is a poly(ethyleneglycol)acrylate-based 
aldehyde copolymer. (c) 1H NMR spectra (D2O, 300 MHz) of aldehyde scaffold P6 (i), P6 + morpholine 




2.3.5.   Synthesis and Characterization of Polyelectrolyte SCPNs 
Cationic single chain polymer nanoparticles (Cationic SCPNs) displaying ‘hard’ quaternary 
ammonium positive charges were synthesized (Fig. 6a) by intramolecular crosslinking of the 
linear polyelectrolyte chain (P3) with succinic dihydrazide (SD) (i-ii) under high dilution of ≤ 5 
mg/mL. Appropriate conditions for controlled SCPN formation were determined from 
preliminary experiments; dropwise addition of 0.33 mM SD into a fast-stirred aqueous solution 
of P3 (5.00 mg/mL), which afforded ‘dynamic’ Cationic SCPNs (1). Two crosslinker 
stoichiometries were explored; Cationic SCPN-1 (a) and Cationic SCPN-2 (b) which were 
engineered to contain 1 and 2 crosslinks per polymer chain, respectively. The covalent 
crosslinks embedded within these SCPNs were acyl hydrazone linkages (Fig. 6a, iii), the 
dynamic covalent nature of which is key to the concept of ‘structural metamorphosis’.  
Figure 6: Synthesis (a) and characterization (b) of Cationic SCPNs. (a) Addition of 1-2 equivalents of 
succinic dihydrazide (i-ii) induced intra-chain crosslinking of linear polycation P3 to yield Cationic 
SCPNs (1), which contain dynamic covalent acyl hydrazone crosslinks (iii). Chemical reduction (iv) of 
‘dynamic’ Cationic SCPNs afforded ‘fixed’ Cationic SCPNs (2), whose crosslinks were no longer 
dynamic on account of their reduction from acyl hydrazone (a dynamic bond) (ii) to the corresponding 
amine (non-dynamic / fixed) (v). (b) Normalized differential refractive index (dRI) traces revealed a small 
increase in retention time (RT) for Cationic SCPN-1 (purple) and Cationic SCPN-2 (blue) relative to 
that of the linear polycation P3 (red), consistent with chain collapse. (c) Retention times at peak maxima 




To ensure that no unwanted ‘structural metamorphosis’ occurred during their characterization, 
cyanoborohydride reduction (Fig. 6a, iv) of the ‘dynamic’ acyl hydrazone bonds (iii) within the 
SCPNs was employed to chemically ‘fix’ the crosslinks as the corresponding amine (v), thus 
preventing any further structural rearrangement by component exchange. These ‘fixed’ 
Cationic SCPNs (Fig. 6a, 2) were then characterized by GPC (Fig. 6b-c). 
Successful formation of SCPNs was confirmed by GPC analysis (Fig. 6b), which revealed a 
chain collapse consistent with intra-chain crosslinking.12 The GPC traces (Fig. 6b) of Cationic 
SCPN-1 (purple) and Cationic SPCN-2 (blue) – which contain 1 and 2 equivalents of SD, 
respectively – showed a slight increase in retention time (RT) relative to linear polycation (P3) 
(green). Furthermore, GPC traces of Cationic SCPN-1 and Cationic SCPN-2 revealed a 
steady increase in RT as the density of SD crosslinker was increased. These observations were 
entirely consistent with literature,12 which states that the observed increase in RT can be 
rationalized by the formation of intra-chain crosslinks, which cause a collapse of linear polymer 
chain (Fig. 7), thus reducing the hydrodynamic radius (Rh) and increasing the time to be eluted 









Figure 7: Chain collapse upon formation of SCPNs. Increasing the density of intra-chain crosslinks 




Morpholine SCPNs were prepared (Fig. 8a) by intramolecular crosslinking of morpholine-
functionalized scaffold P7 with 1 equivalent of succinic dihydrazide under high dilution (5 
mg/mL P7). Chemical reduction of ‘dynamic’ Morpholine SCPNs (i) with sodium 
cyanoborohydride afforded ‘fixed’ Morpholine SCPNs (ii), which were characterized by GPC 
(Fig. 8b). GPC of Morpholine SCPNs (red GPC trace) revealed the anticipated increase in 
RT, relative the linear polymer chain P7, which was consistent with the formation of 





Figure 8: (a) Preparation of Morpholine SCPNs (i) by intramolecular crosslinking of linear 
morpholine scaffold P7 (ii) with succinic dihydrazide under high dilution. (b) GPC characterization 




2.3.6.   ‘Shrink-Wrapping’ Studies with SV40 Viral Capsid 
To address the objective of developing a polymer ‘wrap’ for virus-like particles (VLPs), initial 
work focussed on ‘wrapping’ samples of SV40 viral capsid. The SV40 VLPs were produced in 
the laboratory of Prof. W. B. Turnbull at the University of Leeds by recombinant expression of 
the major capsid protein (VP1) from E. Coli. Dialysis of VP1 pentamer (Fig. 9b) against 
increasing concentrations of ammonium sulfate afforded successful assembly of the complete 
SV40 viral capsid (Fig. 9a), which was confirmed by TEM (Fig. 9d) and DLS analysis (Fig. 10). 
The icosahedral viral capsid of SV40 (Fig. 9a) is a spherical protein assembly whose outer shell 
is comprised of 72 pentamer subunits (360 copies of VP1 total), which are connected 
predominantly through disulfide linkages and calcium-mediated interactions,13 to afford a 
‘hollow’ football-like structure with an external diameter ≈ 50 nm.14 
SV40 capsid was characterized by dynamic light scattering (DLS) (Fig. 10a-d, f) and zeta 
potential (ZP) (Fig. 10e) measurements. ZP measurements revealed that the capsid possessed 
a net negative surface charge (ZP = - 34 ± 3 mV) at neutral pH, consistent with the reported 
electrostatic surface (Fig. 9b) and ZP values reported 15 for the major capsid protein (VP1), 
which was ZPVP1 = - 15 mV at neutral pH. This result suggests moderate stability against the 
aggregation of viral capsids in aqueous solution, on account of significant electrostatic 
repulsion between approaching particles. Importantly, the negative surface charge implies that 
the SV40 viral capsid would interact favourably with polycations at neutral pH. Strong 
electrostatic interactions between Cationic SCPN-1 and viral capsid are crucial, as this binding 
provides a driving force for the for the concentration of Cationic SCPN-1 chains upon the 
capsid surface (Fig. 11b) and their subsequent ‘metamorphosis’ into an intermolecularly 
crosslinked polyelectrolyte film. 
Figure 9: (a) The cryoEM-derived structure (PDB entry: 1sva) of SV40 viral capsid (ribbon 
representation) and its associated electrostatic charge map (c). Positive and negative charges are 
shown in red and blue, respectively. SV40 is assembled from pentamers of VP1 (c), the major capsid 
protein. (d) TEM micrograph of assembled SV40 capsids stained with uranyl acetate contrast agent, 





On account of the reported14 50 nm diameter of SV40 virus, it was strongly anticipated that the 
capsid would have a hydrodynamic diameter of 50 – 65 nm. Whilst DLS (Fig. 10c-d) 
consistently reported a number-average Dh of 59 ± 6 nm, the z-average and volume-average 
Dh were significantly larger than expected, at 106 and 186 nm, respectively. These observations 
suggest the presence of multi-capsid aggregate species, which may distort the measured 
hydrodynamic diameters (Dh) to larger than expected values,16 in excess of 180 nm. 
Furthermore, DLS reported a PDI of 0.265, considerably higher than what would be expected 
for a mono-disperse sample of viral capsids. 
Figure 10: DLS (a-d) and zeta potential (e) characterization of SV40 viral capsid: (a) Representative 
DLS correlation functions and (b) their associated z-average particle-size distributions (PSDs). (c) PSDs 
derived from the number-average (orange), z-average (blue) and volume-average (grey) data. (d) DLS 
summary table. Zeta potential (e) and DLS (f) of SV40 capsid in the presence (70 mM NaCl) and absence 
of salt. All measurements were made with [capsid] = 1.29 nM in 10 mM TRIS (pH 7.4), 1 mM CaCl2, 0 - 





In the hope of eliminating any capsid aggregation, stability screenings were conducted to 
identify conditions under which the SV40 capsid displayed good colloidal stability, and thus the 
DLS results obtained should be more optimal, with values closer to those expected (Dh ≈ 50 – 
65 nm) for near-monodisperse SV40 VLPs. A range of aqueous buffers types (TRIS, HEPES, 
phosphate), salt compositions and concentrations (0 – 200 mM NaCl) (Fig. 10e-f) were 
explored, and a range of capsid concentrations (0.01 - 120 nM) were investigated. Successive 
filtering/sonication of the sample and addition of SDS surfactant did not yield significant 
improvements to the observed DLS of viral capsid – observations which suggest that the viral 
capsid supplied was slightly polydisperse in nature, perhaps containing partially assembled or 
capsid was progressed to further experimental study, on account of the possibility that the 
adsorption of a virus-bound polyelectrolyte layer might improve the colloidal stability of the 
SV40 and thus supress aggregation, leading to DLS analysis of improved quality. Adsorption 
of polycation (Cationic-SCPN-1) (Fig. 11b, i) onto the periphery of the negatively-charged 
SV40 capsid (Fig. 11b, ii) was monitored by DLS analysis (Fig. 12), which was anticipated to 
reveal a subtle increase in hydrodynamic diameter (Dh) of the ‘coated’ virus (Fig. 11b, v) relative 
to the Dh of ‘naked’ capsid that would be consistent with the formation of a virus-adsorbed 
polyelectrolyte layer of thickness, L (Fig. 11b, v).  
Figure 11: (a) The slightly polydisperse nature of SV40 viral capsid by DLS may be explained by the 
presence of partially formed/fragmented capsids (i) or a range of capsid sizes (ii) within the sample. (b) 
Adsorption (i) of Cationic SCPNs onto negatively-charged (ii) SV40 viral capsid to form a thin 
polyelectrolyte ‘coating’ (iii) within a thin polyelectrolyte layer. Addition of excess Cationic SCPNs (iv) 
was required to obtain SV40 capsid which were fully ‘wrapped’ (v) within a polyelectrolyte layer with 




SV40 viral capsid was ‘wrapped’ (Fig. 11b, i-v) with a polyelectrolyte layer by titrating small 
quantities of Cationic SCPN-1 into a buffered (pH 7.4) solution of SV40 capsid and the 
hydrodynamic diameter (Dh) was monitored by DLS analysis (Fig. 12a, ii). The z-average Dh 
of ‘naked’ viral capsid was reported as 121 ± 5 nm (Fig. 12a, i), whilst the Cationic SCPN-1 
‘wrapped’ capsid had Dh 155 ± 10 nm, thus revealing a 34 nm increase in Dh, consistent with 
the formation of a thin polyelectrolyte layer (17 nm) adsorbed onto the pehiphery of the viral 
capsid. The apparent thickness of this polyelectrolyte layer (L) was calculated by substracting 
the hydrodynamic radius, Rh of the ‘coated’ capsid (77 ± 5 nm) from that of the naked capsid 
(60 ± 2), giving a layer thickness, L of 17 ± 7 nm. 
The titration profiles for the addition of Cationic SCPN-1 into SV40 capsid were obtained by 
DLS (Fig. 12a, ii), where Dh (z-average, volume, number) is plotted as function of the molar 
concentration ratio [polycation]/[capsid] and error bars indicate standard deviation. The 
corresponding polymer layer thickness, L values were calculated and plotted (Fig. 12a, iii) as 
a function of [polycation]/[capsid]. DLS results (Fig. 12a, ii) revealed that the number-average 
Dh showed an average of 67 ± 3 nm over the entire titration profile, indicating a negligible (0 ± 
2 nm) increase in particle size upon increasing the concentration of Cationic SCPN-1 – an 
observation which suggests no polymer is bound upon the periphery of SV40 capsid. The 
Figure 12: (a) DLS characterization of ‘wrapped’ SV40 capsids. [capsid] = 29.3 nM in 7.7 mM TRIS (pH 
7.4), 20 mM NaCl, 1 mM CaCl2. (i) Hydrodynamic diameter (Dh) of ‘naked’ capsid and polyelectrolyte 
‘wrapped’ SV40 capsid ([Polycation]/[Capsid] = 500). (ii) DLS titration profiles for addition of Cationic 
SCPN-1 into SV40 capsid, where Dh of the ‘wrapped’ viral capsids is given as a function of the 
[polycation]/[capsid] ratio. The apparent thickness (L) of the adsorbed polymer layer (iii) was derived 
from changes in the particle diameter (Dh). (iv) Polydispersity index (PDI) versus [Polycation]/[Capsid] 
stoichiometry. Error bars show standard deviation. (b) Addition of Cationic SCPN-1 to viral capsid was 




volume and z-average Dh, however, revealed a significant increase in particle size, especially 
when Cationic SCPN-1 was present in greater than a 600-fold excess relative to the viral 
capsid ([polycation]/[capsid] > 600). At [polycation]/[capsid] ≈ 500 the volume-average Dh was 
129 ± 10 nm, a number which sharply increased to Dh = 162 ± 11 nm at  [polycation]/[capsid] 
≈ 1000, with no evidence of reaching a plateau. The latter Dh value corresponded to a thickness, 
L of 30 nm (Fig. 12a, iii), a number which is significantly larger than expected.** Furthermore, 
the sample polydispersity index (PDI)(Fig. 12a, iv) was observed to dramatically increase at 
[polycation]/[capsid] > 600. These observations, together with an observed decrease in the 
quality of the DLS correlation function, suggests that above [polycation]/[capsid] = 600 the 
particle sizes measured by DLS were significantly distorted by aggregation which leads to 
larger than expected Dh values,16 (Fig. 12a, i-ii) most likely on account of the formation of multi-
particle aggregates (Fig. 12b, iii). DLS results obtained at [polycation]/[capsid] > 600 were thus 
considered unreliable and discounted from the discussion, whilst DLS obtained below 
[polycation]/[capsid] ≈ 600 was considered acceptable, on account of minimal levels of 
aggregation being observed by DLS. Below [polycation]/[capsid] ≈ 600, the ‘coated’ particle 
size (Fig. 12a, ii) was approximately constant, with Dh = 128 ± 6 nm, indicating a polymer layer 
thickness, L ≈ 10 - 15 nm (Fig. 12a, iii).  
Intriguingly, repetition of the above experiment in the absence of 20 mM NaCl – a salt which 
was anticipated to exacerbate aggregation of ‘wrapped’ SV40 capsids in aqueous solution†† – 
afforded slightly inferior DLS results (Fig. 13), with aggregation processes now dominating DLS 
at [polycation]/[capsid] < 250. An extended range of polycation:capsid stoichiometries were 
explored ([polycation]/[capsid] = 0 – 7500 ) to investigate whether a large excess of polycation 
would afford colloidally stable ‘wrapped’ SV40 capsids (Fig. 11b, v). However, it did not. 
Aggregation was still observed and increased scatter (larger error bars) within the DLS 
measurements (Fig. 13a, ii) was significant, particularly upon increasing the concentration of 
Cationic SCPN-1 beyond [polycation]/[capsid] = 1000. It was observed that the addition of 
Cationic-SCPN-1 destabilizes the colloidal suspension of SV40 capsids, thus driving the 
formation of multiparticle aggregates. It was hypothesized that these aggregates form on 
account of ‘patchy’ adsorption of Cationic-SCPN-1 onto the viral surface to afford partially 
‘wrapped’ capsids (Fig. 12b, ii), which display both regions of positive and negative charge and 
thus drive the formation of aggregates containing multiple capsids (Fig. 12b, iii). 
 
** SV40 capsid is a particle with a hydrodynamic diameter, Dh ≈ 60 nm. The adsorption of a 30 nm polycation (P3) 
layer adsorbed onto its surface thus seems unlikely, but not inconceivable. DLS measurements report the 
hydrodynamic diameter. If the polycation-coated SV40 is highly hydrated, this may account for why the DLS-
reported polymer layer thicknesses (L) are ≈ 30 nm at [polycation]/[capsid] = 1000. 
†† The presence of NaCl ‘screens’ electrostatic forces of repulsions between approaching colloidal particles, and 




Finally, a control experiment (Fig. 13b) was conducted, in which small volumes of TRIS buffer 
were titrated into the viral capsid, instead of the Cationic SCPN-1. The titration volumes of the 
control experiment, and thus the concentrations of viral capsid, matched exactly those used in 
the previous titration with Cationic SCPN-1. Although DLS measurements (Fig. 13b, i) 
revealed that the mean particle size (Dh = 196 ± 16 nm),‡‡ was approximately constant over the 
range of capsid concentration employed during the titration experiment, the observed scatter 
in the DLS measurements was significant (± 16 nm), and comparable to the apparent thickness 
of the adsorbed polyelectrolyte layer (10 – 15 nm) deduced from previous DLS experiments 
(Fig. 12a).  
 
‡‡ A large particle size was obtained on account of the low colloidal stability of SV40. Processes of particle-particle 
aggregation have been reported to decrease the reliability of DLS analysis for measuring accurate particle sizes, as 
transiently formed aggregate species distort the measured Dh values to larger than expected values.16 
Figure 13: DLS characterization for titration of Cationic SCPNs into SV40 capsid (a) and control 
experiment (b) in which buffer was titrated in SV40 capsid. [Capsid]init = 29.3 nM in 7.7 mM TRIS (pH 
7.4), 1 mM CaCl2. The apparent hydrodynamic diameter (Dh) of ‘naked’ capsid and polyelectrolyte 
‘coated’ SV40 capsid. (ii) DLS titration profiles for addition of Cationic SCPN-1 into SV40 capsid, where
Dh of the ’coated’ viral capsids is given as a function of the [Polycation]/[Capsid] ratio. The apparent 
thickness (L) of the adsorbed polymer layer (iii) was derived from changes in the particle diameter (Dh). 
(b) Dilution of SV40 capsid in control titration experiment was monitored by DLS, revealing significant 




It was thus concluded that although Cationic SCPN-1 may have been successfully adsorbed 
onto the periphery of SV40 capsid, DLS failed to provide an accurate characterization handle 
for monitoring the ‘shrink-wrapping’ process, largely on account three contributing factors: (1) 
The ‘naked’ SV40 capsid was moderately polydisperse (PDI ≈ 0.30) in nature, leading to 
increased scatter in subsequent DLS measurements. (2) The ‘naked’ capsids lacked colloidal 
stability, leading to larger than expected particle sizes (z-average Dh > 120 nm, whereas Dh ≈ 
50 nm was expected). (3) The adsorption of Cationic SCPN-1 onto the viral capsid modulates 
the colloidal stability of the resulting particle, often giving rise to increased scatter in the 
measured DLS data. In isolation, these factors can be dealt with, however in unison they 
preclude the highly accurate DLS analysis required to rigorously characterize a 5 – 15 nm 
polymer layer attached to the surface of a ≈ 50 nm capsid. 
2.3.7.   Fluorescence Titration Experiments Investigating Electrostatic Binding of 
Polyelectrolytes to SV40 Viral Capsid 
In order to further understand the nature of the interaction between polyelectrolytes and SV40 
capsid, a fluorescence titration experiment was conducted in which three polymers were 
gradually titrated into a solution of the capsid (Fig. 14a): Aldehyde scaffold P1, linear polyanion 
P2 and linear polyanion P3. It was anticipated that only polycation P3 would bind to the 
negatively-charged surface SV40, on account of a complementary electrostatic interaction 
between the two species. In this experiment, the intrinsic emission of tryptophan residues (λem 
= 325 nm) (Fig. 14) located within SV40 capsid proteins was observed by excitation at λex = 
280 nm. Emission quenching (Fig. 14c) was observed as the polymer concentration increased, 
an observation consistent with binding interactions between the polymer and viral capsid 
surface. A steep decrease in the emission intensity of the capsid as polymer is titrated into 
solution, is indicative of stronger binding. It was therefore deduced that the linear polycation 
P3 (Fig. 14c, iii) binds to SV40 more strongly than the aldehyde polymer P1 (Fig. 14c, i), which 
displays a gradual decrease in emission. Weak binding by P1 was expected, as this scaffold 
exhibits little electrostatic attraction to the negatively-charged surface of SV40. The gradual 
emission quenching observed for P1 was rationalized as non-specific binding of aldehyde 
polymer scaffold onto the viral surface. Whilst polycation P3 featured the greatest quenching 
in the emission, the control experiment with negatively-charged P2 also exhibited quenching, 
albeit to a lesser to extent. This surprising result was rationalized by the mixed electrostatic 
nature of the viral capsids surface, which displays both regions of positive and negative charge 




The polymer:capsid binding stoichiometry at saturation was deduced as approximately 1000:1 
for linear polycation (P3), since no further decrease in emission was observed above 
[polycation]/[capsid] ≈ 1000, implying saturation of the viral surface with polymer. Although 
quantitative analysis of polymer-capsid binding would be beneficial, this unfortunately was not 
possible on account of significant scatter in the data set. Careful repetition of anomalous 
measurements did not significantly improve the quality of the dataset. The observed ‘scatter’ 
in the data was attributed to high PDI of the supplied SV40 samples, which were believed to 
contain a partially assembled or fragmented capsids (Fig. 11a, i), leading to error in the 
[polymer]:[capsid] ratio at which saturation was observed.  
Figure 14: (a) Titration of polymers (P1, P2, P3) into an aqueous solution of SV40 viral capsid affords 
emission quenching of surface-bound tryptophan residues on account of polymer-capsid binding. (b) 
Emission spectra show the quenching observed for linear polyaldehyde P1 (i), linear polyanion P2 (ii) 
and linear polycation P3 (iii). (iv) Broad emission peak was observed at λ ≈ 380 nm on account of an 
increasing polymer concentration, where each chain contains ~ 21 aromatic hydrazone units. (c) 
Emission quenching profiles of polymers P1, P2 and P3, where the corrected emission intensity ΔI (see 





Summary of work with SV40 
The process of shrink-wrapping the viral surface of SV40 was studied by zeta potential 
measurements and DLS analysis. A fluorescence spectroscopy titration also revealed that 
‘hard’ polycations bind to the viral capsid surface, presumably through multiple non-specific 
electrostatic interactions. However, despite careful repetition of experimental work, 
quantitative binding analysis could not be obtained on account of inconsistencies observed in 
data observed from all these experiments. These inconsistencies are attributed to a relatively 
high polydispersity of the SV40 samples. In the absence of structurally well-defined SV40 viral 
capsid, and without analytical techniques available which could accurately characterize 
formation of thin polymer films upon the viral surface, an alternative approach was adopted to 
allow the continued development of the ‘shrink-wrapping’ concept.  
2.3.8.   Investigations on the ‘Shrink-Wrapping’ of Polystyrene NPs 
To circumnavigate the issues of sample polydispersity (DLS) found with SV40 viral capsid, the 
‘shrink-wrapping’ of alternative 3D nanoscale objects was explored. Sulfonate-functionalized 
polystyrene latex nanoparticles constitute a good VLP model system on account of their 
commercial availability, their high colloidal stability and extremely monodisperse size 
distributions. DLS revealed that these particles typically had excellent PDI values of < 0.05 and 
(under the appropriate conditions) their hydrodynamic diameters could consistently be 
measured to an accuracy of ± 1 nm, a value which was substantially less than the anticipated 
thickness of the adsorbed polyelectrolyte layers located upon the particle surface. An 
established protocol17 was available for time-resolved dynamic light scattering (TR-DLS) and 
zeta potential (ZP) measurements to monitor the adsorption of ‘hard’ polyelectrolytes (P2, P3 
and Cationic SCPN-1) onto the charged surfaces of polystyrene-sulfonate nanoparticles 
(sNPs). Experiments began with Cationic SCPN-1 (prepared from P3) which was anticipated 
to ‘shrink-wrap’ (Fig. 15a), the polystyrene substrate within an intermolecularly crosslinked 
polyelectrolyte film (Fig. 15d) on account of the ‘structural metamorphosis’ of the dynamic 
covalent acyl hydrazone crosslinks (Fig. 15b-c) embedded within the SCPN architecture. 
Figure 15: An overview of the hypothesized polyelectrolyte film formation upon the surface of 
polystyrene nanoparticles. (a) It is hypothesized that Cationic SCPN-1 chains adsorb onto the 
polystyrene surface and the intra-chain crosslinks ‘reach’ out (b) and react (via hydrazone exchange) 
with ‘neighboring’ polymer chains on the surface (b) or capture SCPNs from solution (c) to form an 




In this experiment, small amounts of Cationic SCPN-1 were titrated (Fig. 16a) to a 1 mg/mL 
suspension (50 mM H4NOAc-AcOH/H2O, pH 4.5) of negatively-charged sNPs and the 
subsequent change in the hydrodynamic diameter (Dh) of the resulting particles was monitored 
as a function of time by TR-DLS (Fig. 16b). Prior to the addition of polymer, the ‘naked’ sNPs 
(Fig. 16b, i) featured a mean size of Dh = 108 ± 2 nm, which remained constant with respect to 
time, indicative of excellent colloidal stability. Upon the addition of Cationic SCPN-1 to the 
sNPs, Dh revealed a step-like increase in particle size (Fig. 16b, blue to orange), from 108 to 
112 nm, which was immediately followed by a stable period in which the Dh of the ‘wrapped’ 
sNPs remained constant with time. These observations were consistent with the rapid 
adsorption of Cationic SCPN-1 onto the periphery of sNPs and suggest that the resulting 
polyelectrolyte ‘wrapped’ particles featured reasonable colloidal stability. 
In subsequent additions of cationic SCPNs further step-like increases in Dh (Fig. 16b-c) were 
observed. Figure 16c gives the mean diameters Dh of the ‘wrapped’ sNPs as a function of 
polymer dose (PD), a mass/mass ratio defined as: 
Polymer Dose (PD) = 
mass of polymer (mg)
mass of polystyrene NPs (g)
   (Eqn. 2) 
The observed increase in particle size (Dh) correlated with the amount of polymer added (Fig. 
16b-c), with a significant (70 nm) increase in particle size at PD = 10 – 100 mg/g (red/yellow). 
Beyond PD = 500 mg/g, further additions of Cationic SCPN-1 did not yield significant increases 
Figure 16: (a) Adsorption of Cationic SCPN-1 chains onto negatively-charged sNPs was monitored by 
TR-DLS. (b) TR-DLS measurements showing the z-average hydrodynamic diameter (Dh) as a function of 
time during the titration of Cationic SCPN-1 into sNPs (1 mg/mL). A range of polymer doses (PD = 0 – 
1000 mg/g) were explored, where polymer dose is defined as the number of mg of polymer per g of 
sNPs. (c) Z-average diameter, Dh as a function of polymer dose. Error bars show standard deviation. (d) 




in particle size, thus indicating that saturation of the sNP surface had likely been achieved. 
Passing the polymer ‘wrapped’ sNPs through a 450 nm filter afforded a notable (79 nm) (Fig. 
16b, ii) decrease in particle size (green to dark blue), an observation that indicated a small 
population of multi-particle aggregates was present within the sample, which distort the 
measured particle sizes towards larger than expected values.16,17 The hydrodynamic thickness 
(L) of the adsorbed polymer layers were calculated, as outlined in earlier discussion, and 
presented as a function of polymer dose (Fig. 16d). The number-average layer thickness L 
(grey)(Fig. 16d) revealed saturation of the sNP surface, with a maximum layer thickness of 30 
nm. In contrast, the z-average data revealed thick polymer layers of > 65 nm, significantly 
thicker than could feasibly adsorb onto a 100 nm particle. These results were rationalized by 
the fact that adsorption of polyelectrolytes onto oppositely-charged colloidal particles (Fig. 17a, 
i) is often accompanied by particle-particle aggregation processes (ii) which distort DLS 
towards larger than expected Dh values (Fig. 17c), thus leading inaccurate determination of the 
hydrodynamic thickness L. Figure 17 shows the difference between a stable (b) and 
aggregating system (c). In the stable system, the measured hydrodynamic diameter rapidly 
reaches a plateau after addition of polymer, which indicates the sample has good colloidal 
stability and so should afford DLS measurements free from the effects of aggregation. Crucially, 
high precision (error < ± 3 nm) Dh measurements were required to accurately determine the 
thickness (L) of the adsorbed polyelectrolyte layer by DLS analysis. 
Figure 17: (a) Adsorption (i) of polyelectrolytes on oppositely charged colloidal particles is often 
accompanied by particle aggregation (ii). Scheme for measurement of the hydrodynamic layer 




In order to more accurately characterize the hydrodynamic thickness of polyelectrolyte films 
present upon the particle surface, further TR-DLS experiments (Fig. 18a) were undertaken in 
which Cationic SCPN-1 was added to aqueous suspensions of sNPs at pH 4.5. A range of 
polymer doses (PD = 0.01 – 5000 mg/g) were investigated. TR-DLS allows for the Dh to be 
monitored as a function of time, and processes of particle-particle aggregation (Fig. 17a, ii) can 
be observed as a steady increase in Dh (Fig. 17c).17 Identifying conditions in which the colloidal 
particles are stable towards aggregation processes allows for the Dh, and thus thickness of the 
particle-bound Cationic SCPN-1 layers to be determined with a high level of accuracy. To 
assist with the accuracy of DLS measurements, a reduced sNP concentration of 0.2 mg/mL 
was employed. This dilute particle concentration was observed to supress the rate of particle-
particle aggregation processes. TR-DLS results were compiled into Figure 18b, which shows 
the hydrodynamic thickness of the Cationic SCPN-1 ‘wrapping’ as a function of polymer dose.  
Figure 18: (a) Representative TR-DLS traces showing the expected increase in hydrodynamic diameter 
Dh upon addition of Cationic SCPN-1 to sNPs, consistent with the formation of an adsorbed 
polyelectrolyte layer upon the particle surface. A range of polymer doses (PD = 0.1 – 2000 mg/g) were 
explored. Measurements of Dh (z-average data shown) were made before (blue circles) and after 
(orange circles) addition of Cationic SCPN-1 to sNPs. (b) Hydrodynamic layer thickness L, given as a 




At PD = 0.1 mg/g (see Fig. 18a, i) negligible increase in particle size was observed, thus the 
deduced hydrodynamic layer thickness, L was zero ± the error associated with the DLS 
measurement. The TR-DLS trace at PD = 50 mg/g (see Fig. 18a, ii) was typical of an 
aggregating system (cf. Fig. 17c), in which the polyelectrolyte-covered particles are close to 
their isoelectric point, thus DLS was dominated by multi-particle agglomerate species. L values 
obtained for PD = 10 – 100 mg/g, were therefore omitted from Figure 18b on account of 
aggregation processes leading to inaccurate measurement of the polymer layer thickness by 
DLS. In contrast, at high polymer doses, PD > 300 mg/g (Fig. 18b) the system was stable 
towards aggregation (cf. Fig. 17b), with TR-DLS revealing an immediate ‘step’ increase in Dh 
upon addition of polyelectrolyte (Fig. 18a, iii), which was consistent with the rapid formation of 
a polyelectrolyte layer and indicates good colloidal stability. Thus, under these conditions 
accurate L values were obtained, indicating that the hydrodynamic layer of Cationic SPCN-1 
on the polystyrene surface was 10 – 15 nm thick, depending on the precise PD used.  
To gain additional insight to the formation of polyelectrolyte films, the zeta potential 
measurements (Fig. 19a) were also obtained, which revealed that the polystyrene substrate 
becomes positively charged as the polymer dose increased, consistent with the formation of a 
thin polyelectrolyte layer adsorbed at the nanoparticle surface. At low polymer doses (PD < 10 
mg/g), the zeta potential remained constant at ZP ≈ - 62 ± 8 mV (Fig. 19a), indicating a strongly 
negative surface charge, very similar to that observed for the ‘naked’ polystyrene particles (ZP 
= - 63 ± 4 mV). These observations were consistent with a partially ‘wrapped’ species (Fig. 19a, 
i), where the number of negative surface charges far exceeds the number of positively charged 
quaternary ammonium groups on the surface-bound polyelectrolyte. At a polymer dose of 30 
– 40 mg/g, the polyelectrolyte ‘coated’ polystyrene particles passed through an isoelectric point 
(IEP) (Fig. 19a) – where the total number of positive charges on the adsorbed polyelectrolytes 
exactly matches the number of negative charges on the particle surface – and with further 
addition of polycation underwent a reversal of the electrostatic charge upon their surface. This 
phenomenon is well known in colloid chemistry, and is commonly observed when multivalent 
ions, such as polycations,  adsorb onto oppositely-charged surfaces.18 When working near the 
IEP (Fig. 19a) particle-particle aggregation presented a significant issue to obtaining reliable 
DLS characterization of the adsorbed polyelectrolyte layer. The particles no longer 
electrostatically repel one another, and thus, poor colloidal stability was observed in the form 
of precipitation (Fig. 19b). By avoiding working near the IEP it was possible to supress these 
aggregation processes and obtain colloidally stable ‘wrapped’ sNP nanoparticles, whose sizes 
could readily be accurately determined by DLS analysis. At PD > 100 mg/g, the particles 
possessed a net positive charge (ZP = ≈ + 35 mV) and their colloidal stability was regained 




(Fig. 19a, iii) is adsorbed onto oppositely-charged surfaces. Consequently, at PD > 300 mg/g, 
the polystyrene surface becomes supersaturated with polyelectrolyte and good colloidal 
stability was achieved. 
 
Figure 19: (a) Plot showing zeta potential of Cationic-SCPN-1 ‘wrapped’ sNPs as a function of polymer 
dose (PD) added. (b) Image showing the loss of colloidal stability near the isoelectric point (IEP), which 




Further TR-DLS measurements were undertaken to investigate the thickness of polyelectrolyte 
layers formed from linear polycation (P3) and linear polyanion (P2), which were adsorbed onto 
polystyrene nanoparticles. Figure 20a-b reveals the hydrodynamic thickness, L of the 
polyelectrolyte layer for Cationic SCPN-1 (red), linear polycation P3 (orange) and linear 
polyanion P2 (blue). It was anticipated that polyanion (P2) would show no increase in particle 
size, on account of the electrostatic repulsion between pendant sulfonate groups on the 
polymer scaffold and the negatively-charged polystyrene surface. Surprisingly, the addition of 
P2 also afforded an increase in Dh, consistent with the adsorption of a 9 nm polyanion (P2) 
layer onto the negatively-charged polystyrene particles. This observation was initially 
rationalized by the presence of electric double layer (Fig. 20c) which effectively ‘screens’ the 
charge-charge repulsion between polyanions and polystyrene nanospheres. Countercations in 
the Stern layer permit the association of polyanion within a loosely bound diffuse layer (DL) 
which surrounds the particle. It was later understood that the adsorption of polyanion P2 onto 
negatively-charged sNPs is an entropically driven process, which will be discussed on page 
61. Figure 21 shows the ZP of polystyrene particles as a function of polymer dose, for Cationic 
SCPN-1 (red), polycation P3 (orange) and polyanion P3 (blue). As anticipated, polyanion P2 
does not afford charge reversal of the particle surface, whereas linear polycation P3 and 
Cationic SCPN-1 do, indicating that sNPs have been ‘coated’/’wrapped’ with a positively 
charged layer of polymer. 
Figure 20: Z-average (a) and number average (b) hydrodynamic thickness (L) of polyelectrolyte layers 
formed by adsorption of Cation SCPN-1 (red), polycation P3 (orange) and polyanion P2 (blue) onto 
sNPs These values were determined by TR-DLS experiments. Error bars indicate standard deviation. (c) 
Electric double layer arrangement of ions surrounding polystyrene colloidal particle. Countercations at
the Stern layer were initially hypothesized to ‘shield’ the negatively-charged polystyrene surface from 




Surprisingly, the addition of polyanion P2 to sNPs revealed a + 46 mV increase in the measured 
zeta potential (Fig. 21a). This observation was consistent with the previous DLS data, and 
indicates that polyanion P2 attaches onto the surface negatively-charged sNPs, and strongly 
suggest that the adsorption of polyelectrolytes is not solely governed by electrostatic 
attractions/repulsions, but was likely a more complex process driven by the entropically 
favourable displacement of counterions from the polystyrene surface to the bulk solution (Fig. 
22).20 The observation that adsorption of polyanion P2 increases the measured ZP from - 66 
mV to - 23 mV (see Fig. 21b) instead of maintaining a constant ZP value close to that of the 
‘naked’ sNPs (ZP ≈ - 66 mV) could be rationalized by partial protonation of dimethylacrylamide 
units located upon the polymer scaffold, which effectively decrease the overall negative charge 
within the adsorbed polyelectrolyte layer.  
Figure 22: Adsorption of a ‘hard’ polyelectrolytes (i) onto the surface of polystyrene-sulfonate 
nanoparticles is an entropically favourable process driven by the displacement (ii) of counterions to the 
bulk solution (iii). 
Figure 21: (a) Zeta potential of sNPs ‘coated’ in linear polyanion P2 (blue), linear polycation P3
(orange), or ‘wrapped’ in Cationic SCPN-1 (red). Error bars show standard deviation. (b) Zeta potential 




Negative-stain transmission electron microscopy (TEM) provided further evidence that sNPs 
were successfully encapsulated within a polyelectrolyte layer (Fig. 23). TEM analysis (Fig. 23f) 
obtained before (orange) and after (blue) the addition of Cationic SCPN-1, revealed a 
significant shift (Δ) in the observed particle size distributions (PSDs), consistent with the 
formation of a thin polyelectrolyte film upon the sNPs surface. Analysis of TEM micrographs 
revealed the average thickness of the polyelectrolyte film was 5 ± 3 nm, consistent with the 
hydrodynamic layer thickness (L) measured by TR-DLS (13 ± 2 nm). Uranyl acetate staining 
allowed for Cationic SCPN-1 to be visualized by TEM (Fig. 23b), where discrete light ‘patches’ 
approximately measuring 15 x 30 nm were observed. These particles were significantly larger 
than expected for individual SCPNs (Dh = 7.7 nm by DLS), thus were likely multi-chain polymer 
aggregates formed by concentrating the Cationic SCPNs onto the TEM grid by slow 
evaporation. TEM micrographs of ‘shrink-wrapped’ sNPs (Fig. 23d) revealed a ‘bumpy’ surface 
morphology compared to the ‘naked’ sNPs (Fig. 23e), which appeared to have ‘smooth’ 
surfaces, observations which further indicate successful ‘wrapping’ of sNPs. Figure 23c-d 
show the ‘wrapped’ sNPs were surrounded by light-coloured patches, consistent with regions 
of ‘unbound’ Cationic SCPN-1, which overlapped more extensively and were less regular in 
Figure 23: TEM images of (a) 100 nm polystyrene nanospheres (sNPs), (b) Cationic SCPN-1, and (c) 
‘shrink-wrapped’ sNPs (PD = 2000 mg/g, Cationic SCPN-1). Magnified TEM image of ‘wrapped’ sNPs
(d) and ‘naked’ sNPs (e). (f) TEM particle size distributions (PSDs) before (orange) and after (blue) 
‘shrink-wrapping’ with Cationic SCPN-1. PSD histograms were obtained by measuring the diameters of 
50 particles, so to produce statistically significant mean values, and revealed a shift (Δ) in the mean 




appearance compared to those seen in Figure 23b, suggesting that the ‘discrete’ Cationic 
SCPN-1 had undergone more widespread ‘shrink-wrapping’ to form an extensively 
intermolecularly crosslinked polymer films. 
Results thus far have successfully demonstrated that Cationic SCPN-1 chains are adsorbed 
onto the periphery of negatively-charged polystyrene nanoparticles. Zeta potential (Fig. 21) 
measurements revealed a strongly positive surface charge (ZP = 35 ± 5 mV) of the Cationic 
SCPN-1 ‘wrapped’ sNPs and DLS analysis (Fig. 20) consistently showed the thickness of the 
Cationic SCPN-1 ‘wrapping’ to be 10 - 15 nm, results which were then further corroborated 
by TEM (Fig. 23). Whilst it is highly likely that sNPs were successfully ‘shrink-wrapped’ within 
a crosslinked polyelectrolyte film (Fig. 23c) after the addition of Cationic SCPN-1, definitive 
proof of the crosslinked nature of this polyelectrolyte film is yet to be demonstrated. Contrary 
to expectations, negligible differences between Cationic SCPN-1 and linear polycation P3 
were observed by DLS and ZP measurements. Addition of Cationic SCPN-1 was anticipated 
to afford thicker polyelectrolyte films upon the particle surface than were linear polycation (P3), 
on account of Cationic SCPN-1 chains having the capacity to ‘grow’ the thickness of the 
adsorbed film through component exchange of the dynamic covalent crosslinkers (Fig. 15b-d). 
DLS, TEM and ZP measurements did not, however, reveal significant differences between 
adsorption of linear (non-crosslinked) polycation P3, which cannot crosslink, and Cationic 
SCPN-1 which does have the capacity to form crosslinks. These observations revealed that 
the ‘structural metamorphosis’ of Cationic SCPN-1 chains into an intermolecularly crosslinked 
polymer film was a subtle process, thus obtaining definitive proof of this process would be 
challenging to elucidate, as will be later discussed on page 65. 
2.3.9.   Triggered ‘Unwrapping’ of Polystyrene Nanoparticles 
DLS, zeta potential and TEM results have confirmed the successful attachment of Cationic 
SCPN-1 chains onto the surface of sNPs. In order to demonstrate reversible and on-demand 
‘un-wrapping’ of this VLP model system, experiments were undertaken to displace the 
Cationic SCPN-1 film to re-expose the underlying substrate. Cationic SCPN-1 ‘wrapped’ 
sNPs were incubated with hydroxylamine (Fig. 24a), followed by centrifugal dialysis to remove 
‘unbound’ polymer chains. Hydroxylamine was anticipated to displace all charged (R1) and 
crosslink (SD) residues from the polymer backbone, in favour of forming the more 
thermodynamically stable21 oxime-functionalized polymer scaffold (Fig. 24a, i). This chemical 
modification breaks the electrostatic attraction between the polymer and polystyrene surface, 
which was anticipated to afford dissociation of the now neutrally charged coating from the 
surface (Fig. 24a, ii). Removal of the polyelectrolyte film was then observed by DLS (Fig. 24b) 




diameter (Fig. 20a) and the corresponding shift in the particle size distribution, whilst the zeta 
potential decreased by 37.5 mV (from ZP ≈ + 27.4, to - 10.1 mV) (Fig. 20c), indicating a 
reduction of positive charge at the polystyrene surface. Figure 20c shows the shift in zeta 
potential distribution, towards but not fully returning to that of the ‘naked’ particle (ZP ≈ - 60 
mV). These results show that a combined approach of hydroxylamine addition, followed by 
centrifugal dialysis afforded partial removal of the polymer coating. With firm evidence of 
particle ‘unwrapping’ in hand, studies were undertaken to demonstrate the Cationic SCPN-1 
chains adsorbed upon the surface of ‘wrapped’ sNPs have in fact formed an intermolecularly 
crosslinked film. This evidence is important in demonstrating that the ‘structural’ 
metamorphosis’ of SCPN chains into crosslinked polymer films has occurred, and thus should 
prove that ‘shrink-wrapping’ can be achieved upon the surface of nanoscale objects. Figure 25 
describes the experiments which were undertaken to investigate the crosslinked nature of 
Cationic SCPN-1 polymer films, and the control experiment (Fig. 25a-c) which should provide 




Figure 24: (a) Addition of hydroxylamine (i) cleaves hydrazide residues from the polymer scaffold, in 
favour of forming the more hydrolytically stable oxime polymer (ii), which is charge neutral, thus 
anticipated to dissociate from the polystyrene (sNP) surface. (a) TR-DLS before (orange) and after 
(blue) removal of coating revealed a 13 nm decrease in z-average size, Dh. (b) ZP values of ‘naked’ 
sNPs, polycation ‘coated’ sNPs, and ‘unwrapped’ sNPs after treatment of hydroxylamine and 
centrifugal dialysis to remove unbound polymer. A 38 mV decrease in zeta potential, towards that of the 










2.3.10.   Attempted Removal of ‘Hard’ Polyelectrolyte Coatings 
It was strongly anticipated that experiments investigating the removal of polyelectrolyte layers 
would provide firm evidence that sNPs were successfully ‘shrink-wrapped’ within 
intermolecularly crosslinked polyelectrolyte films. Appropriate control experiments, with 
polycation (P3), were expected to show that polyelectrolyte ‘coatings’ consisting of non-
crosslinked (linear) polymer chains (Fig. 25a-b) can easily be removed (Fig. 25c) through a 
combination of sonication, washing, and centrifugal dialysis, whereas the polyelectrolyte 
‘wrapping’ formed by  Cationic SCPN-1 (Fig. 25d-e) should remain attached (Fig. 25f) on 
account of intermolecular covalent crosslinks having formed within the adsorbed 
polyelectrolyte layer. These observations are required to prove that the substrate was indeed 
‘shrink-wrapped’ within a crosslinked polyelectrolyte film, thus differentiating this novel 
chemistry from passive adsorption of linear (i.e. non-crosslinked) polymer chains (Fig. 25b) 
onto colloidal particles. Initial experiments focused on the displacement of P3 ‘coatings’ from 
particle surfaces, as getting this key control experiment (Fig. 25a-c) to work was crucial to 
obtaining proof of successful ‘shrink-wrapping’. 
Suspensions of linear polycation (P3) ‘coated’ sNPs (Fig. 25b) were incubated with a range of 
different salt/surfactant solutions for 48 h, which were anticipated to ‘screen’ electrostatic 
interactions between P3 and the negatively-charged polystyrene surface, thus facilitate the 
removal of the surface-bound polymer layer. Unbound polymer chains were then removed by 
centrifugal filtering and the ‘uncoated’ particles were analyzed by DLS (Fig. 26a) and ZP (Fig. 
26b). Of the conditions explored for polyelectrolyte coating removal, 2M KBr afforded the 
largest reduction in ZP, which decreased from + 34 mV (‘coated’ sNPs) down to + 2 mV, 
suggesting that partial removal of the polymer coating had at least been achieved. 
Figure 25: (a) Addition of linear polycation P3 results in a passively adsorbed polyelectrolyte layer (b), 
which should easily be removed through a combination of centrifugation/washing, salt addition and 
dialysis. Complete removal of the P3 coating would afford ‘naked’ polystyrene particles (c). (d) Addition 
of Cationic SCPN-1 in anticipated to result in the ‘shrink-wrapping’ of sNPs (e). The formation of a 
covalently interlocked polymer film, which cannot be removed (f), on account of the intermolecular 





Figure 26: A summary of experimental conditions explored to facilitate the removal of the adsorbed 
polycation (P3) layer from the surface of sNPs. Particle size and surface charge were measured by DLS 




In contrast, DLS (Fig. 26a) revealed that conditions where polymer coating had been most 
successfully been removed (sat. NaCl, sat. NaBr, 2M KBr) also featured significant aggregation, 
leading to large particle sizes, where Dh > 250 nm. This observed decrease in colloidal stability 
was rationalized by the removal of excess polyelectrolyte from the sNP surface, which pushes 
the particle back towards the isoelectric point (where ZP = 0, Fig. 26b). Although DLS/ZP 
results suggest that incubation of ‘coated’ sNPs with high salt concentrations may afford at 
least partial removal of the polymer layer, complete coating removal was incredibly challenging 
to achieve for ‘hard’ polyelectrolytes, which are thought to adsorb irreversibly onto oppositely-
charged colloidal particles.22 Furthermore, it was concluded that the challenges associated for 
accurately monitoring the removal of 5 – 15 nanometre thick ‘hard’ polyelectrolyte coatings 
from the surface of polystyrene nanoparticles using DLS were too great, on account of the 
colloidal stability of sNPs being modified by the adsorption of polymer chains, which influenced 
the quality of the DLS analysis obtained. Extensive experiments to facilitate the complete 
removal of ‘hard’ polyelectrolyte ‘coatings’ from the oppositely-charged polystyrene surface 
were largely unsuccessful. Whilst partial removal of the polymer coating was achieved by 
washing with excess salt, these conditions severely degraded the quality of the DLS analysis, 
making it difficult to accurately characterize the thickness of the remaining polymer layer.§§ It 
was concluded that adsorption of ‘hard’ polyelectrolytes onto oppositely-charged colloidal 
particles is essentially an irreversible process, driven by the entropically favourable 
displacement of counterions into the bulk solution,20 rather than simply an electrostatic 
attraction between oppositely-charged species.  
To circumnavigate the characterization issues associated with monitoring the displacement of 
polyelectrolyte ‘coatings’ by DLS, the decision was made to check for coating removal from 
microparticles, large enough to be visualized by microscopy. Further evidence that adsorption 
of ‘hard’ polycations is irreversible was observed by a fluorescence microscopy (Fig. 27) 
experiment, in which dansyl polycation (P4) was adsorbed onto 5 µm sulfonate-functionalized 
polystyrene microparticles (sMPs) (Fig. 27a). The inclusion of dansyl fluorophores within 
 
§§ Additional experiments were conducted in which alternating layers of ferrocene-labelled polycation P5 and 
polyanion P2 were built up layer-by-layer (LbL) upon surface of sNPs, and this process was monitored by TEM, DLS 
and ZP (see Appendix A, Fig. 40 - 41 for details). LbL assemblies contain several layers of loosely-bound 
polyelectrolyte upon the particle surface, and so it was hypothesized that LbL assemblies consisting of non-
crosslinked polyelectrolytes would readily collapse upon addition of salt. In contrast, LbL assemblies containing 
crosslinked polyelectrolytes (e.g. Cationic-SCPN-1) were expected to be more difficult to displace, on account of 
inter-chain crosslinks having formed between adjacent polymer layers. Whilst these experiments were anticipated 
to provide access to the control experiments required to demonstrate successful ‘wrapping’ of sNPs within 
crosslinked polyelectrolyte film, DLS, ZP and TEM analysis showed that LbL-covered sNPs had low colloidal stability 
and tended to form ill-defined aggregates, thus making it difficult to characterize the formation and displacement of 
polymer layers from the particle surface. Therefore, no further experiments were conducted with LbL-covered sNPs 
as these ill-defined constructs were unlikely to afford clear evidence of successfully ‘wrapping’ by the available 




polycation P4 allowed for the surface-bound polyelectrolyte layer to be observed as brightly 
emissive corona (Fig. 27b, i), which were exclusively localized to particle surfaces, indicating 
that no ‘unbound’ P4 was present. Removal of the polycation ‘coating’ was then attempted by 
repeatedly washing, centrifuging and re-suspending the ‘coated’ sMPs with saturated NaCl 
solution. After 10 consecutive washes with sat. NaCl fluorescence microscope images (Fig. 
27b, ii) revealed that the sMPs remained covered with a layer of polycation P4, as was evident 
by the brightly emissive coronas, which persisted upon the surface of sMPs. 
  
Figure 27: (a) Preparation of dansyl polycation (P4) ‘coated’ 5 µm sulfonate-functionalized 
microparticles (sMPs) and attempted ‘coating’ removal (b) by repeated washes with sat. NaCl solution, 
followed by centrifugation to remove the ‘unbound’ polyelectrolyte. (b) Fluorescence microscope 




2.3.11.   Adsorption of ‘Soft’ Polyelectrolytes onto Polystyrene NPs 
On account of the challenges associated with removing ‘hard’ quaternary ammonium 
polyelectrolyte layers (P3, P4) from the surface of oppositely-charged polystyrene particles, an 
alternative class of ‘soft’ polyelectrolytes were prepared. These ‘soft’ polyelectrolytes feature 
morpholine moieties (Fig. 28, i), which upon increasing the pH of solution (ii), can be 
deprotonated (iii) to effectively ‘switch off’ the electrostatic charge attraction between polymer 
and the polystyrene surface to which the polymer layer was adsorbed. It was thus hypothesized 
that ‘switching off’ the electrostatic binding between polymer and particle, that the charge-
neutral layer would be re-dispersed into the bulk solution (iv), effectively displacing adsorbed 
polymer coating from the sNPs surface to again yield the ‘naked’ polystyrene particles (v). 
It was anticipated that the reversible formation/removal of the adsorbed ‘soft’ polyelectrolyte 
(P7) layer (Fig. 28) would permit access to the key experiment for definitive proof of ‘shrink-
wrapping’ (Fig. 29a). In this key experiment, the adsorbed layer of linear ‘soft’ polycation (Fig. 
29a, i) should be displaced by raising the pH (ii), whereas the same experiment with 
Morpholine SCPNs (Fig. 29b) was expected to yield ‘wrapped’ sNPs (i), where the polymer 
film cannot be displaced (ii) on account of the intermolecular crosslinks which hold the film in 
place. pH titration (Appendix A, Fig. 37c) revealed that the morpholine nitrogen of hydrazide 
R5 (Fig. 30) was weakly basic, with a pKa of 6.4. It was therefore anticipated that ‘soft’ 
polyelectrolytes displaying pendant morpholine (R5) residues would be fully deprotonated 
above pH 8, thus have no electrostatic charge to hold the polymer coating on the periphery of 
the polystyrene nanoparticles.  
Figure 28: Adsorption of a ‘soft’ polycation P7 onto sNPs yields a polymer coating which can be 
removed by raising the pH. Charged groups (i) within ‘soft’ polycation P7 can be deprotonated by 
raising the pH of solution (ii), which renders a charge-neutral polymer (ii) which should be displaced 




The protonation state of morpholine decorated scaffold P7 (Fig. 30a) was studied as a function 
of pH by zeta potential measurements (Fig. 30b, iii), which revealed a the ‘soft’ polycation was 
protonated, and thus positively charged (ZP = 37 ± 2 mV) at pH 3. In contrast, P7 was 
deprotonated, hence charge-neutral above pH 7.2, where ZP = - 1.1 ± 1 mV. These results 
indicate that it should be possible to reversibly ‘switch’ on/off the electrostatic charge upon the 
‘soft’ morpholine polycation P7, simply by adjusting the pH of solution after P7 has been 
adsorbed onto the periphery of sNPs.  
Figure 29: Key experiments to demonstrate the successful ‘shrink-wrapping’ of sNPs. (a) Control 
experiment with linear ‘soft’ polycation (P7). The adsorbed ‘soft’ polyelectrolyte (i) should be displaced 
(ii) by basifying the solution to pH 8 and removal of the unbound polymer should yield ‘naked’ sNPs.
(b) Concentration of Morpholine SCPNs on to the surface of sNPs was anticipated to yield within an 
intermolecularly crosslinked polymer film (i), which cannot be displaced (ii) by raising the pH. 
Figure 30: (a) Reversible deprotonation of ‘soft’ morpholine polycation P7. (b) DLS (i-ii) and ZP (iii) 
characterization of P7, as a function of pH. (i) Z-average Dh of P7 as a function of pH. (ii) Z-average 





In this experiment sNPs were added to varying doses (PD = 0 – 10000 mg/g) of morpholine 
polycation P7. Zeta potential and DLS measurements (Fig. 31a) were obtained to determine 
the surface charge of the resulting particles, over a range of pH values (pH 1 – 9.0).  
ZP revealed that low polymer doses of 0.1 – 10 mg/g (Fig. 31a, v) did not afford positively 
charged particles, and featured ZP values close to that of the ‘naked’ sNPs (ZP ≈ - 40 mV), 
even under acidic conditions (pH 1), where all morpholine residues would be positively 
charged. Note that the ZP of ‘naked’ sNPs (Fig. 31a) (PD = 0 mg/g, green) remain 
approximately constant over the range pH = 1 – 9. Intermediate polymer doses (PD = 100 
mg/g) (yellow) afforded ‘partially’ coated particles (Fig. 31a, iv) at pH 1 - 3, with a ZP ≈ 0 mV, 
close to the isoelectric point (IEP). At PD = 100, just enough polymer is present to balance the 
total number of negative charges on the particle surface, thus no net charge is observed for 
the particle as it is close to the IEP. Raising pH partially deprotonated the positive charges on 
morpholine scaffold, thus the particles ZP value was shifted back to negative surface charge 
and away from the IEP. Addition of a large excess of morpholine polycation P7, however, 
afforded fully ‘coated’ sNPs (Fig. 31a, i) under acidic conditions, as was evident from their 
strong positive surface charge (ZP = + 30 mV). Encouragingly, both PD = 1000 and 10000 
mg/g afforded an identical ZP profile, which implies saturation of the particle surface with 
polymer. Increasing the pH, however, afforded deprotonation of morpholine residues within the 
adsorbed polymer layer (Fig. 31a, ii), until the ‘coated’ particle was no longer positively charged 
(iii), as evidenced by the now negative zeta potential (ZP = -30 mV at pH 9), with a very similar 
value to that of the ‘naked’ sNPs (ZP = - 40 mv for PD = 0 mg/g at pH 9). The hydrodynamic 
thickness (L) of the adsorbed polymer layers (Fig. 31b) were obtained from DLS analysis and 
were expressed as a function of the polymer dose (PD). These results (Fig. 31b) were 
consistent with the adsorption of a thin polymer layer, with the maximum hydrodynamic 
thickness being 5 nm.   
Figure 31: (a) Zeta potential as a function of pH. Polymer Doses 0 – 10000 mg/g were explored. (b) 
Hydrodynamic thickness (L) of the adsorbed polymer layer presented as a function of Polymer Dose at 




Further DLS/ZP experiments were conducted using morpholine polycation (P7) (Fig. 32c-d), a 
polymer which was absent in covalent crosslinks and Morpholine SCPNs (Fig.32a-b), which 
were prepared by intramolecular crosslinking of P7 with 1 equivalent of succinic dihydrazide. 
Morpholine SCPNs were anticipated to ‘shrink-wrap’ the periphery of sNPs (Fig. 29b) on 
account the dynamic covalent nature of their crosslinkers, whilst P7 will form non-crosslinked 
polymer ‘coatings’, and thus were employed for control experiments. P7 ‘coated’ (Fig. 32c) 
and SCPN ‘wrapped’ (Fig. 32a) sNPs were prepared at pH 1 (red) and the zeta potentials were 
measured for each sample. Figures 32a,c report ZP as a function of the polymer dose. Under 
acidic conditions (pH 1) the expected surface charge reversal was observed at PD ≈ 100, with 
positive ZP at PD > 1000 indicating that the sNPs were ‘coated’ in polymer. Morpholine polymer 
P7 showed a more positive surface charge than the crosslinked polymer, which was 
rationalized by the crosslinked Morpholine SCPNs having a slightly lower density of positively 
charge morpholine residues than the parent linear polymer P7.*** After basifying the samples 
 
*** Crosslinking of P7 with succinic dihydrazide results in the displacement morpholine hydrazide, and thus 
Morpholine SCPNs have few morpholine residues per polymer chain. 
Figure 32: ‘Shrink-wrapping’ experiment with Morpholine SCPNs (a-b) and control experiment with 
morpholine polymer P7 (c-d). (a and c) Zeta potential as a function of pH. Polymer doses 0 – 10000 
mg/g were explored. (b) Hydrodynamic thickness (L) of the adsorbed polymer layer before (pH 1) and 




to pH 9 (Fig. 32a,c), morpholine residues within the polymer coating were neutralized, and thus 
the surface charge of the polymer-encapsulated sNPs reverted back to negative zeta potentials 
(ZP ≈ - 20 mV), towards that of the ‘naked’ sNPs (ZP = - 43 ± 3 mV). This observation may 
suggest the polymer is still loosely associated with the surface of sNPs and has not been fully 
displaced. Intriguingly, after basifying the samples to pH 9 the ZP profile for Morpholine 
SCPNs (Fig. 32a, ii) was less negative (closer to neutral) than that of the non-crosslinked 
polymer P7 (Fig. 32b, ii). These observations suggest that the ‘wrappings’ formed from 
Morpholine SCPNs tend to the ‘resist’ displacement of the surface-bound polymer layer, 
whereas P7 (non-crosslinked) layers are more easily displaced. This subtle difference in the 
behaviour of these two polymers is consistent with the hypothesis that Morpholine SCPNs 
have formed an intermolecularly crosslinked film upon the sNPs. Unfortunately, DLS results 
(Fig 32a and b) revealed negligible changes in the thickness of the adsorbed polymer layer. It 
was observed that both P7 and Morpholine SCPNs were adsorbed onto sNPs with a layer 
thickness approximately 10 nm. After attempting to displace the polymer layer, these numbers 
had not significantly decreased, which indicates the polymer layers remained bound to the 
particle surface in both cases.  
In summary, although DLS results suggest polymer layers had not been displaced, zeta 
potential measurements hint at subtle differences in the behaviour of crosslinked (Morpholine 
SCPNs) and non-cross linked (P7) polymers. Having established robust analytical protocols to 
investigate the adsorption of polyelectrolyte chains onto the surface of colloidal particles, 
studies returned to focus on the ‘shrink-wrapping’ of SV40 capsids. 
2.3.12.   Adsorption of Linear Polycation upon SV40 Viral Capsid 
Collaborators from the laboratory of W. B. Turnbull delivered a fresh batch of SV40 capsid, 
which was rigorously characterized by DLS. Experiments with the previous batch of SV40 
suggested that Cationic SPCN-1 had successfully adsorbed onto the viral surface, yet 
definitive proof of the intermolecularly crosslinked nature of the observed polyelectrolyte film 
was difficult to obtain. It was very likely that viral capsid had been successfully ‘shrink-wrapped’ 
by Cationic SPCN-1. Thus, present experiments focused predominantly on getting the 
troublesome control experiment with linear polycation P3 to operate as anticipated, with the 
view of later returning to the ‘shrink-wrapping’ experiments with Cationic SPCN-1. In these 
experiments, solutions of ‘coated’ SV40 were prepared by addition of linear polycation P3 (Fig. 
33a) into a 29.3 nM solution of viral capsid at pH 7.4. A series containing a range of 
[polycation]/[capsid] stoichiometries ([Polycation]/[Capsid] = 0.3 – 23 000) were prepared and 
after incubation at room temperature for 2 h, the ‘unbound’ excess of polycation P3 was 




characterized by DLS (Fig. 33b) and ZP (Fig. 33d), revealing the anticipated increase in particle 
size (Dh) and reverse in electrostatic charge present upon the periphery of SV40 capsid, 
respectively. DLS (Fig. 33b) revealed a 2 - 30 nm increase in Dh, which was consistent with a 
polyelectrolyte bound upon the capsid surface, with a hydrodynamic layer thickness (L) of 1 – 
15 nm depending on the [Polycation]/[Capsid] stoichiometry (Fig. 33c). Encouragingly, both 
the z-average (orange) and number-average (blue) data afforded similar values, despite the 
fact that the raw z-average DLS data (Fig. 33b, orange) was slightly skewed towards larger 
particle sizes, on account of a small population of multiparticle particle aggregates within the 
sample. 
The next stage of this investigation involved the removal of the surface-bound ‘hard’ polycation 
layer by addition of excess salt, which was anticipated to displace the P3 ‘coating’ from the 
viral surface, by disrupting the electrostatic interactions between polymer and capsid. Whilst 
the adsorption of P3 onto oppositely-charged sNPs – a hard polyanion with high density of 
sulfonate groups – was an essentially irreversible process, it was hypothesized that the 
adsorbed P3 layer should be reversibly displaced from SV40 capsid, on account of the viral 
surface being only a ‘soft’ polyelectrolyte which displays both regions of both regions of 
positive and negative charge. Furthermore, the density of ‘soft’ negative charges displayed by 
the SV40 capsid was expected to be considerably lower than that of ‘hard’ anionic groups upon 
the polystyrene-sulfonate (sNPs) particles. To displace the surface-bound P3 layer from SV40, 
Figure 33: (a) Adsorption of linear polycation P3 onto SV40 viral capsid results in ‘coated’ SV40 , with 
a polyelectrolyte layer thickness (L) of 2 – 15 nm, depending on the polymer dose. (b-c) DLS and ZP 
measurements of ‘coated’ SV40 capsid. (b) Z-average (orange) and number average (blue) Dh  given a 
as function of [Polycation]/[Capsid] stoichiometry. (c) Hydrodynamic layer thickness (L) of surface-bound 
polycation ‘coating’ upon the viral capsid, expressed as a function of [Polycation]/[Capsid] ratio. (d) ZP 




a range of salt concentrations (0 mM – 2M NaCl) and salt types (NaCl, NaBr, KCl etc.) were 
explored. However, the conditions ([NaCl] > 200 mM) required to displace the polyelectrolyte 
layer was sufficient to drive particle-particle aggregation of viral capsids, which was observed 











Figure 34: DLS polydispersity index (PDI) for P3 ‘coated’ SV40 (i), given as a function of [NaCl]. 
Where high salt concentrations of [NaCl] > 200 mM led to a sharp increase in polydispersity, on 




In an alternative approach (Fig. 35a), the reversible adsorption of ‘soft’ morpholine-
functionalized polycation P7 onto SV40 capsid was considered. P7 required mildly acidic 
media (pH < 4) (see Fig. 30b, iii) to ensure protonation of morpholine residues located upon 
the polymer scaffold and basic conditions (pH ≈ 9) to facilitate removal of the adsorbed polymer 
layer. Thus, the pH-stability of SV40 capsid was investigated by measuring the zeta potential 
of SV40 as a function of pH (Fig. 35b). 
DLS and ZP measurements revealed that SV40 capsid was stable in the range pH 4 - 7.4, whilst 
moderately acidic conditions (pH < 2) afforded disassembly/denaturing of the viral capsid into 
its constituent protein subunits. Zeta potential of SV40 at pH 5 – 7 was ZP ≈ - 24 mV, a strong 
negative surface charge indicative of good colloidal stability. ‘Soft’ morpholine polycation (P7) 
is partially protonated at 5 (Fig. 30b, iii), and thus presents positive charges for complexing 
with SV40 capsid. Future work aims to explore interface SV40 capsid with ‘soft’ 
polyelectrolytes such as Morpholine SCPNs/P7, with the hope of demonstrating successful 
‘shrink-wrapping’ of the viral capsid within intermolecularly crosslinked polymer films. 
Figure 35: (a) Adsorption of morpholine-functionalized ‘soft’ polycation (P7) onto SV40 was anticipated 
to allow for the reversible displacement of the surface-bound polymer layer from the viral surface by 
basifying to pH. Positively charged/protonated polymer layer (red), charge neutral/deprotonated P7 
(orange).  (b) ZP of SV40 viral capsid as a function of pH. SV40 capsid was stable at pH 4 – 7.5, but 





‘Shrink-wrapping’ studies were undertaken in which SV40 viral capsid was interfaced with 
SCPNs displaying multiple positively-charged quaternary ammonium appendages, which were 
anticipated to concentrate polymer onto the virus surface through complementary electrostatic 
interactions, and thus drive covalent crosslinking of adjacent chains into a net-like polymer film. 
Characterisation of the ‘wrapped’ SV40 capsid was consistent with this hypothesis, revealing 
the attachment of a thin (5 - 30 nm) virus-bound polymer layer and a distinct reversal in the 
electrostatic surface charge present upon viral surface. To demonstrate the successful ‘shrink-
wrapping’ led to the formation of intermolecularly crosslinked polymer films, key control 
experiments were undertaken to highlight that crosslinked films are more difficult to displace 
from the virus surface than are non-crosslinked polymer coatings. It was observed that the high 
salt concentrations required to drive the displacement of non-crosslinked polymer coatings 
from SV40 significantly disrupted the colloidal stability of the viral capsid, thus driving 
processes of particle-particle aggregation which decreased quality of DLS analysis obtained. 
Although SV40 had likely been successfully ‘shrink-wrapped’ by Cationic SCPN-1, challenges 
associated with characterizing the displacement of polyelectrolyte layers from the particle 
surface meant that definitive proof of ‘shrink-wrapping’ has so far remained elusive. 
In pursuit of strong evidence to support the ‘shrink-wrapping’ hypothesis, further investigations 
were conducted upon polystyrene nanoparticles (sNPs), a model system that has a similar size 
and surface charge to SV40. DLS, zeta potential TEM characterization revealed the successful 
adsorption of a thin (5 – 25 nm) layer of polymer chains located upon the particle surface. 
Although extensive efforts were made to demonstrate the crosslinked nature of these polymer 
layers, evidence of this could not be easily obtained. DLS and ZP measurements revealed that 
the adsorption of ‘hard’ polyelectrolytes layers onto particle surfaces, is essentially an 
irreversible process, which consequently denied access to the key control experiment that was 
anticipated to prove ‘shrink-wrapping’. This chapter was concluded by experiments to 
circumnavigate the irreversible binding of ‘hard’ polycations to polystyrene surfaces. It was 
anticipated that the reversible deprotonation/protonation of ‘soft’ morpholine polyelectrolytes 
would permit access to the key control experiment by presenting a means to ‘switch off’ the 
electrostatic charges associated with irreversible binding to particle surfaces. In this system 
the key control experiment operated as exactly anticipated with non-crosslinked morpholine 
polymers being successfully displaced after neutralizing their positive charges under basic 
conditions. ‘Wrapping’ experiments revealed that Morpholine SCPNs tended to resist 





2.5. Future Work 
Future work looks to interface ‘soft’ Morpholine SCPNs with SV40 capsid to see if strong 
evidence for the ‘shrink-wrapping’ of viral targets can be obtained. Furthermore, we are keen 
to investigate the effect that the polycation ‘wrapping’ has upon the stability of the virus-like 
particle to elevated temperatures and dehydrating conditions. It is anticipated that the surface-
bound polymer layer will protect the viral ‘cargo’. Verification of this hypothesis should thus be 
explored through a combination of DLS, SDS-PAGE, ELISA, AFM and cryo-TEM experiments 
to reveal if the polymer coating ‘masks’ and thus protects the viral surface over prolonged 
exposure to stimuli known to denature the assembled capsid. 
For example, the addition of reducing agents such as DTT or glutathione (Fig. 36a) are 
known13 to trigger the disassembly of SV40 capsid into its constituent protein subunits (i.e. 
pentamers of VP1) – a process which could readily be monitored by time-resolved DLS 
analysis (Fig. 36b) to reveal a distinct collapse in hydrodynamic diameter (Fig. 36a, i). Future 
studies will examine the differences in stability between ‘naked’ (Fig. 36b) and ‘wrapped’ (Fig. 
36c) SV40 capsids, to understand how polymer ‘wrappings’ could be employed to engineer 
the properties of viral surfaces, extend their ‘shelf-lives’ and improve their performance. 
Figure 36: Addition of reducing agents (a) to SV40 capsids is known to trigger their dissociation into 
pentamers of VP1,13 thus driving their degradation by cleaving disulfide bridges that hold the capsid 
together. (b) Addition of reducing agent to an aqueous dispersion of ‘naked’ SV40 capsids is thus 
hypothesized to trigger a collapse (i) in its hydrodynamic diameter, Dh – a process which could be 
monitored by time-resolved DLS. In contrast, the reduction of ‘wrapped’ SV40 (c) should be stable over 
longer periods (iii) and thus resist collapse in Dh, on account of its protective polymer ‘wrapping’. DLS 
studies should elucidate key differences between ‘naked’ and ‘wrapped’ SV40, thus demonstrating the 
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2.6.1. General Experimental 
All chemicals were purchased from Sigma-Aldrich, Fisher Scientific or Alfa Aesar and were 
used as received without further purification. Functionalized-polystyrene latex nano- and 
microparticles were purchased from Sigma-Aldrich. All solvents were dried prior to use 
according to standard methods. N,N-dimethylacrylamide was purified by vacuum distillation at 
60 ºC. All solvents used for flash chromatography were GPR grade, except hexane and ethyl 
acetate, when HPLC grade was used. Unless state otherwise, all synthetic procedures were 
performed in oven-dried glassware under a N2(g) atmosphere. 
 
2.6.2. Instrumentation 
1H and 13C NMR spectra of synthesised compounds were recorded on a Bruker Avance 300 
spectrometer (300 and 75 MHz respectively), Bruker Avance 400 spectrometer (400 MHz and 
100 MHz, respectively), Bruker Avance III HD spectrometer (at 500 MHz and 125 MHz, 
respectively), or Bruker 700 Avance III HD spectrometer (700 MHz and 175 MHz, respectively). 
In all cases, the residual solvent signal was used as an internal standard. High-resolution mass 
spectrometry was performed on a Waters LCT Premier mass spectrometerα Gel permeation 
chromatography (GPC) was conducted on a on a Varian ProStar instrument (Varian Inc.) 
equipped with a Varian 325 UV-Vis dual wavelength detector with a 254 nm laser, a Dawn 
Heleos II multi-angle laser light scattering detector (Wyatt Technology Corp.), a Viscotek 3580 
differential refractive index detector and two PL gel 5 μm Mixed D 300 × 7.5 mm columns with 
guard column (Polymer Laboratories Inc.) in series. Chromatogram analysis was performed on 
Galaxie software (Varian Inc.) and analyzed with the Cirrus software (Varian Inc.) and Astra 
software (Wyatt Technology Corp.). Near monodisperse poly(methyl methacrylate) standards 
(Agilent Technologies) were used for calibration.  DLS and zeta potential measurements were 
performed on a Malvern Instruments Nano ZS. Fluorescence microscopy images were 
obtained were obtained using Zeiss Axioskop 2 Plus. pH measurements were made using a 






2.6.3. Synthesis of Aldehyde Monomer M1 
 
Scheme 2: Synthesis of aldehyde acrylamide monomer M1. Step (i) CH(OMe)3, H2SO4, MeOH, reflux, 
18 h. Step (ii) 1,2-Ethylenediamine, reflux, 48 h. Step (iii) Acryloyl chloride, Et3N, CH2Cl2, 0 o, 18 h. Step 
(iv) 50:50 Acetone:2M HCl(aq). 
 
Synthesis of Methyl 4-(dimethoxymethyl)benzoate (1): 
4-Carboxybenzaldehyde (15.4 g, 102.6 mmol), trimethylorthoformate (32.7 g, 308.1 mmol) and 
H2SO4 (12 drops) were dissolved in MeOH (100 mL) and the mixture was refluxed for 48 h. 
The reaction mixture was neutralized with saturated NaHCO3(aq) (100 mL) and the product 
was extracted with CH2Cl2 (3 × 150 mL). The organic extract was dried over MgSO4, filtered, 
and dried under vacuum to afford the title product as a clear oil (19.8 g, 92 %). 1H NMR (CDCl3, 
300 MHz) δ (ppm): 8.00 (d, 2H, Ar, J3 = 8.1 Hz), 7.54 (d, 2H, Ar, J3 = 8.1 Hz), 5.41 (s, 1H, 
CH(OCH3)2), 3.85 (s, 3H, COOCH3), 3.31 (s, 6H, CH(OCH3)2). 13C NMR (CDCl3) δ (ppm): 167.1, 
143.8, 130.8, 129.8, 127.1, 103.1, 53.0, 52.1. FT-IR (wavenumber, cm-1): 2943 (C–H), 2904 (C–
H), 2836 (C–H), 1724 (C=O), 1450 (C=C), 1434 (C=C), 1409 (C=C). 
Synthesis of N-(2-Aminoethyl)-4-(dimethoxymethyl)benzamide (2): 
Methyl 4-(dimethoxymethyl)benzoate 1 (6.0 g, 28.5 mmol) was dissolved 1,2-diaminoethane 
(100 mL), heated to reflux for 24 h and then evaporated to dryness to afford a viscous yellow 
oil. Crude product 2 was dissolved in a minimal volume of CH2Cl2, then filtered to remove 
residual 1,2-diaminoethane, which was observed as a white precipitate. 2 was purified by 
column chromatography (Si2O, CH2Cl2/EtOH/Et3N 80:15:5) to afford the product as a yellow oil 
(4.1 g, 61 %). 1H NMR (CDCl3) δ (ppm): 7.73 (d, 2H, Ar, J3 = 9.0 Hz), 7.38 (d, 2H, Ar, J3 = 9.0 
Hz), 7.33 (t, 1H, NH), 5.30 (s, 1H, CH(OCH3)2), 3.61 (br s, 2H, NH2), 3.46 (q, 2H, CH2), 3.22 (s, 
6H, CH(OCH3)2), 2.91 (t, 2H, CH2). (CDCl3, 100 MHz) δ (ppm): 166.4, 143.0, 130.2, 129.6, 126.8, 






Synthesis of N-Ethylacrylamide-2-(4-(dimethoxymethyl)benzamide (3): 
A solution of 2 (4.1 g, 17.2 mmol) and Et3N (5.2 g, 51.3 mmol) in CH2Cl2 (100 mL) was cooled 
to 0 ˚C and acryloyl chloride (2.3 g, 25.8 mmol) in CH2Cl2 (50 mL) was added dropwise over 1 
h. The reaction was stirred overnight, gently allowing to warm back to room temperature, then 
washed with saturated NaHCO3(aq) (150 mL). The aqueous layer was extracted with CH2Cl2 (2 
× 150 mL) and the combined organic extracts were dried over MgSO4, filtered, and evaporated 
to dryness. The crude solid was purified by column chromatography [SiO2, EtOAc-Et3N (95:5)], 
affording the title product as a white solid (2.0 g, 40 %). 1H NMR (300 MHz, CDCl3) δ (ppm): 
7.82 (s, 1H, NH), 7.79 (d, 2H, Ar, J3 = 8.1 Hz), 7.44 (d, 2H, Ar, J3 = 8.1 Hz), 7.36 (s, 1H, NH), 
6.21 (dd, 1H, alkene CH, J = 17.2 Hz), 6.13 (dd, 1H, alkene CH, J = 17.2 Hz), 5.56 (dd, 1H, 
alkene CH, J = 9.7 Hz), 5.34 (s, 1H, CH(OCH3)2), 3.50 (m, 4H, (CH2)2), 3.28 (s, 6H, CH(OCH3)2). 
13C NMR (75 MHz, CDCl3) δ (ppm): 168.6, 167.5, 142.1, 134.6, 133.3, 131.3, 130.0, 128.2, 
127.3, 103.1, 53.1, 41.3. 
Synthesis of N-Ethylacrylamide-2-(4-formylbenzamide) (M1): 
N-ethylacrylamide-2-(4-(dimethoxymethyl)benzamide) 3 (2.0 g, 6.8 mmol) was dissolved in 1:1 
Acetone:1M HCl(aq) (15 mL), stirred at room temperature for 1 h and neutralized with sat. 
NaHCO3(aq) (85 mL). The aqueous layer was extracted with EtOAc (3 × 120 mL). The organic 
extracts were combined and dried over MgSO4, filtered, and evaporated to afford the title 
product as a white solid (1.4 g, 84 %). 1H NMR (300 MHz, d6-DMSO) δ (ppm): 10.07 (s, 1H, 
CHO), 8.23 (s, 1H, NH), 8.79 (s, 1H, NH), 8.03 (d, 2H, Ar, J3 = 8.4 Hz), 7.99 (d, 2H, Ar, J3 = 8.4 
Hz), 6.23 (dd, 1H, alkene CH, J = 17.1 Hz), 6.09 (dd, 1H, alkene CH, J = 17.1 Hz), 5.59 (dd, 1H, 
alkene CH, J = 9.6 Hz), 3.72 (m, 4H, (CH2-CH2). 13C NMR (75 MHz, d6-DMSO) δ (ppm): 193.0, 
166.1, 165.5, 140.1, 138.2, 132.3, 129.6, 128.3, 125.2, 39.6, 38.7. FT-IR (wavenumber, cm-1): 
3264 (N–H), 3091 (C–H, alkene), 2943 (C–H, alkyl), 1699 (C=O, aldehyde), 1627 (C=O, amide), 
1549 (C=O, amide), 1447 (C=C, aromatic), 1414 (C=C, aromatic). HRMS+ C13H15N2O3: 
Theoretical: 247.1083. Actual: 247.1081. 
 
2.6.4. Synthesis of Hydrazide Residues (R2/R4) 
Synthesis of Potassium ethyl sulfoacetate (4) 
Ethyl chloroacetate (5.00 g, 4.08 mmol) and potassium sulfite (6.46 g, 4.08 mmol) were 
combined in H2O (40 mL) and heated under reflux for 8 h, then left to stir at room temperature 
for 18 h. The solution was evaporated to dryness, yielding a white powder. Recrystallisation 
from hot 70:30 EtOH/H2O yielded the title compound as a white solid (5.39 g, 64%). 1H NMR 
(300 MHz, D2O) δ (ppm): 4.14 (q, 2H, J = 6 Hz), 3.86 (s, 2H, -O3SCH2), 1.18 (t, 3H, J = 6 Hz, 
CH2CH3). 13C NMR (100 MHz, D2O) δ (ppm): 166.93 (C=O), 62.93 (-O3SCH2), 56.10 (CH2CH3), 




Synthesis of Sulfoacetylhydrazide (R2)  
Hydrazine hydrate (3.52 mL, 72.7 mmol) was added to a stirred solution of ethyl sulfoacetate 6 
(1.00 g, 4.85 mmol) in H2O (20 mL). The reaction mixture was left to stir at room temperature 
for 18 h, then evaporated to dryness, yielding a colourless oil (4.02 g). The oil was cooled in an 
ice-bath, and MeOH was added dropwise to yield the title product as a white precipitate which 
was isolated by filtration (0.54 g, 58%). 1H NMR (300 MHz, D2O) δ (ppm): 3.10 (s, -O3SCH2). 
13C NMR (100MHz, D2O) δ (ppm): 165.57 (C=O). 55.43 (-O3SCH2). HRMS(ES-) C2H5N2O4S: 
Actual: 153.0660. Theoretical: 152.9970. 
 
Scheme 3: Synthesis of ferrocene hydrazide (R4). Step (i): tert-Butyl carbazate, EDC, CH2Cl2, rt, 18 h. 
Step (ii): H2NN2.H2O, EtOH, reflux, 18 h. 
Synthesis of Ferrocenylhydrazide-Boc (7): 
Ferrocene carboxylic acid (1.00 g, 4.35 mmol) was dissolved in CH2Cl2 (30 mL) and stirred 
under nitrogen at RT. EDC (574.8 mg, 4.35 mmol) and tert-butyl carbazate (835.8 mg, 4.36 
mmol) were each dissolved in CHCl2 (20 mL) and added to the vessel and stirred for 18 h. 
Reaction was judged complete by TLC (6:4 CH2Cl2/EtOAc, ninhydrin stain, product Rf  = 0.7). 
The reaction mixture was washed with brine (140 mL), the organic extract was dried over 
MgSO4, filtered, and then evaporated to afford the crude product as a brown solid. The product 
was purified by column chromatography (SiO2, 6:4 CH2Cl2/EtOAc) to afford the product as an 
orange solid (482 mg, 32 % yield). 1H NMR (CDCl3, 300 MHz) δ (ppm): 7.45 (1H, s, -CO-NH-
NH-), 6.54 (1H, s, -CO-NH-NH-), 4.73 (2H, t, subst. Fc), 4.39 (2H, t, subst. Fc), 4.29 (5H, s, 
unsubst. Fc), 1.51 (9H, s, -O(CH3)3). 
Synthesis of Ferrocylhydrazide (R4): 
Ferrocenylhydrazide-Boc R4 (311 mg, 0.90 mmol) was dissolved in CH2Cl2 (6 mL) and TFA 
(3.3 mL, 14.4 mmol) was added dropwise at 0°C and stirred for 1 h then allowed to gently warm 
to room temperature. The reaction was neutralized by dropwise addition of sat. Na2CO3(aq) (10 
mL), diluted with DI water (40 mL) and the product extracted with CHCl2 (3 x 50 mL). The 
organic extracts were combined, dried over MgSO4, filtered, and evaporated to dryness. The 
product was dissolved in CDCl3 (6 mL) and dried under N2 flow, then under high vacuum for 
12 h. Product was obtained as an orange solid (142.5 mg, 65 % yield). 1H NMR (CDCl3, 300 
MHz) δ (ppm): 6.92 (1H, s, -CO-NH-NH2), 4.65 - 4.37 (5H, m, Fc), 4.21 (5H, s, unsubst. Fc), 





2.6.5. Preparation of Aldehyde-Functionalized Polymer Scaffold P1 
 
Scheme 4: Preparation of aldehyde-functionalized dimethylacrylamide copolymer scaffold. 
S-1-Dodecyl-S’-(α,α-dimethyl-α’’-acetic acid)trithiocarbonate5 (DDMAT) (1 eq, 22.35 mg, 61 
μmol) and AIBN (0.2 eq, 2.05 mg, 12.5 μmol) were added to a small schlenk tube. N,N’-
Dimethylacrylamide (DMA) (80 eq, 0.545 g, 5.50 mmol) and N-ethylacrylamide-2-(4-
formylbenzamide) (M1) (20 eq, 0.363 g, 1.37 mmol) were then added followed by DMF (3 mL). 
The reaction mixture was degassed five times, and then the vessel was backfilled and purged 
with N2, then allowed to warm to room temperature. The reaction mixture was then placed in 
an oil bath at 70 ˚C, and the polymerization was quenched in liquid N2 after 18 h. The reaction 
mixture was dissolved in a minimal amount of THF and added dropwise to a large excess of 
ice-cold diethyl ether. The polymer was then isolated by filtration and the precipitation was 
repeated before drying under high vacuum. Polymer P1 was obtained as a pale yellow solid. 
1H NMR (300 MHz, CDCl3) δ (ppm): 10.04 (br, CHO), 8.59 (br, NH), 8.07 (br, Ar), 7.88 (br, Ar), 
3.4 – 3.6 (br, (CH2)2), 2.88 (br, N(CH3)2), 2.2 - 2.7 (br, CHCH2, polymer backbone), 1.4 - 1.8 (br, 
CHCH2, polymer backbone). The composition of P1 can be determined by comparing the 
integration of the aldehyde protons of M1 with the integration of the N(CH3)2 protons of DMA. 
The composition (DMA:M1) of monomer units within the polymer chain, as determined by 1H 
NMR spectroscopy, were not identical to the feed ratios on account of a difference in monomer 
reactivity. 
 
2.6.6. General Procedure for ‘Decoration’ of Aldehyde Copolymers 
Aldehyde copolymer P1 or P2 were dissolved in 100 mM H4NOAc-AcOH, pD 4.5 (5 mL) for a 
polymer concentration of 20 mM. Hydrazide residues (R1 - R3) (400 - 750 mM) were dissolved 
in 100 mM acetate/D2O buffer and then stirred at rt for 12 h and the reactions were then judged 
to be complete by 1H NMR spectroscopy, which revealed the complete disappearance of 
aromatic aldehyde signal. All unbound contaminants, such as excess hydrazide residue and 
acetate buffer were removed by dialysis in water (Spectra por, 3kDa MWCO), and then freeze 





2.6.7. General Procedure for the Preparation of SCPNs 
Linear polyelectrolytes (P2, P3 or P7) were dissolved in 100 mM H4NOAC-AcOH/H2O buffer, 
pH 4.5, [Polymer] = 2 mg/mL. To the rapidly stirred polymer solution, succinic dihydrazide (1 – 
3 mL, 1 – 3 eqv. relative to the number of hydrazone units displayed upon the polymer scaffold) 
was added dropwise over 1 h via an automated syringe-pump. The solution was stirred for a 
further 17 h at rt. Small (200 µL) aliquots of the polymer solution were removed and reduced 
by NaCNBH3 (see below) to chemically ‘fix’ the acyl hydrazone crosslinkers. SCPN formation 
was confirmed by GPC analysis of the reduced SCPNs. Although SCPNs display reasonable 
kinetic stability in aqueous solution, samples were then flash frozen at – 78 oC and stored at – 
20 oC to present unwanted structural rearrangement of intra-chain acyl hydrazone crosslinks 
through component exchange.  
2.6.8. Reduction of SCPNs and Analysis by GPC 
Small (400 µL) aliquots of SCPNs (≈ 2 mg/mL) were removed from reduced by addition of 400 
µL 100 mM NaCNBH3 (in DI H2O) stirred for 4 h, then dried under vacuum and re-dissolved in 
10 g/L LiBr in DMF ([polymer] = 2 mg/mL) for analysis by GPC. Successful SCPN formation is 
observed as an increase in retention time (RT) relative to the linear (non-crosslinked) polymer 
chain. consistent with the expect chain collapse through intramolecular crosslinking. Each 
sample was run three times to ensure negligible drift in RT between runs. 
2.6.9. Emission-Quenching Experiment with SV40 Capsid 
Aqueous of solutions of polymers P1, P2 or P3 were titrated into SV40 (29.3 nM viral capsid, 
20 mM NaCl, 1 mM CaCl2, 10 mM TRIS, pH 7.4) to achieve [Polymer]/[Capsid] stoichiometries 
in the range 0 – 5000, and then emission spectra were measured.  
Emission quenching plots shown in Figure 14c show the corrected in emission intensity (ΔI) as 
a function of [Polymer]/[Capsid] stoichiometry. ΔI was calculated according to Eqn. 2: 
∆𝐼 = 𝐼 − 𝐼     (Eqn. 2) 
Where 𝐼  is the measured intensity at [Polymer]/[Capsid] = 𝑥, and 𝐼  is the emission intensity 
measured at the titration endpoint. i.e. the emission at titration endpoint (𝐼 ) was subtracted 
from each of the measured emission values during the titration (𝐼 ). 
2.6.10.  Time-Resolved DLS Measurement Protocol  
Measurements were performed on a Malvern Instruments Zetasizer Nano ZS, which employs 
a He/Ne laser operating at 633 nm as a light source and an avalanche photodiode as a detector. 
For TR-DLS each correlation function was accumulated for 30 s, and the apparent 
hydrodynamic radius was calculated with a second order cumulant fit. Because of the low 
polymer concentrations, no viscosity corrections are necessary. Such measurements were 
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Figure 38: DLS titration profile for addition of SDS surfactant into SV40 capsid.
[Capsid] = 117 nM in 1.8 mM TRIS, 18 mM NaCl, 0.9 mM CaCl2, pH 7.4 
Figure 37: Synthesis (a) and characterization (b) of morpholine hydrazide R5. (a) Synthesis of R5
by hydrazinolysis of ethyl ester 7. Step (i): N2H4.H2O, EtOH, reflux,12 h. (b) 1H NMR spectrum (CDCl3, 
300 MHz) of R5 with structural assignments shown. Arrows indicate J3 coupling observed by COSY 
NMR spectroscopy. (c) pH titration profile (i) of R5 revealed that the morpholine nitrogen had a pKa





Ferrocene hydrazide (R4) was prepared in two steps (Fig. 39a) and isolated by column 
chromatography as an orange solid (21 % yield). Surprisingly, the alternative synthetic route 
(Fig. 39b) was unsuccessful on account of failed hydrazinolysis of methyl ester 7. 
  
Figure 39: Successful (a) and failed (b) synthesis of ferrocenyl hydrazide R4 and its characterization by 
1H NMR spectroscopy (c) (a) Step (i) tert-Butylcarbazate, EDC, CH2Cl2, rt, 18 h. Step (ii) 1:1 TFA, CH2Cl2, 
0°C. (b) Step (i) H2SO4, MeOH, reflux, 18 h. Step (ii) N2H4.H2O, MeOH, reflux 18 h. (c) 1H NMR spectrum 




Ferrocene polycation (P5) was adsorbed onto sNPs in the presence of NaCl (0 – 200 mM)(Fig. 
40a). These experiments revealed that thicker adsorbed polyelectrolyte layers were obtained 
at higher salt concentrations, see Fig. 40d for DLS hydrodynamic layer thickness (L), which is 
given as a function of [NaCl].  
  
Figure 40: (a) Adsorption of ferrocene polycation P5 onto negatively-charged sNPs. (b) DLS and ZP 
(c) characterization of P5-’coated’ sNPs prepared in the presence of different salt concentrations, 









Figure 41: (a) Layer-by-layer (LbL) adsorption of ferrocene-labelled polycation P5 and polyanion P2, 
which form alternating layers upon polystyrene nanoparticles (sNPs). Between each addition of 
polyelectrolyte the ‘unbound’ polymer chains were removed by repeated centrifugation wash cycles. (b) 
Zeta potential characterization of LbL ‘coated’ sNPs, which is given as a function of the number of 
polymer layers (N). (c) DLS analysis of LbL P5/P2 adsorption on sNPs. These experiments set out to 
prepare thick polyelectrolyte layers upon sNPs, in the hope that addition of salt would ‘screen’ 
electrostatic interactions between oppositely charged polyelectrolyte chains in the LbL assembly, and 
thus result in a clear ‘collapse’ of this architecture by DLS. It was hypothesized that LbL architectures 
formed from Cationic SCPN-1 would resist collapse upon addition of salt on account of intermolecularly 
crosslinking of the adjacent polymer layers. DLS analysis (c), however, revealed larger than expected 
particle sizes (and an increase in PDI) as the number of polymer layers (N) was increased, and thus this 
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In nature, complementary carbohydrate-protein recognition events trigger essential biological 
processes and play a central role in interactions and communication between living cells.1 In 
this chapter, a chemical system is described, in which carbohydrate-receptor interactions were 
exploited to trigger the ‘structural metamorphosis’ of discrete polymer chains into 
intermolecularly crosslinked glycopolymer films upon the surface of 3D nano- and microscale 
objects. Carbohydrate-decorated single chain polymer nanoparticles (glyco-SCPNs) were 
prepared in aqueous solution by intramolecular crosslinking of a linear glycopolymer chain with 
succinic dihydrazide. Specific molecular recognition events between the protein-functionalized 
particles and carbohydrate appendages displayed upon the glyco-SCPNs concentrate 
polymers onto the surface. Crosslinks embedded within these glyco-SCPNs possess a 
dynamic covalent nature that allows for their intra- to inter-chain conversion, which thus 
facilitates the ‘shrink-wrapping’ of particles within an intermolecularly crosslinked polymer film. 
This chapter builds upon previous studies2 on the ‘shrink-wrapping’ of 2D surfaces by 
demonstrating that the ‘shrink-wrapping’ concept can be adapted to the encapsulation of three-
dimensional substrates with micro- and nanoscale dimensionality. Nano-dimensional objects 
possess large surface areas with considerable surface energies, and thus are incredibly 
vulnerable to non-specific adsorption and particle-particle aggregation. These unwanted 
processes presented a considerable barrier in obtaining reliable DLS characterization of 
polymer ‘wrapped’ nanoparticles, and thus the ‘shrink-wrapping’ of 3D nanoscale objects 
proved to be particularly difficult to investigate in the absence of analytical techniques which 
can accurately characterize the formation of nanometre-thick polymer films upon colloidal 
particles. Thus, the ‘shrink-wrapping’ of larger objects of microscale dimensionality was 
investigated, revealing a facile method to probe the ‘wrapping’ process by fluorescence 
microscopy. The successful ‘shrink-wrapping’ of lectin-functionalized silica microspheres was 
accomplished, which constitutes the very first step towards the end goal of ‘wrapping’ bacteria, 







Cell surfaces display a structurally rich array of membrane-bound glycolipids and 
glycoproteins, the exact ‘glycolandscape’ of which are often specific to the species, tissue, and 
cell type.3 Through evolution spanning millions of years, pathogens have learnt to exploit these 
glycolandscapes with great effect, recognising the unique ‘barcode’ of their target host cell and 
tissues. Amongst the vast array of strategies that pathogens use to exploit the host surface and 
escape the defence mechanisms, they display proteins – either lectins, toxins or adhesins – 
which have the capacity to selectively recognize complex oligosaccharides present upon the 
host tissue (Fig. 1) through specific molecular recognition events. Once established, these key 
interactions provide the ‘foothold’ by which pathogens gain first entry to susceptible host cells, 
thus infiltrating the defences to facilitate invasion of the organism.  
Whilst diverse in their shape, size, surface morphology and density of carbohydrate receptors, 
pathogens a-f (Fig. 1) represent a mere cross-section of the > 14004 antigens known to cause 
infectious diseases in humans. Collectively, they impose a great burden on human health, the 
economy and stretch healthcare systems worldwide. Influenza virus (d) alone was predicted to 
have cost the U.S. $10.4 billion in direct medical expenses (2017),5 with annual outbreaks 
causing 3 – 5 million severe illnesses globally6 and up to 646,000 deaths.7  In contrast to the 
serious risk to human health posed by influenza, the bacteria staphylococcus aureus (a), 
pseudomonas aeruginosa (P. aeruginosa)(c) and taxoplama gondii (f) are often responsible for 
less acute illnesses, typically colonising immuno-compromised patients as part of a secondary 
infection, and are thus categorised as ‘opportunistic’ pathogens. The combined effect of these 
antigens, however, places a substantial burden on healthcare systems, with secondary 
Figure 1:  Pathogens (a-f) interact with or adhere to cell surfaces by selective binding of specific 
membrane-bound carbohydrates (i-ii). These recognition events facilitate their entry into cells, thus 




Figure 2: (a) TEM micrograph showing the long ‘sticky’ filaments of E. coli, known as fimbriae. 
Reproduced with permission of ref. 12, copyright of PLoS Biology, 2006. These fimbriae display 
carbohydrate-binding proteins to facilitate adherence to host cells and promote the colonization by 
attachment to neighbouring bacteria.13 (b) Schematic representation of E. coli and its type 1 pili (c) 
assembled by the Fim system. Fim H, located upon the fimbriae tip, is a mannose-binding lectin. 
infections often increasing the length of hospital admissions.8 Whilst diverse in their structure 
and the diseases that they cause, pathogens a-f are united in their dependence on specific 
carbohydrate recognition events to facilitate cell entry. A pathogen ‘capture’ mechanism was 
envisaged in which glyco-SCPNs bearing carbohydrate residues bind to complementary 
receptors located upon the pathogen surface through specific molecular recognition events. 
These interactions are anticipated to concentrate glyco-SCPNs onto the receptor-displaying 
surface and thus drive ‘shrink-wrapping’ of the pathogen within a glycopolymer film. 
3.2.1. Carbohydrate-Binding Pathogens 
The class of carbohydrate-binding proteins known as lectins have significant biological 
consequences, which are often implicated with disease. Pathogens Escherichia coli (E. coli)9 
(Fig. 2a-b) and P. aeruginosa10 (Fig. 1c) are rod-shaped Gram-negative bacteria which display 
mannose- and galactose-binding receptors upon their surfaces, respectively. These receptors 
(lectins) recognise specific carbohydrate residues located upon the surface of host cells, and 
thus facilitate adhesion to host tissues. Carbohydrate receptors are displayed at the ends of 
micro-length hair-like appendages (Fig. 2a) named fimbriae (Fig. 2c), which enhance adhesion 
to host tissues through a ‘catch-bond’ mechanism11 and thus promote colony formation. These 
carbohydrate-binding bacteria have a micron-sized dimensionality, and thus lectin-displaying 
microparticles (Fig. 3) constitute a good model system to begin initial developments towards 
the ‘shrink-wrapping’ of pathogenic bacteria. The overarching aim of this chapter was thus to 






3.3. Results and Discussion 
3.3.1. ‘Shrink-Wrapping’ Overview 
In the previous chapter, complementary electrostatic interactions – the nature of which are 
omni-directional and non-specific – were employed to drive the ‘shrink-wrapping’ of nano- and 
microscale objects. In contrast, this chapter exploits specific molecular recognition events 
between carbohydrate-functionalized SCPNs (glyco-SCPNs) (Fig. 3a, i-ii) and lectin-
functionalized silica particles to facilitate successful ‘wrapping’. These specific interactions 
were hypothesized to drive the concentration of glyco-SCPNs upon the surface of the 
spherical object. Now spatially close, the subsequent ‘structural metamorphosis’ would lead to 
the formation of covalently crosslinked glycopolymer films (Fig. 3a, v). ‘Structural 
metamorphosis’ should be facilitated by the dynamic covalent nature of acyl hydrazone bonds 
(Fig. 3, iv) embedded within the glycopolymer film. Although deceptively simple, this subtle 
‘structural metamorphosis’ of the dynamic covalent crosslinkers constitutes a central pillar 
underpinning the ‘shrink-wrapping’ concept, differentiating this novel concept from 
rudimentary adsorption of non-crosslinked polymer chains (Fig. 3b). 
Figure 3: (a) Overview of the ‘shrink-wrapping’ of lectin-functionalized particles. (i) Concanavalin A 
functionalized nano- or microparticles were incubated with glyco-SCPNs grafted with the 
complementary carbohydrate (mannose hydrazide). (ii) Specific molecular recognition events 
concentrate the glyco-SCPNs upon the Con A particle surface, and this increase in local polymer 
concentration initiates ‘structural metamorphosis’ of the dynamic covalent hydrazone crosslinks (iii) 
contained within the SCPNs. Rearrangement of the intra-chain crosslinks proceeds via component 
exchange (iv) and ultimately leads to the formation of covalently crosslinked polymer films (v) featuring 
inter-chain hydrazone crosslinks which remain ‘dynamic’ in nature. (b) Control experiments with ‘fixed’
glyco-SCPNs (vi) where the crosslinks are ‘non-dynamic’, and linear glycopolymer (vii) where no 
crosslinks are present will demonstrate that the particles have been ‘shrink-wrapped’ within a covalently 




3.3.2. Specific Carbohydrate-Receptor Recognition Events 
In this chapter glyco-SCPNs were designed to exploit specific molecular recognition between 
the carbohydrate-binding protein (lectin) Concanavalin A (Con A) (Fig. 4a, I) and its 
complementary carbohydrate ligand (mannose), which was grafted onto polymer scaffolds and 
intramolecularly crosslinked to produce mannosylated SCPNs (Fig. 4c). Con A is isolated from 
Canavalia ensiformis (Jack Bean) and at neutral pH exists as a tetrameric protein complex14 
(Fig. 4a, I) consisting of four identical 26.5 kDa protein subunits, each containing a single 
carbohydrate binding site. Con A (Fig. 4a, I) possesses a pH-dependent structure, with the 
tetramer (1) dissociating into dimeric structures at pH < 6 (2). Mn2+ and Ca2+ metal ions are 
shown as purple and green spheres, respectively, (Fig. 4a, I) and play a crucial role in stabilizing 
the ‘active’ protein conformation for carbohydrate binding.15 An alternative lectin, heat-labile 
Figure 4: (a) Structures of lectins Concanavalin A (I), Heat-Labile Toxin (II) and their complementary 
carbohydrate ligands (b). At pH > 6 Con A exists as a tetramer (1) consisting of four identical 28 kDa 
subunits. Mn2+ (purple) and Ca2+ (green) metal ions – the positions of which are highlighted – are 
necessary to maintain Con A in an ‘active’ conformation for carbohydrate binding. At pH < 6 Con A 
dissociates into dimeric structures (2). (II) Structure of Heat-Labile Toxin pentamer, with its 
associated carbohydrate ligands. (b) Structures of carbohydrate ligands which selectively bind to 
Con A (c) and LTB (d). The respective Kd values are given for binding to tetrameric Con A16  and 




toxin (LTB) (Fig. 4a, II) was also employed for control experiments,* on account of its lack of 
binding to mannose residues located upon the glycopolymer scaffolds. LTB (Fig. 4a, II) is a 
galactose-binding protein secreted by the pathogenic bacteria E. Coli. Belonging to the AB5 
family of toxins, LTB features a ring-like structure (Fig. 4a, II) consisting of five 18.5 kDa B 
subunits, each of which presents a single carbohydrate binding site. LTB selectively binds 
galactose residues (Fig. 4b, IV) and its complex oligosaccharide derivatives with moderate 
binding constants. In contrast, Con A selectively binds D-glucose (Kd ≈ 267 mM),16 D-mannose 
(Kd ≈ 166 mM),16 and α-D-methyl mannopyranoside (Kd ≈ 30 mM),16 with a slight preference for 
the latter carbohydrates (Fig. 4b, III). Although these binding constants appear relatively low, 
this issue can be circumnavigated by multivalent expression of carbohydrates upon a polymer 
scaffold, where an ensemble of low-affinity supramolecular interactions reinforce one another 
to facilitate high-affinity binding of glycopolymer to the lectin substrate.17 Glyco-SCPNs bearing 
multiple pendant mannosyl groups were thus selected for synthesis (Fig. 4c). The building 
blocks from which these glyco-SCPNs are constructed will now be discussed, starting with the 
aldehyde-functionalized polymer scaffolds onto which mannose hydrazide is grafted. 
3.3.3. Synthesis of Aldehyde-Functionalized poly(Acrylamide) Scaffolds 
Aldehyde-functionalized copolymer scaffolds (P1 - P5) were prepared by RAFT polymerization 
(Fig. 5a) of aldehyde monomer M1 and N,N-dimethylacrylamide (DMA), affording a range (5 – 
25 %) of aldehyde densities (Fig. 5b). 1H NMR spectroscopy and gel permeation 
chromatography (GPC) characterization of acrylamide-based scaffolds P1 - P5 was entirely 
consistent with previous literature reports2 and allowed for the polymer composition (m + n), 
degree of polymerization (Dp), molecular weight and polydispersity index (PDI) to be 
determined (Fig. 5b). GPC traces of P1 - P4 (Fig. 5c) revealed monomodal distributions with 
low PDI values, indicative of controlled RAFT polymerization processes. A limitation of the 
acrylamide-based aldehyde scaffolds, however, is their poor solubility in aqueous solutions. 
Polymer scaffolds which contained > 30 % aldehyde (M1) unit were virtually insoluble in 
aqueous solution, and thus were excluded from further study.†  
 
* In order to prove that the ‘shrink-wrapping’ of Con A-functionalized microparticles (MP2) was driven by specific  
mannose-Con A recognition events, ‘wrapping’ experiments were performed on silica microparticles functionalized 
with the galactose-binding lectin LTB to afford microparticles (MP5) (see page 105, Table 1) which were absent in 
the complementary receptor for the mannose residues located upon the SCPNs. 
 
† The observed lack of aqueous solubility was rationalized by the highly hydrophobic nature of the benzaldehyde 
(M1) moiety, which was not sufficiently compensated by the hydrophilicity of DMA comonomer. To address these 
inadequacies with the acrylamide scaffold, a new generation of aldehyde-functionalized scaffold was prepared (see 
pages 121-122), which featured high aqueous solubility even at > 50 % aldehyde content. The abundance of 
hydrophilic poly(ethylene glycol) units offsets the highly hydrophobic nature of the benzaldehyde unit, whilst 
allowing for a neutral polymer backbone which carries no electrostatic charge – an important requirement when the 
intention is to reversibly bind to polymer scaffolds with complex biomacromolecular targets, such as virus-like 




3.3.4. Synthesis of Mannose Hydrazide 
Mannose hydrazide residue (MAN) was synthesized in three steps and isolated as an off-white 
solid (1.36 g, 40 % yield) (Fig. 6a). Characterization of MAN was consistent with previous 
literature reports,2 revealing successful isolation of the α-anomer. Deliberate inclusion of the 
hydrophobic phenyl moiety at the reducing end of the carbohydrate was anticipated to 
enhance the binding constant of MAN to its complementary carbohydrate-binding proteins. 
Intermediate 3 was prepared by a Lewis acid-catalysed glycosylation (Fig. 6a, i) of acetate-
protected D-Mannose, purified by column chromatography and isolated by recrystallization to 
afford large cubic platelets of the α-anomer 3. Deacetylation of 3 furnished the deprotected 
sugar 4 and subsequent hydrazinolysis of the methyl ester afforded mannose hydrazide (MAN). 
1H NMR spectroscopy (Fig. 6b) revealed MAN was isolated as the α-anomer (●, δ 5.68 ppm). 
Figure 5: (a) Preparation of aldehyde-functionalized polymer scaffolds (P1-P4) by RAFT polymerization 
of M1 with dimethylacrylamide. (b) Table of GPCb and 1H NMR spectroscopya end-group 
characterization. (c) GPC traces of P1 and P3 - P5, obtained in DMF + 1 g/L LiBr. (d) 1H NMR (CDCl3, 




3.3.5. Synthesis and Characterization of Mannose-Grafted Scaffolds 
Mannose hydrazide (MAN) was grafted onto aldehyde-functionalized copolymers (P1 - P5) 
(Fig. 7a) through hydrazone formation to afford a series of glycopolymers (P1-MAN - P5-MAN) 
that display a range of carbohydrate (MAN) densities. P1-MAN - P5-MAN were then purified 
by dialysis against DI water, lyophilized to afford white solids and then characterized by 1H NMR 
spectroscopy. Figure 8e shows a representative 1H NMR spectrum of mannose-functionalized 
scaffold P3-MAN after purification by dialysis. For fluorescence microscopy experiments, 
glycopolymers (P1-MAN - P5-MAN) were additionally labelled (Fig. 7b) with small quantities of 
dansyl hydrazide (DAN) (1 - 2 equivalents per polymer chain).  
 
Figure 6: (a) Synthesis of mannose hydrazide residue (MAN). Step (i) BF3.Et2O, dichloroethane, 50 ºC, 
18 h. Step (ii) NaOMe, anhydrous MeOH. Step (iii) H2NNH2.H2O, MeOH, reflux, 18 h. (b) Partial 1H NMR 
spectrum (D2O, 300 MHz) of MAN. 
Figure 7: Aldehyde scaffolds (P1 - P5) were ‘decorated’ with mannose hydrazide (MAN) (a) to afford 
linear glycopolymers (P1-MAN – P5-MAN) of varying mannose density. For fluorescence microscopy 
experiments, these glycopolymers were additionally labelled (b) with small quantities of dansyl 




Grafting of MAN onto polymer scaffolds (P1-P5) was monitored by 1H NMR spectroscopy (Fig. 
8a-d), which revealed complete ‘decoration’ of aldehyde functionality, as evidenced by the 
disappearance of ‘diagnostic’ (●) aldehyde signal at δ 10.02 ppm and broadening of signals 









Figure 8: Grafting of mannose hydrazide (MAN) to aldehyde-functionalized copolymers (P1 - P5) was 
monitored by 1H NMR spectroscopy. Representative 1H NMR spectra (D2O, 300 MHz) of: (a) Aldehyde 
scaffold P3 (b) MAN residue,  (c) P3 (1.2 mM) + MAN (30.2 mM) after 10 min and (d) after 2 h at room 
temperature, 50 mM H4NOAc-AcOH/D2O (pD 4.5), stoichiometry of aldehyde unit (P3) : MAN = 1 : 1.50. 
(e) Assigned 1H NMR spectrum (d6-DMSO, 300 MHz) of MAN-grafted polymer scaffold (P3-MAN) after 




3.3.6. Synthesis and Characterization of Acrylamide Glyco-SCPNs 
A series of glyco-SCPNs bearing pendant mannosyl groups (MAN-SCPNs) were prepared by 
intramolecular crosslinking of linear glycopolymer chains (P1-MAN - P5-MAN) with succinic 
dihydrazide (SD) (Fig. 9a), which afforded MAN-SCPNs featuring a range of mannose 
densities. Addition of excess NaCNBH3 to ‘dynamic’ MAN-SCPNs (dyn-MAN-SCPNs) (Fig. 9b) 
afforded chemical reduction of the dynamic covalent hydrazone bonds to the corresponding 
amine, thus yielding ‘fixed’ MAN-SCPNs (fix-MAN-SCPNs). This step was taken as 
precautionary measure to ensure that no unwanted intermolecular crosslinking of MAN-SCPNs 
occurred during their characterization by GPC analysis (Fig. 10b-e). 
3.3.7. GPC Characterization of SCPN Formation 
The successful formation of SCPNs can be confirmed by GPC, which reveals a chain collapse 
consistent with intra-chain crosslinking (Fig. 10a), if successful intramolecular crosslinking has 
occurred.18 MAN-SCPNs were thus characterized by GPC analysis (Fig. 10b-c), which revealed 
the intramolecularly crosslinked fix-MAN-SCPN chains displayed a small increase in retention 
time (RT) relative to their corresponding linear glycopolymer scaffolds (P2-MAN - P3-MAN), 
an observation which was consistent with the intra-chain crosslinking expected during the 
formation of SCPNs. 
Figure 9: Preparation of MAN-SCPNs. Linear glycopolymers (P1-MAN – P5-MAN) were 
intramolecularly crosslinked (a) with succinic dihydrazide (SD) under high dilution to afford dyn-
MAN-SCPNs. (b) Addition of excess NaCNBH3 to dyn-MAN-SCPNs afforded chemical reduction of 




Glycopolymers that featured MAN densities > 18 % (P4-MAN – P5-MAN) were observed to 
have (i) broadening of their GPC traces (Fig. 10d-e), (ii) evidence of peak tailing and (iii) less 
pronounced RT shift, observations which indicated that these glycopolymers exhibited an 
interaction with the GPC columns. Furthermore, these same high MAN density glycopolymers 
featured diminished aqueous solubility, such that the 25 % MAN polymer (P5-MAN) was almost 
completely insoluble in water at > 5 mg/mL.‡ Intriguingly, the corresponding aldehyde scaffolds 
(P2 – P5) were all water soluble at 10 mg/mL, and solubility issues only arose after grafting 
with mannose hydrazide, a residue which was anticipated to be highly hydrophilic in nature. It 
was hypothesized that the poor aqueous solubilities of P4-MAN and P5-MAN arises on account 
of these mannosylated polymer scaffold containing two aromatic moieties (Fig. 11c, shown in 
blue/red), which present a highly hydrophobic region within the grafted glycopolymer, 
sufficient to disrupt the hydrophilic/hydrophobic balance in favour of precipitation in water.§ 
 
‡ P3-MAN and their corresponding SCPNs (dyn-MAN-SCPNs) were employed for ‘shrink-wrapping’ experiments 
within this chapter, on account of this polymer scaffold displaying a reasonable aqueous solubility of ≥ 5 mg/mL, 
together with it displaying a relatively high number of carbohydrate (MAN) residues. 
 
§ It was observed that small changes in the polymer composition afforded significant changes in the aqueous 
solubility of glycopolymers P1-MAN – P5-MAN. P3-MAN afforded the optimum balance between high mannose 
density versus reduced aqueous solubility. 
Figure 10: (a) Intramolecular crosslinking of P1-MAN – P5-MAN with succinic dihydrazide (SD) was 
anticipated to afford contraction of the polymer chain, resulting in a smaller hydrodynamic diameter and 
corresponding increase in the retention time observed by GPC. (b-e) GPC characterization of linear 
glycopolymers (P2-MAN – P5-MAN) (orange lines) and their corresponding fix-MAN-SCPNs (blue, 
black, purple lines), containing 1, 2 or 3 equivalents of crosslinker (SD). (b-c) GPC traces showing 
successful formation of SCPNs, as evidenced by the increase in RT upon crosslinking. (d-e) Failed GPC 
characterization (ii) of fix-MAN-SCPNs, was observed on account of broadening of the GPC traces 
which was observed at for scaffolds displaying higher carbohydrate densities. All GPC analysis was 




To achieve the goal of ‘shrink-wrapping’ Con A-functionalized nano- and microparticles 
within aqueous solution requires mannosylated glycopolymers with good water solubuility, but 
also a sufficient number of mannose units located upon their periphery for binding to Con A. 
However, mannosylated polymers prepared from acrylamide-based scaffolds (Fig. 11a-b), 
featured poor aqueous solubilities on account of the hydrophobic nature of the benzaldehyde 
unit of M1 (Fig. 11c). In order to satisfy the requirements for aqueous solubility, glycopolymers 
featuring ≤ 18 mannose (MAN) units per polymer chain were prepared. This number, however, 
is further decreased to just 10 - 15 MAN units after intramolecular crosslinking (Fig. 11d) of 
the linear glycopolymer with succinic dihydrazide, on account of mannose hydrazide being 
displaced through hydrazone exchange reactions.** MAN-SCPNs prepared from P3-MAN were 
utilized for the ‘shrink-wrapping’ experiments discussed within this chapter, on account this 
glycopolymer featuring the highest density of mannose, whilst retaining reasonable aqueous 
solubility. In the next section (pages 107 - 120), “dyn-MAN-SCPNs” refers specifically to 
SCPNs prepared from P3-MAN, which contain 1 dynamic covalent acyl hydrazone crosslink 
per polymer chain, and “fix-MAN-SCPNs” are the corresponding non-dynamic form. 
 
** Note that future optimization of the ‘shrink-wrapping’ chemistry will likely require the density of both MAN and 
crosslinker (SD) residues to be adjusted, such that dyn-MAN-SCPNs display the optimal carbohydrate/crosslinker 
composition for the complete encapsulation of Con A substrates within covalently crosslinked glycopolymer films.  
Figure 11: (a) Acrylamide-based aldehyde scaffolds (P1, P2, P4) with varying aldehyde densities, all 
were water-soluble at 10 mg/mL (b) Linear mannose-grafted polymers P1-MAN, P2-MAN and P4-MAN
display increasing carbohydrate densities. (c) Mannose was grafted to polymer scaffolds through 
dynamic covalent acyl hydrazone bonds. Inconveniently, the hydrophobic aromatic moieties (shown in
red/blue) reduced the aqueous solubility of the ‘decorated’ glycopolymers, presumably by disrupting 
the hydrophilic/hydrophobic balance. Glycopolymers with > 18 % MAN displayed very limited water 
solubility, with > 20 % MAN being virtually insoluble. (d) Intramolecular crosslinking of P2-MAN – P4-




3.3.8. Preparation of Protein-Functionalized Nano- and Microparticles 
Con A particles were prepared in a range of particle sizes (diameters: 100 nm – 20 µm) to allow 
for ‘shrink-wrapping’ to be investigated on nanoscale and microscale substrates. Initial 
experiments typically utilized Con A particles with smaller diameters (100 nm, 300 nm) to allow 
for ‘shrink-wrapping’ to be monitored by DLS measurements. Later investigations were 
performed on much larger Con A microspheres (5 µm and 20 µm), the ‘wrapping’ of which was 
probed by fluorescence microscopy. Table 1 provides a summary of all the particles employed 
in this chapter, detailing their size, ‘core’ material, and surface functionality. Con A-
functionalized particles were prepared via two methods: (i) Immobilization of biotinylated Con 
A onto streptavidin-functionalized polystyrene particles (Fig. 12a), and (ii) covalent attachment 
of Con A onto NHS-functionalized silica particles (Fig. 12b). Con A particles were then purified 
by six consecutive centrifuge-wash-resuspend cycles to remove the excess ‘unbound’ Con A.  
Figure 12: Preparation of Con A-functionalized particles. (a) Immobilization of biotinylated-Con A onto 
streptavidin-modified polystyrene particles (smNPs or smMPs). (b) Covalent attachment of Con A onto 
NHS-functionalized silica particles. Unreacted NHS-ester sites were then ‘capped’ with glycine and the 
particles purified by centrifugation. (c) Preparation of Con A microparticles (b) was optimized by 
preparing a range of 5  µm microparticles (MP9 - MP13) with varying surface densities of Rh-Con A. 
MP9 - MP13 were observed by fluorescence microscopy (i), which revealed emissive coronas localized 
to the particle surface, indicating successful modification with the lectin. (ii) Bright field microscope 
images. The measured particle brightness (MGV) (d) was observed to directly correlate with the dose 




Initial ‘wrapping’ experiments were conducted on NP1 and MP1, particles which consist of a 
streptavidin-functionalized polystyrene ‘core’ (Fig. 12a).†† Later ‘wrapping’ experiments utilized 
MP2 – MP5, 5 µm microparticles which contain a silica-NHS ‘core’ (Fig. 13b).‡‡ 
Con A nanoparticles (NP1) were prepared by titration of biotinylated-Con A (b-Con A) into a 
solution of streptavidin-modified polystyrene nanoparticles (smNPs) with a diameter of 100 
nm. The resultant Con A particles (NP1) were characterized by DLS (Fig. 13b), which revealed 
a 14 nm increase in hydrodynamic diameter, Dh, consistent with the attachment of a b-Con A 
monolayer (7 nm layer thickness, L) onto the particle surface. To confirm the successful 
immobilization of b-Con A onto smNPs, a fluorescence assay (Fig. 13c) (see experimental, 
page 140 for procedure) was conducted with biotin-4-fluorescein (B4F).  
 
†† Results obtained by DLS (page 107), ELLA assay (pages 109 - 112) and fluorescence microscope (pages 112 - 
117), however, revealed that acrylamide-based glycopolymers bind non-specifically to the underlying streptavidin-
modified particle surface. These issues of non-specific binding are discussed on pages 117 - 119. 
 
‡‡ The ‘shrink-wrapping’ of 20 µm Con A microparticles (MP6 – MP8) was also explored, however, these particles 
were observed to undergo fragmentation during their purification by centrifugation, and thus ‘wrapping’ experiments 
were instead conducted with 5 µm microparticles (MP2 – MP5), which were not observed to fragment under 
centripetal force. 
 




The B4F assay reported (Fig. 13d, i) the ‘free’ biotin binding capacity (BC) of smNPs to be 57 
pMol/mg – a value which was anticipated to decrease upon the addition of biotinylated-Con A, 
on account of it binding to the available streptavidin sites upon the particle surface. As 
anticipated, the assay results (Fig. 13d, ii) revealed a decrease in BC relative to smNPs (Fig. 
13d, i), consistent with the attachment of b-Con A. 
 
Figure 13: (a) Immobilization of biotinylated Con A onto smNPs (streptavidin-modified particles, 100 nm). 
The resulting Con A NPs (NP1) were purified by centrifugal washing. Attachment of biotinylated Con A 
(b-Con A) onto smNPs was confirmed by DLS (b), which revealed a small (14 nm) increase in 
hydrodynamic diameter (Dh), and B4F fluorescence assay (c) where the anticipated reduction in the biotin 
binding capacity (BC) was observed. (b) DLS analysis of ‘naked’ smNPs and Con A-immobilized NP1. (d) 
Table of biotin binding capacity of (i) ‘naked’ smNPs, (ii) Con A-immobilized NP1 and (iii) biotin-
immobilized smNPs (negative control) and the approximate number of Con A tetramers per particle. (e) 
Normalized emission profiles obtained by titration of B4F into particles (i)-(iii). Details of the normalization 




3.3.9. ‘Shrink-Wrapping’ Studies with Con A-Immobilized Streptavidin-Modified 
Polystyrene NPs with Acrylamide-Based Glycopolymers 
DLS ‘Wrapping’ Experiments 
DLS studies were conducted to investigate the ‘shrink-wrapping’ of 100 nm Con A particles 
within glyco-SCPN films (Fig. 14a). Con A particles (NP1) were incubated with both crosslinked 
SCPNs (dyn-MAN-SCPNs) (Fig. 14a, 1) and linear glycopolymer (P3-MAN (Fig. 14a, 2) for 24h 
at pH 4.5, which afforded suspensions of ‘wrapped’ NP1 (Fig. 14a, ii) and ‘coated’ NP1 (Fig. 
14a, v), respectively. ‘Unbound’ glycopolymer chains were removed by centrifugation and then 
the ‘wrapped’/’coated’ particles were characterized by DLS (Fig. 14b, before αMM).  
Figure 14: ‘Shrink-wrapping’ of Con A particles (NP1) was investigated by DLS analysis. (a) Schematic 
overview of the ‘wrapping’ experiment. Addition of dyn-MAN-SCPNs (i) was anticipated to afford Con 
A particles ‘wrapped’ within a covalently crosslinked glycopolymer film (ii), which cannot be displaced 
upon addition of αMM (iii). Control experiments with linear glycopolymer P3-MAN (1) and fix-MAN-
SCPN (2), however, were expected to afford ‘coated’ particles, which can readily be displaced by 
incubation with αMM (vi). (b) DLS analysis during ‘wrapping’ experiment (a). Z-average hydrodynamic 
diameter, Dh is reported. (c) Apparent thickness of particle-bound glycopolymer layers. (d) Addition of 




As described in Chapter 2 the apparent thickness, L (Fig. 14c) of the adsorbed polymer layer 
was derived by subtracting Dh of the ‘naked’ particle (NP1) from that of the ‘wrapped’/’coated’ 
particles and then dividing by 2. Results in Figure 14c show that ‘coatings’ formed from fix-
MAN-SCPNs and linear glycopolymer P3-MAN were 14 and 18 nm thick, respectively, whereas 
polymer ‘wrappings’ formed from dyn-MAN-SCPNs were reported to be > 608 nm. Whilst this 
number is not an accurate reflection of the polymer layer thickness, it suggests that the addition 
dyn-MAN-SCPNs drives the formation of multi-particle aggregates (Fig. 14d), whereas the 
control polymers (fix-MAN-SCPNs and P3-MAN) do not. Next, the displacement of the polymer 
layers was attempted (Fig. 14a), in order to provide further evidence of successful ‘shrink-
wrapping’.  
‘Wrapped’ and ’coated’ particles were incubated with excess α-methyl mannose (αMM), a 
monosaccharide which was anticipated to fully displace the bound glycopolymer from the 
particle surfaces by out-competing the polymer chains in their binding to the surface-bound 
Con A. It was hypothesized that glycopolymer films formed from dyn-MAN-SCPNs (Fig. 14a, i - 
iii) should not be displaced on account their ability to undergo ‘structural metamorphosis’ and 
form inter-chain crosslinks, and thus cannot be removed by simply inhibiting the mannose-Con 
A interaction. Control experiments with fix-MAN-SCPNs and P3-MAN, however, do not contain 
intermolecular crosslinks, and thus should be readily displaced. However, layer thicknesses 
determined after αMM incubation (Fig. 14c, green bars) revealed that control polymers 
showed little or no reduction in the thickness of the adsorbed glycopolymer layer (relative to 
purple bars), which suggests that the polymer chains remain adhered to NP1. As anticipated 
the thickness of the dyn-MAN-SCPN ‘wrapped’ layer decreased substantially after αMM, now a 
plausible value of 50 nm. Intriguingly, the ‘wrapped’ layers were considerably thicker than of 
the control polymers, consistent with a network of multiple crosslinked layers upon the particle 
surface. In summary, these DLS studies provided some evidence of successful ‘shrink-
wrapping’. However, issues of low colloidal stability were observed, leading to particle-particle 
aggregation. These unwanted processes were shown to increase the sample polydispersity, 
thereby reducing the accuracy with which DLS analysis can characterize the thickness (L) of 
surface-bound polymer films. It was thus concluded that numbers deduced from DLS 
‘wrapping’ experiments should be treated with caution and the decision was made to explore 





Enzyme-Linked Lectin Assay (ELLA) 
To further investigate the displacement of glycopolymer films from Con A nanoparticles (NP1), 
an enzyme-linked lectin assay (ELLA) protocol was developed (Fig. 15). This inhibition-type 
ELLA reported the relative concentrations of mannose-functionalized polymer scaffold (P3-
MAN) with an assay readout (absorbance) that was inversely proportional to the glycopolymer 
concentration bound upon the particle surface. This ELLA experiment utilizes Con A-HRP 
conjugate, where enzyme (HRP) is covalently linked to the mannose-binding lectin Con A, thus 
allowing for the inhibition assay. Readout was observed as a blue colour, which develops on 
account of the ABTS substrate with the enzyme horseradish peroxidase (HRP) (Fig. 15a).  
The standard protocol for the inhibition-type ELLA experiment (Fig. 15b) begins (1) with the 
incubation of glycopolymer ‘coated’ Con A particles in 0.25 mg/mL Con A-HRP, pH 7.4 PBS, 
rt, 1 h. Of the total number of Con A-HRP conjugates ΧTOT, a portion ΧA (Fig. 15b, 2) will bind 
to the glycopolymer upon the Con A particle surface, and thus be removed by the subsequent 
washing step (2). Step (2) was employed to remove the particles from the solution by 
successive pelleting (5 x 25 min 15 000 rcf), after which the supernatant liquid was transferred 
(3) to a mannan-coated 96-well plate and incubated for 1 h at rt, allowing the remaining Con 
Figure 15: Inhibition-type ELLA assay of glycopolymer ‘coated’ Con A particles. (a) Assay readout is 
produced by the reaction of ABTS with the enzyme horseradish peroxidase, which was covalently 
linked to the lectin Con A. (b) Protocol for running ELLA assay. (1) ‘Coated’ Con A particles were 
incubated with Con. A-HRP for 1 h at rt, then the particles were pelleted by centrifugation (2), and thus 
ELLA reports the readout from Con A-HRP which is not bound to the particle. The supernatant liquid 
was transferred (3) to a mannan-immobilized 96-well plate and incubated for 1 h at rt. Mannan is a 
plant-derived oligosaccharide (a linear polymer of the sugar mannose) onto which Con A-HRP will bind. 
Washing (4) the 96-well plate ensured the removal of non-specifically adhered objects. (5) 




A-HRP to bind to the mannan surface. Non-specifically bound Con A-HRP was removed by 
washing (4) the plate three times with 0.01% Tween 20-PBS buffer (PBST), then assay readout 
was obtained by addition of ABTS/H2O2 solution to develop the blue colour. After 30 min the 
reaction was quenched by addition of 100 mM H2SO4 and the absorbance (λmax = 420 nm) was 
measured on a plate reader. Utilizing this protocol, an ELLA experiment (Fig. 16a) was 
performed on Con A particles (NP1) which had been ‘coated’ with a range of glycopolymer 
doses ranging from 0 - 5 µg/mg (µg glycopolymer per mg of NP1)(Fig. 16a). 
‘Coated’ particles CP1 - CP4 were purified by centrifugal washing to ensure the removal of 
‘unbound’ glycopolymer. ELLA results (Fig. 16b, i) revealed that, as anticipated, readout 
(absorbance) was inversely proportional to the polymer dose (CP1 and CP2 feature low 
absorbance relative to CP4). Alternatively, these results can be presented as a % inhibition plot 
(Fig. 16b, ii). Note that the x- and y-axes indicate; (i) the concentration of particles and (ii) the 
polymer dose present in each sample prior to running the ELLA protocol. As anticipated, the 
control samples (PD = 0 µg/mg) where no glycopolymer was added showed the highest 
Figure 16: (a) Preparation of glycopolymer ‘coated’ particles (CP1-CP4) with a range of polymer doses. 
Coated particles were purified by centrifugation to remove any unbound glycopolymer. (b) ELLA assay 
results for coated particles CP1-CP4. Bars show the average absorbance, where n = 3. Concentrations 




absorbance values (Fig. 16b, i) and, importantly, no significant absorbance decrease was 
observed upon increasing the particle concentration (blue bars, right-to-left). In contrast, the 
PD = 5 µg/mg results (yellow bars) revealed a steady absorbance decrease as particle 
concentration was increased, which manifests as an increase in % inhibition (Fig. 16b, ii). Taken 
together, these observations indicate that it is the concentration of glycopolymer present upon 
the surface of ‘coated’ Con A particles which gives rise to the observed inhibition effect. Whilst 
it was not possible to determine the absolute glycopolymer concentrations bound to the 
particle surfaces, the ELLA could, however, report the relative amounts of surface-bound 
glycopolymer with reasonable accuracy – a parameter which was more than adequate to the 
purposes of investigating the displacement of glycopolymer films from particle surfaces.  
Further ELLA experiments (Fig. 17) were undertaken to investigate the displacement of the 
glycopolymer layers from ‘coated’ Con A particles. ‘Coated’ Con A particles CP5-CP11 (Fig. 
17a) were prepared (PD = 0 – 15 µg/mg)(see Fig. 17b) and the excess glycopolymer was 
removed by centrifugal washing. After purification CP5-CP11 were each split into two equal 
aliquots: (A) which were incubated with αMM for 24 h at 37 °C and thus was anticipated to 
have no surface-bound glycopolymer. The control experiment (B) was absent in αMM, and 
thus no displacement of the glycopolymer layer was anticipated. 
Figure 17: ELLA assay to investigate the displacement of P3-MAN glycopolymer coating. (a) 
Preparation of glycopolymer (P3-MAN) coated particles (CP5-CP11) with polymer doses (b) ranging 
between 0 – 15 µg/mg. (c) ELLA assay results before (i) and after (ii) incubation with αMM to 
displacement of the glycopolymer coating. Concentrations of assay reagents were [Con A-HRP] = 15 




Surprisingly, the subsequent ELLA results revealed only subtle differences before (Fig. 17c, i) 
and after (ii) incubation with αMM. Both showed 50 % inhibition at PD = 15 µg/mg, an 
observation which indicates that the glycopolymer layer was not successfully displaced by the 
conditions employed. Note that the 30 % ‘background’ inhibition observed in the αMM dataset 
(Fig. 17c, ii) at PD < 1 µg/mg was rationalized by the presence of residual αMM 
monosachaaride, which was not fully removed by 5 x centrifugal washes.  
In summary, although the ELLA assay offered a method for quantifying relative amounts of 
glycopolymer upon the surface of Con A particles, the results indicated that incubation with 
αMM did not successfully displace the linear (P3-MAN) glycopolymer layer. This observation 
suggests that the glycopolymer was perhaps non-specifically bound to the particle surface. 
The failure of this control experiment was significant, in that it was important to successfully 
demonstrate that linear glycopolymers (non-crosslinked) can successfully be displaced, 
whereas dyn-MAN-SCPNs form crosslinked glycopolymer films which cannot be displaced. In 
the absence of this control experiment, it would not be possible to prove the ‘shrink-wrapping’ 
concept occurred as envisaged.  
On account of both ELLA assay and DLS affording somewhat inconclusive results, the decision 
was made to utilize an alternative strategy involving the ‘shrink-wrapping’ of 5 µm lectin-
modified microparticles, which were large enough to be investigated by fluorescence 
microscopy. Inclusion of the fluorescent dye (dansyl hydrazide) within the polymer scaffold, 
facilitated imaging of the glycopolymer as it adhered to the periphery of the particles (Fig. 18). 
The decision to move towards the ‘shrink-wrapping’ of micron-sized objects, and away from 
unreliable light-scattering measurements of nanometre-sized objects, is a significant turning 
point in this chapter, which allowed the project to successfully develop. 
Monitoring ‘Shrink-Wrapping’ by Fluorescence Microscopy 
‘Shrink-wrapping’ of micron-sized lectin-immobilized substrates was studied by fluorescence 
microscopy. Dansyl fluorescence tags incorporated upon the polymer scaffold enabled the 
visualization of its attachment to particle surfaces. Preliminary ‘wrapping’ experiments (Fig. 
18a) with dyn-MAN-SCPNs (prepared from dansyl-labelled P3-MAN with 1 eqv. of crosslinker) 
were undertaken to identify the optimal polymer dose to successfully encapsulate Con A 
microparticles (MP1, Table 1) within a glycopolymer film. MP1 (1 mg/mL) were treated with 
dyn-MAN-SCPNs at a range of polymer doses (PD ≈ 0 – 1000 µg/mg), then the particles were 





Microscope images (Fig. 18b) revealed that in the absence of glycopolymer (i) no emission 
was observed, whilst at higher polymer doses (PD ≈ 1 - 100 µg/mg) (iii - v) the glycopolymer 
was observed as a bright emissive corona localized at the particle surface.  At PD = 1000 µg/mg 
(vi), however, the emission observed from dansyl-labelled dyn-MAN-SCPNs were not 
exclusively localized at the particle surface (see Fig. 18b, vi), indicating the presence of excess 
glycopolymer which was not interacting with the Con A-functionalized surface. Intriguingly, the 
addition of relatively low polymer doses (PD = 0.1 - 1 µg/mg) (see Fig. 18b, iii, x 40) afforded 
particles which were encapsulated within thick glycopolymer layers, with large polymer-coated 
aggregates observed after several hours. To further investigate this phenomenon, the gradual 
build-up of glycopolymer films upon Con A microparticle surfaces was monitored as a function 
of time (Fig. 19a) for three polymer doses: (i) 0.1 µg/mg, (ii) 1 µg/mg and (iii) 100 µg/mg. 
dyn-MAN-SCPNs were incubated with MP1 and microscope images (Fig. 19a) were obtained 
after 10 min, 3 h , 5 h and 18 h. Inspection of these images reveals that dyn-MAN-SCPNs build 
up slowly into thick glycopolymer films over an 18 h timeframe, eventually leading to the 
formation of 10 - 50 µm ‘wrapped’ multi-particle aggregates which were entirely encapsulated 
with glycopolymer film. This promising result was entirely consistent with the hypothesis that 
thick glycopolymer films may slowly build up over time, as succinic dihydrazide residues 
undergo slow component exchange processes which leads to the steady ‘growth’ of 
intermolecularly crosslinked films (Fig. 19c) located upon the particle surface.  
Figure 18: (a) Shrink-wrapping of Con A particles MP1 by dyn-MAN-SCPN. (b) Fluorescence 
microscope images (x 10 and x 40 magnification) were obtained for ‘shrink-wrapped’ particles after 24 
h. A range of polymer doses (0 – 1000 µg/mg) were explored (i-vi), where polymer dose (PD) is defined 




Figure 19: Time-resolved shrink-wrapping experiment. Fluorescence microscope images (a) were 
obtained at different time points after adding dyn-MAN-SCPNs to MP1 (Con A particles). A range of 
polymer doses were explored: (i) 0.1 µg/mg, (ii) 1 µg/mg and (iii) 100 µg/mg. The slow emergence of 
a brightly emissive corona around the periphery of the particles suggests that glycopolymer films build 
up gradually upon the particle surface over a 24 h timescale. Further analysis of these images afforded 
the average particle brightness as function of time, which is expressed as the mean gray value (MGV). 
(b) MGV plots (iv-vi) were obtained from image sets (i-iii) and error bars indicate the standard deviation. 
The brightness of ‘wrapped’ MP1 aggregates was determined by further processing of 
microscope images within ImageJ software to afford the mean gray value (MGV), a parameter 
which correlates with the brightness of particles within the image.§§ MGV values report on the 
brightness of fluorescence within the image, and thus a higher MGV indicates a higher 
concentration of dansyl-labelled polymer upon the particle surface. The mean grey values 
(MGVs) of the ‘wrapped’ MP1 aggregates were plotted as a function of time (Fig. 19b, iv-vi). 
  
 
§§ Mean Gray Value (MGV) is defined as the average gray value within the selection. This is the sum of the gray 
values of all the pixels in the selection divided by the number of pixels. MGV has a maximum value 255 (a white 
pixel) and a minimum of 0 (a black pixel). The higher the MGV, the brighter the pixels within the selection, which is 




Repeating the above experiment with P3-MAN, a linear glycopolymer which contains no 
crosslinks, afforded ‘coated’ particle aggregates (Fig. 20) which were very similar in 
appearance to the ‘wrapped’ Con A particles (Fig. 19a). Furthermore, the non-crosslinked 
glycopolymer films build up at a comparable rate to those formed from dyn-MAN-SCPNs, 
indicating that the gradual build-up of glycopolymer-coated aggregates should not be 
attributed to the formation of intermolecularly crosslinked glycopolymer films. Although dyn-
MAN-SCPNs had most likely undergone successful ‘metamorphosis’ to form crosslinked 
glycopolymer films upon the microparticle surface, fluorescence microscope images revealed 
no obvious differences in the appearance of dyn-MAN-SCPNs ‘wrapped’ MP1 (Fig. 19a) and 
P3-MAN ‘coated’ MP1 (Fig. 20). In pursuit of definitive evidence of ‘shrink-wrapping’, 
experiments were conducted to investigate the displacement of glycopolymer layers from the 
particle surface (Fig. 21). 
It was hypothesized, on account of their intermolecularly crosslinked nature, that dyn-MAN-
SCPN films (Fig. 21a, i - iii) should be significantly more difficult to displace from the particle 
surface than ‘coatings’ formed from linear glycopolymer. If dyn-MAN-SCPNs (i) have 
successfully ‘shrink-wrapped’ MP1 with an intermolecularly crosslinked polymer film (ii), then 
incubation with overnight αMM will reveal that those polymer films cannot be displaced, and 
thus MP1 should remain ‘wrapped’ (iii). In contrast, a control experiment with non-crosslinked 
glycopolymer P3-MAN (Fig. 21a, iv) yields ‘coated’ MP1 (v). Incubation with αMM is thus 
Figure 20: Control experiment in which MP1 (Con-A immobilized particles, 5 µm) were incubated with 
linear glycopolymer P3-MAN to form ‘coated’ particles, whose glycopolymer layers lack the dynamic 
covalent crosslinks required for ‘shrink-wrapping’. Formation of P3-MAN encapsulated particles was 
studied as a function of time for three polymer doses: (i) 0.1 µg/mg (ii) 1 µg/mg and (iii) 100 µg/mg. All 




anticipated to fully displace the glycopolymer chains from the particle surface. Consistent with 
this hypothesis, the fluorescence microscope images indicated that dyn-MAN-SCPN 
‘wrappings’ were not displaced, as evidenced by the brightly emissive corona, which remains 
present even after treating ‘wrapped’ MP1 with αMM (Fig. 21b, ii). The control experiment with 
P3-MAN (Fig. 21c), however, did not return the expected result, with fluorescence microscope 
images after αMM incubation (ii) revealing that MP1 remained coated in an emissive 
glycopolymer layer. Although ‘shrink-wrapping’ had likely occurred, the failure of this control 
experiment to return the anticipated result denied access to convincing evidence of this 
phenomenon. Furthermore, the intriguing observation that P3-MAN was not significantly 
displaced by excess αMM, was highly indicative of non-specific binding between P3-MAN and 
Figure 21: (a) Overview of the ‘shrink-wrapping’ experiment. (b-c) Fluorescence microscope images 
of ‘wrapping’ experiments performed with Con A particles (b) and control experiments with streptavidin-
modified particles (c). Images were obtained before (i) and after (ii) incubation with αMM, which was 
anticipated to displace the glycopolymer coatings from particle surfaces. Experimental conditions: 1




the particle surface of MP1. To further investigate this possibility, a series of control 
experiments (Fig. 22a) was undertaken to investigate whether glycopolymers P3-MAN and 
dyn-MAN-SCPNs were bound to MP1 through specific recognition of Con A by their mannose 
residues, or if they simply adhered on account of non-specific interactions with the underlying 
streptavidin-modified particle surface. Figure 22a provides a schematic overview of these 
experiments and their outcomes. 
P3-MAN or dyn-MAN-SCPNs (Fig. 22a) were added to (i) streptavidin-modified polystyrene 
microparticles and (ii) glycine-capped silica microparticles (MP4), both of which are absent of 
Con A, and thus lack the carbohydrate receptors required to drive the concentration of 
glycopolymers onto the particle surfaces through specific molecular recognition events. After 
incubating P3-MAN/dyn-MAN-SCPNs with the particles for 24 h, ‘unbound’ polymer chains 
were removed by five consecutive centrifuge-wash-resuspend cycles, and then the particles 
were imaged under the microscope (see Fig. 22b-c, i). Bright coronas in these images revealed 
Figure 22: (a) Schematic overview of control experiments undertaken to investigate possible non-
specific binding between the glycopolymers (P3-MAN/dyn-MAN-SCPNs) and smMPs/MP4, 
microparticles which are absent of Con A, thus lack the carbohydrate receptors required to drive 
concentration of polymer chains onto particle surfaces through specific molecular recognition events. 
(b-d) Fluorescence microscope images from control ‘wrapping’ experiments performed with 
streptavidin-modified microparticles (smMPs) (b) and glycine-capped silica microparticles (MP4) (c). 
Images were obtained before (i) and after (ii) incubation with αMM, which was anticipated to displace 




that both dyn-MAN-SCPNs and P3-MAN remained bound non-specifically upon the 
streptavidin particles despite there being no Con A proteins present to recognise the 
glycopolymers. Glycine-capped silica particles (MP4)(Fig. 22c, i), however, showed little or no 
emission, which was indicative of negligible non-specific interactions. Further microscope 
images (Fig. 22b-c, ii) were obtained after treatment of these control experiments with αMM. 
After removal of ‘unbound’ glycopolymer by centrifugal washing, images revealed a very slight 
decrease in emission upon the streptavidin-modified particles (Fig. 22b, ii), however, significant 
non-specific binding was still observed. It was therefore concluded that acrylamide-based 
glycopolymers bind to MP1 predominantly through ill-defined non-specific interactions.*** 
These observations were corroborated by, and entirely consistent with the earlier ELLA assay 
results (Fig. 17), which also showed that incubation of glycopolymer-coated NP1 with αMM 
caused little or no removal of the polymer coating. 
Further evidence of non-specific binding was observed by DLS studies (Fig. 23b) in which P3-
MAN (Fig. 23a) was titrated into streptavidin-modified nanoparticles (smNPs). The DLS titration 
profile (Fig. 23b) which revealed a dramatic increase in particle size (Dh) and polydispersity 
index, consistent with the binding of P3-MAN onto the particle surface (Fig. 23c). Streptavidin 
particles which are partially ‘coated’ with glycopolymer feature low colloidal stability and thus 
exhibit a tendency to aggregate with one another (Fig. 23a). Continuation along this pathway 
diminishes the quality of DLS analysis, which is known to require a dispersion of colloidally 
stable particles in order to return accurate particle size data. In combination, these unwanted 
processes of non-specific binding and particle-particle aggregation rationalize why ‘shrink-
wrapping’ could not be accurately characterized by DLS analysis.  
  
 
*** It has, however, been reported19 that streptavidin-biotin interactions can be inhibited by millimolar concentrations 
of mannose. An observation which suggests that pendant mannosyl groups displayed upon P3-MAN and dyn-MAN-
SCPNs most likely interact with residues in the biotin binding pocket of streptavidin.  
Figure 23: Non-specific binding was confirmed by a DLS titration experiment. (a) Control experiment 
in which P3-MAN was titrated into smNPs (streptavidin-modified nanoparticles, 100 nm) to afford DLS 
titration profile (b). (b) DLS titration profile for smNPs/P3-MAN revealed significant aggregation at 
polymer doses > 2 µg/mg. These observations further indicate that P3-MAN exhibits non-specific 




3.3.10.  Factors Inhibiting the ‘Shrink-Wrapping’ of 3D Nano- and Micro-Objects 
Two factors inhibited the ‘shrink-wrapping’ of 3D nano- and microscale objects: (i) Non-specific 
binding of glycopolymers to the underlying streptavidin particle surface and (ii) the 
hydrophobic nature of acrylamide-based glycopolymers. 
(i) Non-Specific Binding: 
Observations by DLS (Fig. 23b), ELLA assay (Fig. 17c) and fluorescence microscopy (Fig. 22b) 
were consistent with one another and provided strong evidence that dyn-MAN-SCPNs were 
concentrated onto NP1/MP1 predominantly through ill-defined non-specific interactions 
between the mannose-functionalized polymer scaffolds and the underlying streptavidin-
modified particles. These non-specific interactions prevented correct operation of the control 
experiment in which non-crosslinked glycopolymer ‘coatings’ should be displaced from the 
particle surface, and thus stifled progress of the ‘shrink-wrapping’ project. Furthermore, the 
scope of the chapter was to demonstrate that lectin-functionalized particles can be selectively 
‘shrink-wrapped’ through specific molecular recognition between the glycopolymers and the 
particle surfaces, and thus the presence of non-specific polymer-particle interactions 
fundamentally undermines this objective and presented a significant barrier to investigating the 
‘shrink-wrapping’ of 3D nano- and microscale objects.††† To address the issues of non-specific 
binding, all future ‘wrapping’ experiments were conducted with microparticles (MP2 - MP8) 
prepared from a silica-based particle core, which displayed negligible non-specific binding to 
glycopolymers (Fig. 22c, ii). 
(i) Hydrophobic Nature of Acrylamide-Based Glycopolymers 
Results in this chapter revealed that acrylamide-based glycopolymers constituted a poor 
choice of polymer scaffold for ‘shrink-wrapping’ of 3D nano- and microscale objects in aqueous 
media. Acrylamide-based glycopolymers displayed low aqueous solubility on account of their 
hydrophobic nature (Fig. 11). Fluorescence images (Fig. 24a, i) show that acrylamide-based 
glycopolymers (P3-MAN) exhibit a strong tendency to aggregate in aqueous solution on 
account of their intrinsic hydrophobicity.‡‡‡ These aggregation processes (Fig. 24b, iv) are 
thought to present a kinetic barrier (Fig. 24b, iii) to the individual ‘shrink-wrapping’ of 3D nano- 
and microscale objects within a homogeneous layer of glycopolymer film. Acrylamide 
glycopolymer chains are relatively hydrophobic, and thus are hypothesized to contract in an 
aqueous environment in order to minimize their interactions with water. These processes of 
 
††† It should be noted that the issues of non-specific binding observed for the microparticle system P3-MAN/MP1 
(Fig. 21c/22b) will likely be amplified significantly for 3D nanoscale objects on account of their high surface areas.  
 
‡‡‡ Acrylamide-based glycopolymers (P3-MAN and the corresponding dyn-MAN-SCPNs) formed large multi-chain 
polymer aggregates, with diameters in well excess of 20 µm. The presence of these aggregate species in 
fluorescence microscope ‘shrink-wrapping’ experiments made it difficult to differentiate ‘wrapped’ Con A 




hydrophobic aggregation are anticipated to inhibit the binding of acrylamide-based 
glycopolymers onto the surface of Con A microparticles through specific Con A-mannose 
interactions. To address the inherent hydrophobicity of acrylamide glycopolymers and the 
related issues, a highly hydrophilic poly(ethylene glycol)-based polymer scaffold (P6) was 
prepared, from which the next-generation of polymer ‘wrapping agents’ were constructed (Fig. 
25), and will now be discussed.  
  
Figure 24: (a) Fluorescence microscope images of (i) acrylamide-based glycopolymer P3-MAN and (ii) 
PEG-based glycopolymer P6-MAN in aqueous solution. (b) It is hypothesized that acrylamide-based 
glycopolymers (i) aggregate in aqueous solution on account of their intrinsic hydrophobicity (iv). It is 
hypothesized that acrylamide glycopolymers aggregate to minimize contact with water on account of 
their relatively hydrophobic nature. These aggregation processes are anticipated to present a kinetic 
barrier to the individual ‘shrink-wrapping’ of 3D nano- and microscale objects within a homogeneous 
polymer film. In contrast, PEG-based glycopolymers (such as P6-MAN) (a, ii) are highly hydrophilic in 
nature, and thus constitute an idea scaffold for ‘coating’ aqueous dispersions of Con A-functionalized 




3.3.11.  Synthesis and Characterization of PEG-Based Glyco-SCPNs 
PEG-based dyn-MAN-SCPNs were prepared (Fig. 25) using the previously described method 
of grafting mannose hydrazide (MAN)(a) onto aldehyde-functionalized copolymer (P6) 
followed by intramolecular crosslinking (b). For the remainder of this chapter, all references to 
“dyn-MAN-SCPNs” and “fix-MAN-SCPNs” relate to glycopolymers derived from P6-MAN. 
Preparation of Aldehyde-Functionalized PEG Copolymer Scaffolds 
The preparation of PEG-based aldehyde scaffold polymer scaffold (P6) first required the 
synthesis of aldehyde-TEGA monomer (M2), which was synthesized (Fig. 26a) by the activation 
of 5 with thionyl chloride to afford acid chloride 6. Esterification of 6 with a large excess of 
triethylene glycol (TEG) afforded predominantly the mono ester 7, the terminal hydroxyl of 
which was then acetylated by dropwise addition of acryloyl chloride, thus affording the acrylate 
ester M2. Purification by column chromatography isolated M2 as a colourless oil (2.59 g, 33 % 
yield overall), which was diluted in CH2Cl2 and stored at – 20 °C to prevent autopolymerisation.  
Figure 26: (a) Synthesis of aldehyde-TEGA monomer, M2. Step (i) 5 eqv. SOCl2, 18 h reflux in toluene. 
Step (ii) Intermediate 6 was added dropwise into triethylene glycol, Et3N, CH2Cl2, 8 h at 0 oC. Step (iii) 
acryloyl chloride, Et3N, CH2Cl2, 18 h at 0 oC. (b) Assigned 1H NMR (CDCl3, 300 MHz) spectrum of M2. 
Figure 25: Preparation of dyn-MAN-SCPNs from PEG-based aldehyde scaffold P6. (a) P6 was
‘decorated’ with mannose (MAN) and dansyl (DAN) hydrazide residues (pD 4.5), followed by 




PEG-based aldehyde scaffolds (P6-P7), which differ in their molecular weights on account of 
different reaction times Tr (Fig. 27b), were prepared by RAFT polymerization of aldehyde 
monomer M2 with the commercially available and highly hydrophilic comonomer OEGA500 (Fig. 
27a). GPC analysis revealed monomodal polymer distributions of low polydispersity, consistent 
with controlled polymerization processes. PEG scaffolds P6 – P7 were characterized by 1H 
NMR spectroscopy (Fig. 27b, 28) to determine (i) polymer composition (m/n) (ii) the number-
average molecular weight (Mn) by end group analysis. The kinetics of RAFT polymerization 
(Fig. 27c) were determined for P6 using 1H NMR spectroscopy to monitor the % conversion as 
a function of time, which revealed the polymerization was controlled and completed (> 80 % 
monomer conversion) within 2.5 h. Additionally, GPC analysis revealed a subtle increase in PDI 
throughout the polymerization process. DLS analysis of P6 revealed a monomodal size 
distribution (Fig. 27d) with average hydrodynamic diameter, Dh ≈ 5.8 ± 0.2 nm, indicating 
excellent aqueous solubility and negligible aggregation of polymer chains. 
Figure 27: (a) Preparation of highly hydrophilic water-soluble aldehyde copolymer scaffolds (P5-P6) by 
RAFT polymerization of aldehyde monomer M2 with OEGMA500. (b) Table of characterization for scaffolds
P5-P6: stoichiometries of CTA, AIBN and monomer feed ratios. Characterization: % monomer conversion
(% Conv.), reaction time (Tr) degree of conversion (Dp), polymer composition (m, n), molecular weights 
(Mn, Mw) and polydispersity index (PDI). (c) Polymerization kinetics of P6, showing % conversion and PDI 
as a function of time. (d) DLS analysis of P6 in water revealed a monomodal particle size distribution. 




Preparation of Mannose-Grafted Polymer Scaffolds 
The ‘decoration’ P6 with MAN was monitored by 1H NMR spectroscopy (Fig. 29a-c), which 
revealed complete disappearance of the ‘diagnostic’ aldehyde (●) signal at δ 9.98 ppm (Fig. 
29b) and peak broadening of the signals (●, ●, ●) associated with MAN (Fig. 28a), thus 
confirming successful synthesis of P6-MAN. P6-MAN was purified by dialysis against water 
and characterized by 1H NMR spectroscopy (Fig. 29d), which indicated unconjugated MAN 
had been successfully removed. 
 
Figure. 29: Partial 1H NMR (D2O, 300 MHz) spectra of (a) mannose hydrazide, MAN, (b) aldehyde 
scaffold P6, (c) P6 + MAN after 10 min and (d) P6-MAN after purification by dialysis. 
Figure 28:
 




Synthesis and Characterization of MAN-SCPNs 
dyn-MAN-SCPNs were prepared (Fig. 30a) by intramolecular crosslinking of P6-MAN with 
succinic dihydrazide at pH 4.5. SCPNs containing two crosslinker stoichiometries were 
explored: (i) dyn-MAN-SCPN-1 which contains one intra-chain crosslink and (ii) dyn-MAN-
SCPN-2 which contains two intra-chain crosslinkers. These dyn-MAN-SCPNs (1) contain 
dynamic covalent hydrazone crosslinks (iii) which were reduced to the corresponding amine 
(v) to afford fix-MAN-SCPNs (2) by addition of cyanoborohydride (iv). SCPN formation was 
then characterized by GPC analysis (Fig. 30b) of fix-MAN-SCPN-1 and fix-MAN-SCPN-2, 
which revealed the characteristic increase in retention time as the density of intramolecular 
crosslinker was raised. 
  
Figure 30: Synthesis (a) and GPC characterization (b) of fix-MAN-SCPNs prepared from P6-MAN. (a) 
Addition of 1-2 equivalents of succinic dihydrazide (i-ii) induced intra-chain crosslinking of linear 
polymer P6-MAN to yield dyn-MAN-SCPNs (1), which contain dynamic covalent acyl hydrazone 
crosslinks (iii). Chemical reduction (iv) of dyn-MAN-SCPNs afforded fix-MAN-SCPNs (2), whose 
crosslinks were no longer dynamic on account of their reduction from acyl hydrazone (a dynamic bond) 
(ii) to the corresponding amine (non-dynamic / fixed) (v). (b) Normalized GPC traces revealed a small 
increase in retention time (RT) for fix-MAN-SCPN-1 (purple) and fix-MAN-SCPN-2 (blue) relative to 
that of the linear glycopolymer (P6-MAN) (green), consistent with chain collapse.  (c) Retention times 




SCPN formation was further characterized by DLS analysis (Fig. 31a-b), which revealed a 
subtle decrease in the hydrodynamic diameter (Dh) of dyn-MAN-SCPN-1 relative to that of the 
linear (non-crosslinked) glycopolymer P6-MAN (Fig. 31b). This observation was entirely 
consistent with SCPN formation by intramolecular crosslinking of P6-MAN.§§§ DLS experiments 
(Fig. 31c) demonstrated the kinetic stability of dyn-MAN-SCPN-1 towards the formation of 
intermolecularly crosslinked aggregates upon the concentration of polymer chains in aqueous 
solution (50 mM H4NAcO-AcOH, pH 4.5). dyn-MAN-SCPN-1 were stable towards aggregation 
below 10 mg/mL.**** It should also be noted that, in contrast to the hydrophilic acrylamide 
glycopolymers, DLS analysis obtained for PEG glycopolymers always showed monomodal size 
distributions and no signs of aggregation were observed at polymer concentrations < 10 
mg/mL. These observations suggest that PEG-based scaffolds present an ideal scaffold for the 
‘shrink-wrapping’ of 3D nanoscale objects in aqueous media on account of their highly 
hydrophilic nature, which gives rise to excellent water-solubility even at high densities of 
aldehyde-containing unit M2. These scaffolds are thus unlikely to exhibit non-specific binding 
to nanoparticle surfaces, and furthermore may permit parameters such as the carbohydrate 
and crosslinker densities to be adjusted, without impacting on aqueous solubility. 
  
 
§§§ It was also observed that mannose-decorated glycopolymer P6-MAN possessed a slightly larger hydrodynamic 
diameter than did the parent aldehyde polymer scaffold P6, which is consistent with MAN decoration of P6. 
 
**** Intriguingly, P6-MAN was also observed to aggregate at concentrations > 10 mg/mL, whilst the parent aldehyde 
scaffold P6 remained a stable size of Dh ≈ 12 nm. It is hypothesized that P6-MAN aggregates more than P6 in 
aqueous solution, on account of hydrogen bonding which may arise between MAN residues displayed upon 
neighbouring polymer chains  
Figure 31: DLS analysis of PEG polymers: (i) Aldehyde Scaffold P6, (ii) P6-MAN and (iii) dyn-MAN-
SCPN-1. (a) Particle size distributions (z-average Dh) for polymers (i) - (iii). (b) Number-average Dh
shows collapse in hydrodynamic diameter of dyn-MAN-SCPN-1 relative to the linear glycopolymer P6-
MAN, consistent with SCPN formation by intramolecular crosslinking. (c) DLS (z-average Dh) revealed 




3.3.12.  Fluorescence Microscopy ‘Shrink-Wrapping’ Studies with PEG-Based 
Glycopolymers and Lectin-Functionalized Silica Microparticles 
        Proof of Successfully ‘Shrink-Wrapping’ Microscale Objects 
Convincing evidence of successful ‘shrink-wrapping’ was observed by fluorescence 
microscopy experiments which utilized a palette of four different glycopolymer architectures 
(Fig. 32a, i-iv). In these experiments, 5 µm Con A microparticles (MP2) (1 mg/mL) were 
incubated with dansyl-labelled glycopolymers (i-iv) (2.5 mg/mL) for 18 h. The particles were 
then purified by centrifugation and washing to remove any glycopolymer chains which were 
not adhered onto the particle surfaces. Three 5 µL aliquots of each sample were then deposited 
onto a clean glass slide, dried and then carefully imaged on the fluorescence microscope. 
Figure 32: (a) The four types of glycopolymer architecture (i-iv) which were employed for ‘shrink-
wrapping’ studies. dyn-MAN-SCPN-1 (i) were anticipated to ’shrink-wrap’ microparticle surfaces and 
thus resist displacement by incubation with αMM. Linear glycopolymers (iii-iv) and fix-MAN-SCPN-1
(ii) were anticipated to only ‘coat’ the microparticles within non-crosslinked layers, and thus should be 
readily displaced by incubation with αMM. (b) dyn-MAN-SCPN-1 is hypothesized to form a crosslinked 
glycopolymer film upon MP2 which cannot be displaced by αMM incubation. (b) Schematic overview of 
the ‘shrink-wrapping’ experiment protocol, which is shown with control glycopolymers (ii-iv). Incubation 




It is anticipated that the structurally dynamic polymer dyn-MAN-SPCN-1 (i) will ’shrink-wrap’ 
the surface of complementary Con A microparticles (MP2) within intermolecularly crosslinked 
polymer films, and thus should resist displacement by incubation with α-methyl mannose (Fig. 
32b). However, control experiments (Fig. 32c) undertaken with linear glycopolymers (iii-iv) and 
fix-MAN-SCPN-1 (ii) are anticipated to only ‘coat’ the microparticles within non-crosslinked 
layers, thus should be readily displaced by incubation with αMM. With these predictions in 
mind, we now turn our attention to the inspection of the fluorescence microscope images 
shown in Figure 33. 
Fluorescence microscope images (Fig. 33) displayed in C 1 (10 x mag) and C 2 (40 x mag) 
were obtained 18 h after mixing glycopolymers (i - iv) with MP2 and show that the polymers 
were bound onto the periphery of Con A microparticles as evidenced by their bright coronas, 
which were localized to the particles surface.†††† It should be noted that at this stage in the 
experiment, all particles will have glycopolymer bound onto their surface, and thus all particles 
were observed to be emissive. After αMM incubation (C 3 - C 5), however, only the dyn-MAN-
SCPN-1 (i) ‘wrapped’ particles remained emissive, indicating successful ‘shrink-wrapping’ of 
 
†††† Great care was taken to maintain identical imaging conditions when obtaining fluorescence microscope images, 
in order to ensure that image brightness correlates with the concentration of dansyl-labelled glycopolymers 
observed within each image. 
 
Figure 33: Representative fluorescence microscope images of ‘wrapped’ (i) and ‘coated’ (ii-iv) 5 µm 
Con A microparticles (MP2) before (1) and after (2) incubation with αMM, which facilitated the removal 
of non-crosslinked glycopolymer ‘coatings’ (ii-iv) but not crosslinked glycopolymer ‘wrappings’ (i). Care 
was taken to obtain images of the exact same particles under both normal light (C 5) and UV irradiation 




the particle surface within an intermolecularly crosslinked glycopolymer film. The observation 
that non-crosslinked glycopolymers (iii-iv) and non-dynamic SCPNs (ii) were displaced from 
the particle surface indicates that: (i) the presence of a covalent crosslinker brings additional 
stability beyond that of non-crosslinked films, and (ii) ‘shrink-wrapping’ can only occur when 
crosslinks within the SCPN architecture are dynamic covalent in their nature.  Figure 34 shows 
representative fluorescence images which clearly highlight that the glycopolymer ‘wrapping’ 
(Fig. 34, i) cannot be fully displaced from MP2, whereas glycopolymer ‘coatings’ (Fig. 34, iii) 
are readily removed. Further processing of the fluorescence microscope images (shown in 
Figure 33) allowed for the MGV values (Fig. 35a-b) to be determined, thus allowing for more 
accurate comparison of particle brightness to be deduced (see experimental, page 142). 
  
Figure 34:  Representative fluorescence (C 1, C 2) and brightfield (C 3) microscope images of ‘wrapped’ 
(dyn-MAN-SCPN-1) (i) and ‘coated’ (dyn-P6-MAN) (iii) particles before (1) and after (2) incubation with 
αMM. Insets I-III: Further magnified images produced for regions of interest (see highlighted areas) 




Before their treatment with excess αMM (Fig. 35a), all glycopolymer (ii-iv) ‘coated’ 
particles are of comparable brightness and thus feature similar MGVs of ≈ 50 ± 13,  with the  
exception of dyn-MAN-SCPN-1, which was significantly brighter (MGV = 120 ± 15). This 
observation was rationalized by the formation of inter-chain crosslinks that facilitate the 
formation of thicker glycopolymer films upon the particle surface. Following incubation with 
αMM, MGV values (Fig. 35b) for control glycopolymers (dyn-P6-MAN, fix-P6-MAN, fix-MAN-
SCPN-1) were all observed to decrease significantly (MGV: ≈ 50  ≈ 10), whereas the MGV of 
dyn-MAN-SCPN-1 remained relatively high (MGV: ≈ 120  ≈ 70). These observations show 
that control glycopolymers (ii-iv) were all successfully displaced from the surface of MP2 by 
incubation with αMM, whereas dyn-MAN-SCPN-1 could not be readily displaced, which is 
entirely consistent with the proposed hypothesis. It was thus concluded that dyn-MAN-SCPN-
1 yielded intermolecularly crosslinked glycopolymer films, and thus resisted displacement from 
the Con A particle surface, whereas all control glycopolymers (ii-iv) afforded non-crosslinked 
polymer layers which were significantly less robust. Furthermore, the observation that fix-
MAN-SCPN-1 coatings – whose crosslinks were non-dynamic on account of chemical 
reduction – were fully displaced (low MGV ≈ 10 ± 5) after αMM, whereas the dyn-MAN-SCPN-
1 films remained attached suggests that the dynamic covalent nature of the embedded 
crosslinker residues plays a crucial role which is essential to the observed ‘shrink-wrapping’ 
phenomenon. With definitive evidence of ‘shrink-wrapping’ now in hand, further experiments 
were undertaken to prove that dyn-MAN-SCPNs were concentrated onto the surface of MP2 
through specific molecular recognition events. 
Figure 35: Analysis of fluorescence microscope images (shown in Fig. 33) yielded the average particle 
brightness (MGV) of the polymer-covered particles before (a) and after (b) incubation with αMM. The 
bars report the average MGV obtained for analyzes performed on > 100 particles. Error bars report 




Figure 36: (a) Control experiment in which LTB-functionalized microparticles (MP5) were ‘wrapped’ or 
‘coated’ with glycopolymers (i-iii). (b) Fluorescence microscope images were obtained before and after 
centrifugation to remove ‘unbound’ glycopolymer chains. No emission was observed upon MP5 after 
centrifugation, and thus it was concluded that all glycopolymers (i-iii) had been successfully removed. 
      Evidence that Specific Carbohydrate-Receptor Interactions Drive ‘Shrink-Wrapping’ 
A control experiment (Fig. 36a) was undertaken in which glycopolymers (i -vi) were incubated 
with MP5, a 5 µm particle whose surface displays LTB, a galactose-specific lectin. On account 
of MP5 displaying recognition only for galactose-functionalized polymers, it was anticipated 
that dyn-MAN-SCPNs would not ‘shrink-wrap’ MP5, and thus emission would not be observed. 
Fluorescence microscope images (Fig. 36b) revealed that (before centrifugation) 
glycopolymers (i - iii) did not significantly bind onto MP5, as evidenced by the observation that 
emission was not localized to the particle surface.  After centrifugation (Fig. 36b), images 
revealed no emission, indicating that all glycopolymers (i-iii) (including dyn-MAN-SCPN-1) had 
been removed. It was thus concluded that dyn-MAN-SCPN-1 must ‘shrink-wrap’ Con A 
microparticle (MP2) through specific molecular recognition events. In the absence of the 
complementary carbohydrate-binding protein upon the particle surface, however, no ‘shrink-





Further control experiments were performed with glycine-capped particles (MP4, Table 1) – a 
5 µm microparticle whose surface is absent of any carbohydrate-binding receptors. This 
experiment also revealed that glycopolymers (i-vi) exhibited negligible non-specific binding 
onto the glycine particle (MP4) surface (see, Fig. 37b), as evidenced by low MGVs after 
centrifugation and washing to remove ‘unbound’ glycopolymer chains. Figure 37 provides a 
summary of MGVs obtained for all ‘shrink-wrapping’ and control experiments. MGVs reported 
in Fig. 37 are the average MGV ‘wrapped’/‘coated’ particles after steps to remove the surface-
bound glycopolymers.  
With strong evidence of ‘shrink-wrapping’ now in hand, future work will investigate the on-
demand ‘unwrapping’ of Con A microparticles – a spontaneous process which can be triggered 
by exposure of the surface-bound glycopolymer films to a solution of hydroxylamine. This 
highly nucleophilic amine is anticipated to react with acyl hydrazone crosslinks located within 
the glycopolymer film through component exchange, and thus fully displace all acyl hydrazone 
linkages in favour of forming the more thermodynamically stable oxime bond. It was 
hypothesized that this process will ‘etch’ crosslinked polymer films from the Con A 
microparticle surface, thus providing scope to engineer the on-demand ‘unwrapping’ and 
‘release’ of the underlying particle substrate. 
Figure 37: MGVs obtained from ‘wrapping’ and control experiments with 5 µm silica particles 
displaying (a) Con A (MP2), (b) glycine only (MP4) and (c) LTB (MP5). These MGVs were calculated 
from images obtained after steps to displace the glycopolymer ‘wrappings’/’coatings’ from the particle 
surfaces. The bars report average MGVs measured for > 100 individual particles and error bars 
represent the standard deviation.  A no polymer control experiment was included (orange bars), which 





Specific carbohydrate-receptor interactions were exploited to trigger the ‘structural 
metamorphosis’ of discrete polymer chains into intermolecularly crosslinked polymer films 
located upon the surface of 3D nano- and microscale objects. Fluorescence microscopy 
experiments highlighted that the dynamic covalent nature of crosslinks contained within the 
glyco-SCPNs were of instrumental importance to the ‘shrink-wrapping’ process. 
Glycopolymers which lack covalent crosslinkers (P6-MAN) or possess non-dynamic crosslinks 
(fix-MAN-SCPN-1) did not facilitate ‘wrapping’ of microparticle surfaces. These observations 
were entirely consistent with the proposed hypothesis that hydrazone exchange is crucial to 
the ‘shrink-wrapping’ process. Furthermore, key control experiments demonstrated that 
successful ‘wrapping’ of lectin-functionalized silica microparticles occurs only when 
carbohydrate appendages displayed upon the glyco-SCPNs are complementary to the 
receptors located at the particle surface. These observations confirmed that specific molecular 
recognition events between carbohydrate-receptor pairs are responsible for concentrating 
glyco-SCPNs onto particle surfaces, and thus must drive ‘shrink-wrapping’ of lectin-displaying 
micro-objects. These findings constitute the very first step towards the end goal of ‘wrapping’ 
complex biological objects, such as lectin-displaying bacteria. It is anticipated that further 
development of this chemistry may present dynamic covalent glyco-SCPN architectures which 
can selectively recognise, bind, and thus ‘neutralize’ harmful pathogens within crosslinked 
polymer films. Finally, it should be acknowledged that the successful ‘shrink-wrapping’ of 
microscale objects was largely owed to the development of a highly hydrophilic PEG-based 
polymer scaffold (P6), which features excellent aqueous solubility and displays negligible levels 
of non-specific binding to particle surfaces. Now that the appropriate polymer building blocks 
have been discovered, ‘shrink-wrapping’ can finally progress towards the encapsulation of 3D 
nanoscale objects of increased complexity. With this ambitious goal in mind, Chapter 4 now 
explores the synthesis of polymer ‘wrapping agents’ with the capacity to selectively recognise 






3.5.1. General Experimental 
All chemicals were purchased from Sigma-Aldrich, Fisher Scientific or Alfa Aesar and were 
used as received without further purification. All nano- and microparticles were purchased from 
Micromod Partikeltechnologie GmbH (NHS-functionalized silica particles) and Sigma Aldrich 
(smNPs, smMPs). All solvents were dried prior to use according to standard methods. N,N-
dimethylacrylamide was purified by vacuum distillation at 60 ˚C. All solvents used for flash 
chromatography were GPR grade, except hexane and ethyl acetate, when HPLC grade was 
used. Unless state otherwise, all synthetic procedures were performed in oven-dried glassware 
under a N2(g) atmosphere. 
4.5.2. Instrumentation 
1H and 13C NMR spectra of synthesised compounds were recorded on a Bruker Avance 300 
spectrometer (300 and 75 MHz respectively), Bruker Avance 400 spectrometer (400 MHz and 
100 MHz, respectively), Bruker Avance III HD spectrometer (at 500 MHz and 125 MHz, 
respectively), or Bruker 700 Avance III HD spectrometer (700 MHz and 175 MHz, respectively). 
In all cases, the residual solvent signal was used as an internal standard. High-resolution mass 
spectrometry was performed on a Waters LCT Premier mass spectrometerα Gel permeation 
chromatography (GPC) was conducted on a on a Varian ProStar instrument (Varian Inc.) 
equipped with a Varian 325 UV-Vis dual wavelength detector with a 254 nm laser, a Dawn 
Heleos II multi-angle laser light scattering detector (Wyatt Technology Corp.), a Viscotek 3580 
differential refractive index detector and two PL gel 5 μm Mixed D 300 × 7.5 mm columns with 
guard column (Polymer Laboratories Inc.) in series. Chromatogram analysis was performed on 
Galaxie software (Varian Inc.) and analyzed with the Cirrus software (Varian Inc.) and Astra 
software (Wyatt Technology Corp.). Near monodisperse poly(methyl methacrylate) standards 
(Agilent Technologies) were used for calibration.  DLS and zeta potential measurements were 
performed on a Malvern Instruments Nano ZS. Fluorescence microscopy images were 
obtained were obtained using Zeiss Axioskop 2 Plus. pH measurements were made using a 






3.5.3. Nomenclature for Gluco-Configured Monosaccharides 
 
3.5.4. Synthesis of Mannose Hydrazide (MAN) 
4-Methoxycarbonylphenyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside (3): 
β-D-Mannose pentaacetate 1 (5.25 g, 13.3 mmol) and 4-(methoxycarbonyl)phenol 2 (3.05 g, 
26.7 mmol) were dissolved in 1,2-dichloroethane (30 mL), followed by the dropwise addition of 
boron trifluoride diethyl etherate (5.44 mL, 40.0 mmol). The reaction mixture was stirred 24 h 
at 50 ºC and quenched by the addition of aq. NaHCO3 (30 mL). The organic extract was washed 
with aq. NaCl (50 mL), dried over MgSO4, evaporated to dryness and purified by column 
chromatography (SiO2, 2:1 → 1:1 hexane-EtOAc) and the semi-crude product spontaneously 
recrystallised from the column fractions, affording 3 (3.54 g, 55 %) as colourless plates; m.p. 
137-140 °C (from methanol); 1H NMR (500 MHz, CDCl3) δ (ppm): 8.01 (d, J = 8.9 Hz, 2H), 7.13 
(d, J = 8.9 Hz, 2H), 5.60 (d, J1,2 = 1.8 Hz, 1H, H-1), 5.55 (dd, J3,4 = 10.0 Hz, J3,2 = 3.5 Hz, 1H, H-
3), 5.46 (dd, J2,3 = 3.5 Hz, J2,1 = 1.8 Hz, 1H, H-2), 5.37 (t, J4,3 = 10.2 Hz, J4,5 = 10.2 Hz, 1H, H-4), 
4.28 (dd, J6,6' = 12.3 Hz, J5,6 = 5.6 Hz, 1H, H-6), 4.09 – 4.02 (m, 2H, H-5, H-6'), 3.90 (s, 3H, OCH3), 
2.21 (s, 3H, COCH3), 2.06 (s, 3H, COCH3), 2.04 (s, 3H, COCH3), 2.02 (s, 3H, COCH3); 13C NMR 
(75 MHz, CDCl3) δ (ppm): 170.48, 169.95, 169.69, 166.44 (C=O), 158.99, 131.60, 124.84, 
115.94 (ArC), 95.41 (C-1), 69.41, 69.14, 68.68, 65.73, 61.98 (C-6), 52.07 (OCH3), 20.87, 20.70, 
20.69, 20.67 (COCH3); HRMS: Found [M+Na]+ 505.1316, C22H26O12Na requires 505.1316. 
  
Scheme 1: Synthesis of mannose hydrazide residue (MAN). Step (i) BF3Et2O, dichloroethane, 50 ºC, 18 
h. Step (ii) NaOMe, anhydrous MeOH. Step (iii) H2NNH2, MeOH, reflux, 18 h. 




4-Methoxycarbonylphenyl α-D-mannopyranoside (4): 
A solution of 4-methoxycarbonylphenyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranoside 3 (3.00 g 
g, 6.22 mmol) in anhydrous methanol (60 mL) was charged with sodium methoxide (670 mg, 
12.4 mmol). After stirring at room temperature for 24 h the reaction mixture was neutralized 
with amberlite IRC 50 H+ resin, filtered and evaporated to afford 4 (1.56 g, 4.98 mmol, 80 %) 
as a colourless glassy solid; 1H NMR (500 MHz, D2O) δ (ppm): 7.92 (d, J = 7.5 Hz, 2H, ArH), 
7.15 (d, J = 7.5 Hz, 2H, ArH), 5.65 (d, J1,2 = 1.8 Hz, 1H, H-1), 4.11 (dd, J2,3 = 3.1 Hz, J2,1 = 1.8 
Hz, 1H, H-2), 3.99 (dd, J3,4 = 9.7 Hz, J3,2 = 3.1 Hz, 1H, H-3), 3.83 (s, 3H, OCH3), 3.72 – 3.63 (m, 
3H, H-4, H-6, H-6'), 3.59 – 3.56 (m, 1H, H-5); 13C NMR (75 MHz, D2O) δ (ppm): 168.91 (C=O), 
159.47, 131.45, 123.40, 116.26 (ArC), 97.43 (C-1), 73.41, 70.22, 69.63, 66.39 (C-2, C-3, C-4, 
C-5), 60.51 (C-6), 52.37 (OCH3).  
4-Benzoylhydrazide α-D-mannopyranoside (MAN):  
4-Methoxycarbonylphenyl α-D-mannopyranoside 4 (1.51 g, 4.80 mmol) was dissolved in 
methanol (3 mL), hydrazine monohydrate (707 μL, 14.4 mmol) was added and the solution was 
refluxed for 4 h. The solution was then concentrated and lyophilized from water to afford MAN 
(1.36 g, 4.32 mmol, 90%) as a colourless lyophilizate; 1H NMR (500 MHz, MeOD) δ (ppm): 7.81 
(d, J = 8.8 Hz, 2H), 7.23 (d, J = 8.8 Hz, 2H), 5.61 (d, J1,2 = 1.8 Hz, 1H, H-1), 4.06 (dd, J2,3 = 3.5 
Hz, J2,1 = 1.8 Hz, 1H, H-2), 3.95 (dd, J3,4 = 9.5 Hz, J3,2 = 3.5 Hz, 1H), 3.84 – 3.71 (m, 3H, H-4, H-
6, H-6'), 3.59 (ddd, J5,4 = 9.8 Hz, J5,6 = 5.3 Hz, J5,6' = 2.6 Hz, 1H, H-5); 13C NMR (125 MHz, 
MeOD) δ (ppm): 169.33 (CONHNH2), 160.61, 130.02, 127.98, 117.46 (ArC), 100.00 (C-1), 
75.71 (C-5), 72.43 (C-3), 71.89 (C-2), 68.34 (C-4), 62.70 (C-6); JC1-H1 = 171.00 Hz (consistent 
with α-configuration); 8 HRMS: Found [M+H]+ 315.1189, C13H19N2O7 requires 315.1189. 
 
3.5.5. Synthesis of Acrylamide-based Aldehyde Polymer Scaffolds P1 - P5 
M1 was prepared as reported in the experimental section of Chapter 2 (pages 80-81). 
Polymer scaffolds P1 - P5 were prepared according to the experimental procedure reported 
in Chapter 2, page 83. 
 
3.5.6. Synthesis of PEG Aldehyde Monomer M2 
 
Scheme 2: Synthesis of aldehyde-TEGA monomer, M2. Step (i) 5 eqv. SOCl2, 18 h reflux in toluene. 
Step (ii) Intermediate 6 was added dropwise into triethylene glycol, Et3N, CH2Cl2, 8 h at 0 oC. Step (iii) 




4-Formylbenzoyl chloride (6): 
4-Formylbenzoic acid 5 (4.38 g, 29.17 mmol) and thionyl chloride (27.7 g, 232.7 mmol) was 
dissolved in toluene (150 mL), placed under nitrogen atmosphere and refluxed overnight (18 
h). White PTT was isolated by filtration and the filtrate was dried under high vacuum to afford 
the title product as a pale yellow solid (4.34 g, 89 % yield), used without any further purification. 
1H NMR (300 MHz, CDCl3) δ (ppm): 9.89 (s, 1H), 8.31 (d, 2H, J = 8.2 Hz), 8.06 (d, 2H, J = 8.2 
Hz). 13C NMR (75 MHz, CDCl3) δ (ppm): 191.13, 167.96, 140.55, 137.72, 131.93, 129.93. 
2-(2-(2-Hydroxyethoxy)ethoxy)ethyl 4-formylbenzoate (7): 
Triethylene glycol (24.85 g, 165.48 mmol) and Et3N (6.08 g, 60.08 mmol) were dissolved in 
anhydrous CH2Cl2 (40 mL) and stirred under nitrogen atmosphere at 0 ºC. 4-formylbenzoyl 
chloride 5 (4.92 g, 29.17 mmol) was dissolved in CH2Cl2 (20 mL) and added dropwise to the 
solution, which was allowed to gently warm to rt with overnight stirring. The reaction mixture 
was evaporated to dryness and the crude residue dissolved in EtOAc (150 mL) and washed 
with 0.1 M NaOH (3 x 75 mL). The organic extract was dried over MgSO4, filtered and dried in 
vacuo to afford the crude product as a yellow oil (514 g, 63 % Yield). The title product was 
further purified by column chromatography (SiO2, 75:25 EtOAc/hexane, product Rf = 0.35) to 
afford a colourless oil (3.93 g, 48 %). 1H NMR (300 MHz, CDCl3) δ (ppm): 10.10 (s, 1H), 8.23 
(d, 2H, J = 8.2 Hz), 7.96 (d, 2H, J = 8.2 Hz), 4.53 (t, 2H), 3.86 ( t, 2H), 3.71 (m, 6H), 3.61 (t, 2H). 
13C NMR (75 MHz, CDCl3) δ (ppm): 191.78, 165.70, 139.35, 135.15, 130.46, 129.65, 72.63, 
70.86, 69.26, 64.65, 61.95, 60.54.  
2-(2-(2-(Acryloyloxy)ethoxy)ethoxy)ethyl 4-formylbenzoate (M2): 
2-(2-(2-Hydroxyethoxy)ethoxy)ethyl 4-formylbenzoate 7 (2.50 g, 8.84 mmol) and Et3N (1.82 g, 
17.96 mmol) were dissolved in CH2Cl2 (40 mL) and stirred under nitrogen atmosphere at 0 oC. 
Acryloyl chloride (0.884 g, 9.76 mmol) dissolved in CH2Cl2  (30 mL) was added dropwise to the 
solution, which gently warmed to rt with overnight stirring. The reaction mixture was 
concentrated under vacuum and the product partitioned between brine (100 mL) and EtOAc 
(3 x 75 mL). The organic layer was dried over MgSO4, filtered, and dried under vacuum to 
afford a crude yellow oil which was immediately purified by column chromatography (40:60 
EtOAc/petroleum ether). The title product was obtained as colourless oil (2.59 g, 87 %). 1H  
(300 MHz, CDCl3) δ (ppm): 10.10 (s, 1H), 8.22 (d, 2H, J = 8.4 Hz), 7.95 (d, 2H, J = 8.4 Hz), 6.42 
(dd , 1H, J = 17.0, 1.3 Hz), 6.15 (dd, 1H J = 17.0, 10.2), 5.83 (d, 1H, J = 10.2, 1.3 Hz), 4.52 (d, 
2H), 4.32 (d, 2H), 3.86 (d, 2H), 3.83 - 3.63 (m, 6H). 13C NMR (75 MHz, CDCl3) δ (ppm): 191.58, 
166.02, 165.43, 139.15, 134.98, 130.96, 130.21, 129.42, 128.17. HRMS+, [C17H20O7][Na], 




The product was observed to readily auto-polymerize at rt. To avoid such auto-polymerization 
processes the aldehyde monomer was diluted to give a 200 mM stock solution in anhydrous 
CH2Cl2 and stored at - 20 ºC. 
3.5.7. Preparation of PEG Aldehyde Copolymer Scaffolds (P6 - P7)  
Aldehyde scaffolds (P6 – P7) were prepared by RAFT polymerization of aldehyde monomer 
M1 and water-soluble comonomer OEGA500 in DMF at 70 ºC.  
RAFT Polymerization Protocol: OEGA500 (1.16 g, 2.32 mmol), M2 (780 mg, 2.32mmol, 75 eq), 
2-(Dodecylthiocarbonothioylthio)-2-methylpropanoic acid (DDMAT) (11.27 mg, 30.91 
µmol, 1.0 eq) and α,α′-Azoisobutyronitrile (AIBN) (1.01 mg, 6.18 µmol, 0.2 eq) were 
combined in a Schlenk tube equipped with a magnetic stirrer bar and degassed by six 
consecutive freeze-pump-thaw cycles. The reaction was backfilled with nitrogen and subjected 
to 2 further freeze-pump-thaw cycles. The reaction vessel was heated in an oil bath to 70 °C 
and the reaction was stirred for 6 h (P6) or 2.5 h (P7). The polymer was purified by dialysis 
(Spectra por, 3 kDa MWCO) against DI water (3 x 3 L) to afford P6/P7. 1H NMR (300 MHz, 
CDCl3) δ 10.09 (br), 8.18 (br), 7.95 (br), 4.48 (br), 4.15 (br), 3.84 (br), 3.63 (br), 3.37 (br), 0.88 
(br). The final polymer composition was determined by 1H NMR spectroscopy revealing that 
M2 / OEGA500 = 1 : 1.23. 1H NMR spectroscopic end group analysis showed Mn ≈ 27.4 kDa, in 
close agreement with the feed ratio (1:1 M2 : OEGA500). The aldehyde copolymer was purified 
by dialysis against methanol (3 x 2L), water (2 x 2L), then lyophilized to afford a viscous yellow 
oil (731.4 mg, 26.7 µmol). 
  




3.5.8. Preparation of Mannosylated Polymer Scaffolds 
Aldehyde polymer scaffold (P3) was dissolved in 50 mM acetate/D2O buffer (pD = 4.5), to afford 
a polymer solution with [P3] = 1.2 mM (Solution A), which was vortexed (1 min) and sonicated 
(5 min) to ensure complete dissolution of P3. Mannose hydrazide (MAN) was dissolved in 50 
mM acetate/D2O buffer (pD = 4.5), to afford Solution B, containing 30.2 mM MAN. A 500 µL 
aliquot of Solution B (MAN) was added to Solution A (P3) to afford Solution C, in which the 
P3 : MAN stoichiometry is 1 : 25.5 (i.e. 1.50 eqv MAN relative to the number of aldehyde groups 
on P3). Solution C was stirred at room temperature for 2 - 6h and the reaction was monitored 
by 1H NMR spectroscopy, which revealed total disappearance of aldehyde signal (δ 10.04 
ppm), thus confirming that the ‘decoration’ P3 had complete. The mannosylated polymer 
scaffold (P3-MAN) was purified by dialysis (Spectra por, 3 kDa MWCO) against water (3 x 3L) 
to remove small molecule impurities, and then lyophilized to afford P3-MAN as a white solid. 
Mannosylated scaffolds P1-MAN, P2-MAN, P4-MAN – P6-MAN were prepared according the 
above procedure, but concentration of MAN in Solution B was adjusted to compensate for 
differences in the number of aldehyde units located upon the polymer scaffolds (i.e. 
concentration of Solution B was adjusted to ensure 1.50 eqv. of MAN per aldehyde unit).  
 
Polymer scaffolds P4 - P5 were relatively hydrophobic in nature, and thus required small 
volumes (0.25 % v/v) of d6-DMSO or d4-MeOD cosolvent in Solution A to ensure complete 
dissolution of the polymer chains. 
3.5.9. Preparation of Acrylamide- and PEG-Based dyn-MAN-SCPNs 
P3-MAN solution (400 µL, 1.12 µmol) was diluted with 800 µL of 50 mM acetate/D2O buffer 
(pD 4.5) to afford [P3-MAN] = 0.913 mM (26.5 mM hydrazone unit). Succinic dihydrazide (82 
µL, 0.164 mg, 1.12 µmol, 1 eqv) was added to the polymer solution, which was stirred overnight 
at rt. An identical protocol was employed for the preparation of dyn-MAN-SCPNs with higher 
densities of crosslinker, however, the concentration of succinic dihydrazide solution was 
adjusted. This protocol was also employed for the synthesis of PEG-based dyn-MAN-SCPNs, 
however, the molar concentrations were adjusted to (i) account for differences in the number 
of hydrazone reactive sites displayed upon the polymer scaffold, and (ii) to achieve different 
densities of crosslinker moieties within the resultant SCPN architecture. 
3.5.10. Preparation of fix-MAN-SCPNs and fix-P6-MAN 
Solution R: NaCNBH3 (50 – 80 mM) in 100 mM AcOH-H4NOAc/H2O (pH 4.5). 
dyn-MAN-SCPNs (and dyn-P6-MAN) were chemically reduced by addition of NaCNBH3 
(Solution R, 100 µL 2.0 eqv relative to the number of hydrazone units) and the solution was 
stirred overnight at room temperature. Concentration of Solution R was adjusted to 




3.5.11.  Preparation of Buffer Solutions   
General Procedure: pH meter was calibrated prior to use. All buffer solutions were passed 
through a 0.45 µm syringe filter immediately before use to remove unwanted particulates.  
D2O Acetate Buffer: 50 mM H4NOAc-AcOH, pD 4.5. 
Acetate Buffer: 2 mM MnCl2, 2 mM CaCl2,100 mM H4NOAc-AcOH, pH 4.5. 
Phosphate Buffer: 2 mM MnCl2, 2 mM CaCl2, 10 mM Na2HPO4/NaH2PO4, pH 7.4. 
Bicarbonate Buffer: 2 mM MnCl2, 2 mM CaCl2, 10 mM NaHCO3, pH 8.5. 
 
3.5.12.  Preparation of Con A-functionalized Nanoparticles 
Lectin-Functionalization of NHS-Functionalized Silica Particles: NHS-functionalized silica 
particles (Micromod Partikeltechnologie) were suspended in 10 mM bicarbonate buffer (pH 
8.5) with sonication for 5 min to afford Solution A (10 mg/mL). Stock solutions of Rhodamine-
labelled Concanavalin A (Rh-Con A) or unmodified Concanavalin A (Con A) were diluted in 
bicarbonate buffer to afford Solutions B – E (2000 - 2 µg/mL protein concentration). Aliquots 
of Solutions B - E were added to the NHS particles (A), such that the final protein dose was 0 
- 5000 µg protein per mg NHS particles. Particle/protein solutions were incubated at 4 ºC for 4 
h with 950 rpm shaking, then a 100 µL aliquot of 200 mM glycine (in 10 mM bicarbonate buffer) 
was added to ‘cap’ unreacted NHS-ester sites. The protein-functionalized particles were stirred 
overnight at 4 ºC, purified by four centrifugal wash cycles (10 min at 15 krpm) to remove the 
unconjugated protein, then resuspended in phosphate buffer (pH 7.4) for a final particle 
concentration of 12.5 mg/mL. 
Lectin-Immobilization onto Streptavidin-Modified Polystyrene Particles: Streptavidin-modified 
polystyrene nanoparticles (smNPs, diameter: 100 nm) (Sigma Aldrich) were suspended in 10 
mM phosphate buffer (pH 7.4) with sonication for 5 min to afford Solution A’ (5 mg/mL). Stock 
solutions of biotinylated Concanavalin A (b-Con A) were diluted in 10 mM phosphate buffer to 
afford Solution B’ (500 µg/mL protein concentration). An aliquot of Solution B’ was added to 
the suspension of particles (Solution A’), such that the final protein dose was 500 µg b-Con A 
per mg of particles. Particle/protein solutions were then incubated at 4 ºC for 4 h with 950 rpm 
shaking, then purified by four centrifugal washes (10 min at 15 krpm) to remove the 
unconjugated protein, then resuspended in phosphate buffer (pH 7.4) for a final particle 
concentration of  5 mg/mL. b-Con A was immobilized onto streptavidin-modified microparticles 
(smMPs, diameter: 5 µm) (Sigma Aldrich) using the same procedure, and the protein dose was 





3.5.13.  B4F Assay 
Biotin-4-fluorescein (B4F, Sigma Aldrich)(25 mg) was dissolved in DMSO (250 µL) to afford 
stock solution A (BF4A), 155.1 mM concentration. B4FA was divided into 50 µL aliquots and 
stored at - 20 ºC prior to use. B4FA then diluted with 50 mM phosphate buffer (pH 7.4) to afford 
working solutions B4FB (10 mM), B4Fc (1 mM), B4FD (0.5 mM), B4FE (100 µM), B4FF (50 µM), 
B4FG (10 µM), B4FH (1 µM), B4FH (0.5 µM), B4FJ (100 nM).  
An aqueous suspension containing 0.5 mg/mL nanoparticles (smNPs, NP1, or biotin-saturated 
smNPs) prepared with 10mM phosphate buffer, the dispersion was mixed 25 times with a 200 
µL micropipette and an emission spectrum was measured (λem = 500 – 650 nm). Small volumes 
of B4F solutions (B4FB-B4FJ) were titrated into the nanoparticle dispersion, the solution was 
mixed 25 times and an emission spectrum was recorded after each B4F addition. Normalized 
emission profiles are shown in Figure 13e. 
3.5.14.   Normalization of Emission Profiles 
The production of normalized emission profiles shown in Fig. 13e, i – iii, required the measured 
values of emission at λem = 490 nm to be normalized affording to Eqn. 1: 
𝐍𝐨𝐫𝐦𝐚𝐥𝐢𝐳𝐞𝐝 𝐄𝐦𝐢𝐬𝐬𝐢𝐨𝐧, 𝑰𝑵𝒐𝒓𝒎 =
𝐦𝐚𝐱 𝐦𝐢𝐧
(𝐦𝐚𝐱 𝐦𝐢𝐧)
× (𝑰𝒙 − 𝐦𝐚𝐱) + 𝐦𝐚𝐱′ (Eqn. 1) 
Where 𝐦𝐚𝐱  and 𝐦𝐢𝐧  are the new maximum (100) and minimum (0) values of normalized 
emission (𝑰𝑵𝒐𝒓𝒎), respectively. 𝑰𝒙 is the measured emission value prior to normalization. 𝐦𝐚𝐱 







3.5.15.   Protocol for DLS ‘Shrink-Wrapping’ Experiments 
Con A particles (50 µL of 12.5 mg/mL NP1 in 10 mM phosphate buffer) were diluted with 
acetate buffer, pH 4.5 (475 µL) and mixed rapidly 10 times with a 200 µL micropipette. 100 µL 
of glycopolymer solutions (0 - 5000 µg/mL) were added to the suspension of Con A particles 
and the solution mixed by rapidly pipetting 10 times. The solutions were incubated at rt with 
900 rpm shaking for 4 h, purified by five consecutive centrifuge-wash-resuspend cycles and 
then analyzed by DLS. After analysis, α-methyl mannose (200 µL, 2M) was added and the 
solution were incubated for 24 h and then underwent five centrifugal washes, before 
reanalysing by DLS.  
 
3.5.16.   Protocol for Fluorescence Microscope ‘Shrink-Wrapping’ Experiments  
50 µL of Con A particles MP1 or MP2 (12.5 mg/mL in 10 mM phosphate buffer) were diluted 
with 20 mM acetate buffer, pH 4.5 (525 µL) and then 100 µL of glycopolymer solutions (1 - 
5000 µg/mL) were added to achieve a polymer dose of 0 – 10000 µg per mg of particles, final 
particle concentration of 1.0 mg/mL. Microparticle suspensions were mixed rapidly 10 times 
with a 200 µL micropipette. The solutions were incubated at rt with 900 rpm shaking prior to 
imaging by fluorescence microscopy. 0 - 24 h after mixing, ‘unbound’ glycopolymers were 
removed from the samples by five consecutive centrifugal wash cycles. 3 × 5 µL aliquots were 
removed from purified samples, deposited onto a clean glass slide, and then imaged under the 
fluorescence microscope to monitor film formation upon microparticle surfaces. This analysis 
was performed at different time points after mixing to monitor the formation of glycopolymer 
layers upon the microparticle surfaces. Displacement of glycopolymer films was achieved by 
incubation with α-methyl mannose (2M, 200 µL) which was added to each sample, and 
solutions were incubated for 24 h at 37 ºC. Samples were purified by centrifugal washes, before 
re-imaging by fluorescence microscopy to determine whether glycopolymer layers had been 
displaced from the particle surfaces. Control Experiments: Control experiments were 
performed with microparticles MP3 - MP5 exact as above. Additional control experiments were 
performed in the absence of polymer solution, where the 40 µL was substituted for the same 






3.5.17.   Image Analysis to obtain Mean Gray Values (MGVs) 
ImageJ software (1.5i) software was used to process all images. Briefly, images were imported 
into ImageJ and the thresholding tool (default setting) was employed to highlight bright areas 
of the image (emissive particles) (see Fig. 39, red highlighted areas). A region of interest (ROI) 
was generated for each individual particle (Fig. 39, yellow circles labelled with numerical 
identifiers). Greater than 50 ROIs (i.e. 50 particles/particle clusters) were generated from each 
fluorescence micrograph and the MGV was determined for each individual ROI (i.e. MGVROI1 
MGVROI2 etc) and this data was tabulated (see Fig. 39c). The average MGV (see Fig. 39d) 
obtained for particles within that micrograph was then calculated by summing the MGVs for 
each region of interest (MGVROI1 MGVROI2 etc)(Fig. 39c) and dividing by the number of ROIs. 
The standard deviation was of MGVs within each image was also reported. The MGV of the 
‘background’ (MGVbg) was determined in two steps: (1) The threshold tool was employed to 
isolate the darkest areas of the image and a ROI was generated. (2) MGV for this ROI was 
measured. The ‘background’ emission was accounted for by subtracting of the MGV was 
subtracted from each individual particle (MGVROI1 MGVROI2 etc).  
Figure 39: Fluorescence micrographs of emissive particles were analyzed to determine their mean gray 
values (MGVs) using ImageJ software. (a) An unprocessed fluorescence micrograph. (b) ImageJ 
screenshot the analyzed fluorescence micrograph. Brightly emissive particles (highlighted red) were 
selected using the threshold tool. Yellow circles indicate regions of interest (ROIs). A separate MGV was 
obtained from each ROI shown in the image above, and the data was tabulated (c). Greater than 50 
individual particles (ROIs) were selected from each image to calculate the mean brightness (average MGV) 





[1] (a) R. A. Dwek, Biochem. Soc. Trans., 1996, 96, 683−720. (b) Y. C. Lee and R. T. Lee, Acc. 
Chem. Res., 1995, 28, 321–327. (c) C. R. Bertozzi and L. L. Kiessling, Science, 2001, 291, 2357–
2364. 
[2] C. S. Mahon, C. J. McGurk, S. M. D. Watson, M. A. Fascione, C. Sakonsinsiri, W. B. Turnbull and 
D. A. Fulton, Angew. Chem. Int. Ed., 2017, 56, 12913–12918. 
[3] A.  Imberty and A.  Varrot, Curr. Opin. Struct. Biol., 2008, 18, 567–576 
[4] M. E. Woolhouse, S. Gowtage-Sequeria, Emerg. Infect. Dis., 2005, 11, 1842–1847. 
[5] W. C. W. S. Putri, D. J. Muscatello, M. S. Stockwell, A. T. Newall, Vaccine, 2018, 36, 3960-3966. 
[6] (a) C. Reed, S.S. Chaves, P. Daily Kirley, R. Emerson, D. Aragon, E.B. Hancock, et al., PLoS One. 
2015, 103, e0118369. (b) V. J. Lee, Z. J. Marc Ho, E. H. Goh et. al., Influenza Other Respir.  
[7] A. D. Iuliano, K. M. Roguski, H. H. Chang et al., Lancet, 2018, 391, 1285–1300. 
[8] S. Finch, M. J. McDonnell, Hani Abo-Leyah, S. Aliberti and J. D. Chalmers, Ann. Am. Thorac. 
Soc., 2015, 12, 1602-1611. 
[9] (a) J. Vila et al., FEMS Microbiol. Rev., 40, 2016, 437-463. (b) Olivier T., D. Skurnik, B. Picard 
and E. Denamur, Nat. Rev. Microbiol., 2010, 8, 207-217. 
[10] J. De Smet, H. Hendrix, B.G. Blasdel, K. Danis-Wlodarczyk, R. Lavigne, Nat. Rev. Microbiol, 2017, 
15, 517–530. 
[11] (a) G.I. Bell GI, Science, 1978, 200, 618–627. (b) W.E. Thomas, E. Trintchina, M. Forero, V. 
Vogel, E. V. Sokurenko, Cell, 2012, 109, 913–923. (c)  B. T. Marshall, M. Long, J. W. Piper, T. 
Yago, R.P. McEver, C. Zhu, Nature, 2003, 423, 190-193. 
[12] R. Robinson, PLos Biology, 2006, 4, 1473-1485. 
[13] (a) L. Coutte et al., J. Exp. Med., 2003, 197, 735-742. (b) A. M. Krachler and K. Orth, Virulence, 
2014, 4, 284-294 (c) P. Klemm, M. A. Schembri, Int. J. Med. Microbiol., 2000, 290, 27-35 (d) K. 
A. Kline et al., Cell Host Microbe., 2009, 5, 580–592.  
[14] D. F. Senear,and D. C. Teller, Biochemistry, 1981, 20, 3076-3083. 
[15] C. A. Stark and A. D. Sherry, Biochem. Biophys. Res. Commun., 1979, 87, 598-604. 
[16] S. Goto, Kyoko Masuda et al., Chem. Pharm. Bull., 2002, 50, 445-449. 
[17] (a) J. D. Badjić, A. Nelson, S. J. Cantrill, W. B. Turnbull and J. F. Stoddart, Acc. Chem. Res., 
2005, 38, 723-732. (b) U. Boas and P. M. H. Heegaard, Chem. Soc. Rev., 2004, 33, 43-63. 
[18] P. Frank, A. Prasher, B. Tuten, D. Chao and E. Berda, Appl. Petrochem. Res., 2015, 5, 9–17. 












Table of Contents 
4.1. Abstract          146 
4.2. Results and Discussion        147 
4.2.1. Preparation of GM1os       148 
4.2.2. Proposed Strategy for the Synthesis of GM1-SCPNs   149 
4.2.3. Preparation of bis-Functional Linker 3     150 
4.2.4. Validating the Chemoselectivity of Linker 3    151 
4.2.5. Optimizing the Glycoconjugation of Linker 3    153 
4.2.6. Glycoconjugation of Linker 3 to GM1os     157 
4.2.7. Rationalizing the Observed Chemoselectivity of Linker 3   160 
with Carbohydrate Electrophiles 
4.2.8. Functionalization of Aldehyde Polymer Scaffold with    161 
GM1-Linker Glycoconjugates 
4.2.9. Barriers to the Preparation of GM1-SCPNs     162 
4.2.10. An Alternative Synthetic Route to GM1-SCPNs    164 
4.2.11. Glycoconjugation of Boc-Linker 18 to D-Lactose   165 
4.2.12.  Future Work         167 
4.3. Conclusion          168 
4.4. Experimental         170 





Chapter 3 has demonstrated that ‘shrink-wrapping’ of 3D microscale objects can be achieved 
when the ‘wrapping’ process is driven by specific molecular recognition events between 
polymers and the object surface. ‘Shrink-wrapping’ of simian virus 40 (SV40), a small 
icosahedral capsid, was thus envisaged to form an intermolecularly crosslinked glycopolymer 
film (Fig. 1) upon the viral surface. This crosslinked polymer ‘wrapping’ is anticipated to protect 
the ‘shrink-wrapped’ viral ‘cargo’ from dehydrating conditions of the external environment and 
may also serve to ‘neutralize’ the pathogen by masking the virus surface. An overarching aim 
of this thesis was to exploit specific ligand-receptor interactions to drive the ‘shrink-wrapping’ 
of SV40 viral capsid, a small and biologically relevant object. This goal first required the 
synthesis of SCPNs ‘decorated’ with residues of the complementary carbohydrate ligand GM1, 
which is recognized by receptors located upon SV40 exterior. Progress towards the 
preparation of GM1-functionalized SCPNs (GM1-SCPNs) is reported within this chapter. 
 
  
Figure 1: ‘Shrink-wrapping’ of a viral capsid within an intermolecularly crosslinked polymer film. In step 
(i) single-chain polymer nanoparticles (SCPNs) decorated with carbohydrate residues bind selectively 
to receptors situated on the periphery of the capsid. This process ‘concentrates’ the SCPNs, allowing 
their dynamic covalent crosslinkers to undergo intra- to inter-chain reorganisation in step (ii), resulting 
in the ‘shrink-wrapping’ of the capsid within a thin layer of intermolecularly crosslinked polymer chains.  
In step (iii) the application of a stimuli such as a drop in pH or increase in redox potential would be
anticipated to induce cleavage of the crosslinkers, triggering the ‘unwrapping’ of viral capsid. In this 




4.2. Results and Discussion 
This chapter reports progress towards the goal of ‘shrink-wrapping’ virus-like particles. Simian 
virus 40 (SV40) capsid (Fig. 2a) was selected as a target on account of its availability from our 
collaborators in the laboratory of Professor Bruce Turnbull at University of Leeds. SV40 is a 
small (Dh ≈ 50 nm) non-enveloped DNA tumour-virus with a total surface area of 7854 nm2. The 
SV40 capsid is composed of 360 copies of the VP1 major capsid protein (Fig. 2b), organised 
into 72 pentamers that assemble to form an icosahedral architecture (Fig. 2a). Each VP1-
pentamer contains five carbohydrate binding sites, thus the capsid possesses a total of 360 
carbohydrate binding sites displayed upon the viral surface. Although SV40 capsid features a 
relatively high density of carbohydrate binding sites (1 site per 21.8 nm2), their interaction with 
the complimentary pentasaccharide GM1 (Fig. 2d) is relatively weak (VP1-GM1, Kd = 5.8 mM).1 
Although these binding constants appear relatively low, this issue is readily circumnavigated 
by multivalent expression2 of carbohydrates upon a polymer scaffold, where an ensemble of 
low-affinity carbohydrate-receptor interactions reinforce one another to facilitate high-affinity 
Figure 2: (a) SV40 viral capsid is a small non-enveloped DNA tumour-virus, composed from 360 copies 
of the major capsid protein, VP1 (b) which are organised into 72 pentamers that assemble to form the 
icosahedral capsid architecture. Each VP1 protein subunit contains a single carbohydrate binding site 
(c), which binds selectively to the branched oligosaccharide GM1 ganglioside (d). SV40 viral capsid, 




binding to the viral surface. It is anticipated that multivalent display of carbohydrates will 
encourage GM1-SCPNs to bind onto viral capsid. Thus, this effect can be exploited to achieve 
high affinity polymer-virus interactions, which are anticipated to help drive the ‘shrink-
wrapping’ process by effectively concentrating GM1-SCPNs onto the periphery of SV40. 
 
4.2.1. Preparation of GM1os 
GM1 oligosaccharide (GM1os) was synthesized3 (Fig. 3a) by enzymatic cleavage of the 
ceramide tail from GM1 ganglioside (see structure in Fig. 3c) to yield the carbohydrate 
product with a reactive hemiacetal (masked aldehyde group) at its reducing end (Fig. 3a, ii). In 
aqueous solution, the reducing end of GM1os (Fig. 4a) predominantly exists as a ring-closed 
hemiacetal (i) which is in equilibrium with the ring-opened (ii) aldehyde form (< 3 % CHO). 
Figure 3: (a) Enzymatic cleavage of ceramide moiety from GM1 ganglioside by EGCase II afforded 
GM1 oligosaccharide (GM1os) with a terminal hemiacetal group at its reducing end. Partial 1H NMR 




Following purification (see experimental), GM1os was lyophilized and isolated as a white solid 
(254 mg, 78 % yield). Figures 3b-c show the partial 1H NMR spectra of GM1os product and 
GM1 ganglioside starting material, respectively, the assignment of which was consistent with 
literature reports.4 The 1H NMR spectrum of GM1os (Fig. 3b) revealed that quantitative 
cleavage of the ceramide moiety was successful, as evidenced by the total disappearance of 
the associated ceramide signals (δ = 0.89 – 2.90 ppm) and the emergence of new signals (●) 
at δ = 5.22 ppm (J1,2 = 3.66 Hz) and δ = 4.67 ppm (J1,2 = 7.86 Hz), which were assigned to the 
GlcH1 α/β positions on the reducing end of GM1os. Attempts to characterize GM1os by mass 
spectrometry proved unsuccessful on account of difficulties in ionizing the carbohydrate. 
4.2.2. Proposed Strategy for the Synthesis of GM1-SCPNs 
Considerable thought was given to identify functional groups that react efficiently and 
selectively with unmodified carbohydrates. Reactions of alkoxyamine or hydrazide groups with 
‘free’ carbohydrates are known to be chemoselective and have been widely exploited for the 
synthesis of neoglycopeptides,5 neoglycoconjugates6 and carbohydrate-functionalized 
surfaces.7 Consequently, these processes were chosen for the site-specific covalent 
immobilization of ‘free’ carbohydrates onto polymer scaffolds. In the selected strategy for 
preparing GM1-grafted SCPNs, the reducing end (electrophilic site) of GM1os was anticipated 
to react with a nucleophilic Linker 3 (Fig. 4c) to yield an GM1-linker conjugate (Fig. 4d).  
Figure 4: (a) In aqueous solution, the reducing end of GM1os predominantly exists as a ring-closed 
hemiacetal (i) which is in equilibrium with the ring-opened (ii) aldehyde form (< 3 % CHO). (b) Structure 
of aldehyde-functionalized polymer scaffold P3, the synthesis of which was reported in Chapter 3  
(pages 97 - 98). (c) Reaction of GM1os with linker 3 was expected to yield oxime-linked glycoconjugate 
4 as the majority product under thermodynamic control. (c-d) Proposed synthetic strategy for the 
preparation of GM1-grafted polymers by reacting the ‘free’ hydrazide end of GM1-Linker Conjugate 4
(d) with an aldehyde-functionalized polymer scaffold P3 (b) to afford GM1-P3 (e). Intramolecular 




Linker 3 (Fig. 4c) has two nucleophilic sites: A hydrazide and an alkoxyamine, which react with 
carbonyls to form acyl hydrazones and oximes, respectively. Oxime bonds are known to be 
more hydrolytically8a and thermodynamically8b stable than are acyl hydrazones, and it was thus 
anticipated that 3 would react selectively through its alkoxyamine end to yield the stable oxime-
linked glycoconjugate 4 (Fig. 4d), in preference to forming the analogous hydrazone product. 
On the reasonable assumption that oxime conjugate 4 is the majority product obtained under 
thermodynamic control, it was thus envisioned that the ‘free’ hydrazide end of 4 could be 
grafted (Fig. 4e) onto an aldehyde-functionalized scaffold P3 (Fig. 4b) to afford GM1-P3, a 
hydrazone-functionalized polymer scaffold ‘decorated’ with pendant GM1 carbohydrate 
residues. This approach leaves the reducing end of GM1os in its ring-open form – however, 
this should not affect its binding with the capsid, which is predominantly facilitated by the 
terminal sialic acid and galactoside residues.1 Intramolecular crosslinking (Fig. 4f) of GM1-P3 
with succinic dihydrazide (SD) was anticipated to afford GM1-SCPNs. The synthesis and 
characterization of the parent polymer scaffold P3 is reported in Chapter 3 (see pages 97 - 98 
for details). 
4.2.3. Preparation of bis-Functional Linker 3 
In order to facilitate grafting of GM1 to the aldehyde scaffold P3 (Fig. 4c), bis-functional linker 
molecule 3 was prepared (Fig. 5a) in two steps. In step (i) alkylation of N-hydroxyphthalimide 
with bromide 1 yielded intermediate 2. Subsequent hydrazine reflux (ii) of 2 with hydrazine 
monohydrate afforded tandem hydrazinolysis of both methyl ester and N-hydroxylphthalimide 
to furnish linker 3, which contains both hydrazide and alkoxyamine nucleophilic sites. Linker 3 
was isolated as an off-white solid (62 % yield) 
Figure 5: (a) Synthesis of alkoxyamine linker 3. Step (i) N-Hydroxypthalimide, DIPEA, CH2Cl2, 18 h, rt. 




4.2.4. Validating the Chemoselectivity of Linker 3 
Linker 3 (Fig. 6a) may react with carbonyl compounds through its alkoxyamine end to form 
oximes, or through its hydrazide end to form acyl hydrazones. To evaluate linker 
chemoselectivity towards carbonyl-containing electrophiles, control experiments were 
undertaken in which 3 (86 mM, in d6-DMSO with 50 mM AcOH) was reacted with 0.95 eqv. 
benzaldehyde (Fig. 6b) or 0.95 eqv. acetone (Fig. 6c). These processes were monitored as a 
function of time by 1H NMR spectroscopy (Fig. 6e-f) and the associated kinetics traces were 
derived (Fig. 6g-h). Reaction progress was monitored over an 18 h timeframe and upon 
reaching equilibrium the hydrazone : oxime product distributions, % yield, and equilibration 
time (Teq) were determined (Table 1) by integral analysis of ‘diagnostic’ 1H NMR signals (Fig. 
6e-f).  
  
Figure 6: (a) Linker 3 (86 mM in d6-DMSO with 50 mM AcOH) can react through alkoxyamine end to 
form oximes, or through hydrazide end to form hydrazones. Reaction of 3 with 0.95 eqv. benzaldehyde 
(b) or 0.95 eqv. acetone (c) both afforded the oxime product with > 74 % selectivity, as determined by 
1H NMR spectroscopic studies (d-f). Partial 1H NMR (d6-DMSO, 400 MHz) spectra of linker 3 in isolation 
(d), during reaction of 3 with benzaldehyde (e) and acetone (f). Kinetic traces for reaction of 3 with 




During the reaction of 3 with benzaldehyde (Fig 6b) 1H NMR spectroscopy revealed the 
formation of multiple short-lived species (Fig. 6b/e, ● and ●). However, by timepoint T = 11 
min, these transient species had been consumed and the spectra had simplified such that the 
identity of all the species could be assigned. 1H NMR spectra revealed the complete 
disappearance (Fig. 6e) of aldehyde signal (●)(10.02 ppm), rapid consumption of the 
‘diagnostic’ alkoxyamine signal (●)(4.61 ppm) belonging to the unreacted linker 3 and 
concomitant appearance of new 1H NMR signals (●)(5.21 and 5.26 ppm).* The emergence of 
these new signals was attributed to the formation of an oxime product (see Fig. 6b, ●), a 
reaction which had achieved completion by 203 min. The observation that aldehyde signal (●) 
had been fully consumed, yet the unreacted alkoxyamine signal (●) persisted revealed that 
oxime 5 was the predominant product (74 % yield), with hydrazone product 6 accounting for 
the remaining 26 %. The reaction with acetone (Fig. 6c) also showed rapid disappearance of 
the alkoxyamine signal (●) (Fig. 6f) and emergence of a new oxime signal (●)(5.03 ppm), which 
indicated quantitative formation of an oxime product after 2820 minutes. From these initial 
chemoselectivity studies it was concluded that linker 3 has a preference to react with carbonyl 
compounds through the alkoxyamine end, with oxime product typically formed in > 74 % yield.† 
Alkoxyamine linker 3 was thus progressed to trial oxime ligations with carbohydrate substrates 
(Fig. 7), where 3 was also anticipated to display a preference for oxime formation by reaction 
through its alkoxyamine end. 
  
 
* Two 1H NMR signals were observed for the ‘diagnostic’ benzylic protons (●) of benzaldehyde oxime product 5 on 
account of E/Z isomerization of the oxime bond. In contrast, E/Z isomerization was not observed in the case of 
acetone, which is a symmetrical ketone and thus affords only single product, oxime product 7. See the 1H NMR 
spectrum in Fig. 6f, where benzylic protons (●) of oxime 7 show only a single peak at δ = 5.30 ppm. 
 
† Intriguingly, linker 3 reacts with acetone to form oxime 7 in > 98 % yield, yet benzaldehyde forms hydrazone 5 and 
oxime 6 in a 74:26 ratio. Under the assumption that reactions were operating under thermodynamic control, the 
observation that benzaldehyde forms a mixture of products implies that the hydrazone and oxime are of similar 
energy. In contrast, reactions of 3 with acetone revealed a clear difference in stability of the hydrazone and oxime 
products, with a strong preference for the latter. 
Table 1: Equilibration time (Teq), oxime/hydrazone product distributions and % yield for reaction of linker 




4.2.5. Optimizing the Glycoconjugation of Linker 3 
The proposed synthesis of GM1-SCPNs (Fig. 4) required oxime-linked glycoconjugate 4 (Fig. 
4d) to be isolated in a high yield. Working with unprotected GM1 was, however, synthetically 
challenging and presented little scope for purification on account the highly hydrophilic nature 
of this complex carbohydrate and its inherent incompatibility with organic solvents. 
Furthermore, GM1os was time-consuming and costly to produce‡ and therefore only available 
in a limited supply of < 250 mg. Investigations thus focussed on optimizing the linker-sugar 
conjugation chemistry, such that glycoconjugate 4 could be isolated in a high yield and then 
directly grafted onto polymer scaffolds without requiring tedious and wasteful purification 
procedures. The reducing end of GM1os (Fig. 3b) is isostructural with D-Lactose, thus this 
low-cost and commercially available disaccharide served as a suitable model for 
glycoconjugations involving GM1. A range of experimental conditions were screened to 
optimize the glycoconjugation of linker 3 to D-Lactose (Fig. 7) and the conjugation efficiency 
was quantified by 1H NMR spectroscopy, which the reported % conversion values listed in 
Table 2.§  
 
‡ Production of 250 mg GM1os requires three weeks for enzymatic cleavage of the ceramide tail from GM1-
ganglioside. GM1-ganglioside starting material costs £310 for 500 mg (Carbosynth UK, September 2018) and the 
enzyme for ceramide cleavage (EGCase II) cost £309. 
 
§ The reported % conversion values (Table 2) were calculated by integral analysis of the ‘diagnostic’ D-lactose 
anomeric (H1α) signals relative to an internal standard within the 1H NMR spectra. Aromatic 1H NMR signals (δ 7.38 
and 7.78 ppm) of linker 3 were chosen as the internal 1H NMR standard for two reasons: (i) their chemical shifts 
remained unchanged throughout the course of the reaction and (ii) no overlap was observed with adjacent signals. 
 
Figure 7: Conjugation of linker 3 with D-Lactose was monitored by 1H NMR spectroscopy. 
Disappearance of the α- and β- anomeric ‘diagnostic’ 1H NMR signals (●) were employed to monitor the 




Time-resolved 1H NMR spectroscopy permitted in-situ monitoring of glycoconjugation 
reactions, where the steady disappearance of ‘diagnostic’ anomeric (●) signals** associated 
with D-Lactose (Fig. 7) revealed consumption of the carbohydrate starting material and thus 
reported reaction progress. Although this glycoconjugation reaction may yield two potential 
products: (i) Oxime 9 or (ii) hydrazone 10, it was anticipated that oxime 9 (Fig. 7) would be the 
predominant product. Thus, experimental conditions were initially optimized to improve the 
yield of the carbohydrate-linker condensation process with little consideration for the 
oxime/hydrazone product distribution, which was challenging to interrogate on account of the 
complexity observed in 1H NMR spectra.†† Discussion of the products isolated from this 
reaction is, however, provided on page 155. 
Table 2 summarizes the conditions explored to optimize ligation of linker 3 to D-Lactose. 
Entries 6 and 9 employed 4-aminophenol (4-AP) as a nucleophilic organocatalyst, which was 
anticipated to catalyze oxime formation,9 and thus improve the yield of glycoconjugate 
products. The following parameters were adjusted to achieve the highest % conversion of 
lactose substrate: (i) Solvent type and composition, (ii) presence of 4-AP organocatalyst, (iii) 
linker concentration, (iv) carbohydrate concentration, (v) reaction temperature.  
 
** Reaction progress was monitored by integral analysis of the α-anomer 1H NMR signal only. The integral of the β-
anomer (δ 4.17 ppm) was affected by signal overlap, thus could not be employed to reliably monitor the reaction. 
α- and β-anomers rapidly interconvert in solution, however their ratio should remain constant, and thus consumption 
of the α-anomer is expected to representative of the reaction progress. 
 
†† 1H NMR spectra obtained during the monitoring of glycoconjugation processes were highly complex and difficult 
to interrogate, on account of a number of factors: (i) Carbohydrates exist as an equilibrium mixture of α- and β-
anomers, the exact composition of which was directly affected by the glycoconjugation process; (ii) a mixture of 
carbohydrate-linker adducts were obtained, the diagnostic signals of which displayed significant overlap with signals 
of the carbohydrate region (δ 2.80-4.50 ppm); (iii) carbohydrate-linker adducts were observed to exist as a mixture 
of isomers; (iv) glycoconjugation reactions were initially conducted in acetate buffered D2O (Table 2, entries 1-6), 
where the diagnostic alkoxyamine signal (Fig. 8a, ●) of linker 3 was masked beneath the HOD peak. 
Table 2: Summary of reaction conditions for ligation of linker 3 to D-Lactose. Entry 8 was determined 
as the optimal experimental conditions for ligation of linker 3 to carbohydrate substrates. Solvent 
conditions: AcOH/D2O is 150 mM AcOH in D2O, pD ≈ 4.0; AcOH/d6-DMSO is 150 mM AcOH in d6-DMSO. 
In entires 6 and 9 the concentration of nucleophilic organocatalyst 4-aminophenol (4-AP) was 100 mM. 
Entry 8 constitutes optimal experimental conditions for conjugation of linker 3 to D-Lactose 
Table 2: Su ary of reaction conditions for ligation of linker 3 to D-Lactose. Entry 8 was deter ined 
as the opti al experi ental conditions for ligation of linker 3 to D-Lactose, on account of these 
conditions affording the highest % consumption values. The % conversion values were calculated from 
the consumption of D-Lactose starting material, which was determined by 1H NMR spectroscopy. 
Solvent conditions: AcOH/D2O is 50 mM AcOH in D2O, pD ≈ 3.4; AcOH/d6-DMSO is 150 mM AcOH in 




Inspection of Table 2 reveals that anhydrous conditions afforded the highest % conversions for 
glycoconjugation, with entry 8 exceeding 95 % conversion within 24 h. In contrast, oxime 
ligation reactions performed in aqueous solution (pD ≈ 4.9) typically afforded low % 
conversions of < 60 %. Oxime formation is a condensation reaction and thus the conjugation 
of linker 3 to carbohydrates was anticipated to be disfavoured by an aqueous environment. 
The observation that % conversion values were initially low but could be slightly improved by 
increasing the carbohydrate concentration in aqueous solution (see entries 1 and 3), was 
entirely consistent with this hypothesis. It was also concluded that linker-carbohydrate 
conjugation chemistry preceded in a cleaner fashion at room temperature than was observed 
at elevated temperatures, and that the presence of 4-aminophenol catalyst did not significantly 
improve % conversion in organic solvents. Conditions from entry 8 were found to be optimal 
for conjugation of linker 3 to carbohydrate substrates, on account of the highest % conversion 
value, thus were employed for all subsequent glycoconjugation reactions. Under these 
conditions it was demonstrated that linker 3 conjugates to D-Lactose with a high efficiency. 
However, the oxime/hydrazone product distribution had not yet been interrogated and this will 
now be discussed by consideration of the observed 1H NMR spectra (Fig. 8b).  
Figure 8b shows a series of time-resolved 1H NMR spectra obtained during the reaction of D-
Lactose with linker 3 in 150 mM AcOH/d6-DMSO (Table 2, entry 8). These spectra revealed 
that the ‘diagnostic’ alkoxyamine signal (δ 4.60 ppm, ●) was surprisingly not consumed during 
the reaction, thus indicating that the expected oxime conjugate 9 had not formed. The 
observation that ‘diagnostic’ D-Lactose GalH2 and GlcH1 signals (●α,β + ●α,β) were consumed 
and new carbohydrate signals appeared (δ 4.89 and 4.21 ppm, ●α,β) but the alkoxyamine end 
of 3 (●) remained unreacted strongly indicates that hydrazone 10 was a likely product. The 
emerging doublet at δ 6.99 ppm (●) was consistent with the chemical shift of a hydrazone CH, 
again suggesting that hydrazone 10 had been isolated as the predominant product. It should 
be acknowledged, however, that the signal at δ 6.99 ppm (●) does not integrate to the 
anticipated value and thus this conclusion should be treated with caution. The two 
carbohydrate doublet signals at δ 4.89 (●α) and 4.21 ppm, (●β) were assigned to 







Figure 8: (a) Conjugation of linker 3 (94 mM) with D-Lactose (108 mM) was monitored by 1H NMR 
spectroscopy. Disappearance of the ‘diagnostic’ α-anomeric 1H NMR signal at δ  4.89 ppm was 
employed to follow the progress of the glycoconjugation reaction as a function of time. Step (i) was 
performed under conditions optimized for glycoconjugation. See Table 2, entry 8. (b) Partial 1H NMR 




Reactions between carbohydrates and hydrazides are known to yield both acyclic (Fig. 9a) and 
cyclic (Fig. 9b) adducts. Acyclic hydrazide adducts are known to undergo ring-closure 
reactions7 in which OH5 attacks the hydrazone bond (Fig. 9a) to form cyclic hemiaminal 
species (b) such as 12 (Fig. 8a). 1H NMR spectra (Fig. 8b) have provided evidence that D-
Lactose reacts with linker 3 to yield a mixture of hydrazide adducts which may exist in a cyclic 
(12) and acyclic (10) form. The expected oxime product (9), however, was not isolated. These 
intriguing observations will later be rationalized on pag 159, but first the conjugation of linker 3 
to GM1os must be discussed. 
 
4.2.6. Glycoconjugation of Linker 3 to GM1os 
GM1os was conjugated to linker 3 (Fig. 10a) under conditions determined to be optimal for 
glycoconjugation.‡‡ The conjugation reaction was monitored by 1H NMR spectroscopy (Fig. 
10b), where integral analysis of ‘diagnostic’ signals (δ 4.60 ppm, ●) associated with the 
alkoxyamine end of linker 3, GM1os starting material (δ 4.89 ppm, ●), glycoconjugate products 
13 (δ 6.90 ppm, ●) and 14 (δ 7.55 ppm, ●) were employed to monitor reaction progress. 
Reactions were monitored for T ≥ 72 h.  
 
‡‡ 108 mM carbohydrate, 94 mM linker 3 with 50 mM AcOH in d6-DMSO, rt. Note that the linker : sugar stoichiometry 
of 1 : 1.15 equivalents was chosen as a precautionary measure to ensure that the ‘free’ linker molecule had been 
entirely consumed by reaction with carbohydrate. Residual linker molecules may directly react with and thus 
potentially crosslink the aldehyde polymer scaffold P3. An excess of carbohydrate ensures that oxime-linked 
glycoconjugate 4 contains negligible quantities of unreacted linker 3, thus reducing risk of unwanted crosslinking. 
Figure 9: Carbohydrate-hydrazide adducts may exist as acyclic (i) or cyclic (ii) forms. Acyclic hydrazone 
form (i) converts into the cyclic form (ii) by ring closure reaction, in which OH5 attacks the hydrazone 





Figure 10: (a) Conjugation of linker 3 to GM1os may afford three possible products: Ring-opened 
hydrazone 13, ring-closed hemiaminal 14 or the desired oxime product 4. Partial 1H NMR spectra (d6-
DMSO, 400 MHz)  of GM1os (b) and of GM1os during its reaction with linker 3; reaction time 0 h (c), 




Analysis of the 1H NMR spectra (Fig. 10b-h) revealed that after reaction of linker 3 with GM1os 
(Fig. 10d) the ‘free’ alkoxyamine end of 3 (δ 4.60 ppm, ●) remained completely unreacted, 
indicating that the desired oxime conjugate 4 had not formed. However, the intensity of the 
GM1os anomeric signals at δ 4.85 (●, H1α) and 4.25 ppm (●, H1β) had radically decreased, 
almost disappearing from the spectrum obtained at T > 72 h (Fig. 10h), signifying that the 
carbohydrate reducing end had been almost entirely consumed. These observations, in 
conjunction with the new signals (Fig. 10d) which emerged at δ 6.90 ppm (●) and 7.55 ppm 
(●), were consistent with the formation of carbohydrate-hydrazide adducts (Fig. 10a) which 
may exist either as (i) a ring-opened hydrazone (13) or (ii) as a ring-closed hemiaminal (14). 
The formation of 13 and 14 was entirely consistent with the results obtained with D-Lactose 
(Fig. 8), but the isolation of these unexpected products lies in stark contrast with the hypothesis 
that oxime bonds are more thermodynamically stable than hydrazones.8b, 9a Linker 3 displayed 
the expected chemoselectivity in control experiments with simple carbonyl compounds 
(acetone and benzaldehyde)(Fig. 6a), where oximes were observed as the majority products, 
whilst reactions with carbohydrate electrophiles (Figs. 10 and 11), 3 showed the opposite 
chemoselectivity, with hydrazone glycoconjugates being the major products. These conflicting 
but equally intriguing observations demonstrate that, despite both being carbonyl-containing 
electrophiles, carbohydrates demonstrate a very different reactivity to simple carbonyl 
compounds. Rationale for the observed differences in reactivity will now be discussed. 
Figure 11: (a) Reaction of bis-functional linker 3 with acetone or benzaldehyde (a) rapidly afforded 
oxime product in > 75 % yields. In contrast, reaction of 3 with D-Lactose (b) or GM1os (c) both yielded 
0 % oxime glycoconjugates (9, 4), as evidenced by 1H NMR studies (Fig. 8, 10) which showed no change 




4.2.7. Rationalizing the Observed Chemoselectivity of Linker 3 with 
Carbohydrate Electrophiles 
Nucleophilic attack of carbohydrate substrates by hydrazides will initially afford an acyclic 
hydrazone product (Fig. 12c). However, subsequent the ring-closure can occur in which OH5 
attacks the hydrazone bond (see Fig. 9) to afford a cyclic aminal-like product. It is known that 
reactions between carbohydrates and substances containing alkoxyamine groups (Fig. 12a) 
generate acyclic products preferentially.7 In contrast, it has been reported that cyclic adducts 
(Fig. 12c)  with β-configuration are produced predominantly in reactions of carbohydrates with 
hydrazide nucleophiles.10 
Literature suggests that the cyclic forms of hydrazide-carbohydrate adducts (Fig. 12c) are 
more thermodynamically favourable than the corresponding acyclic forms.7 However, in the 
case of the alkoxyamine-carbohydrate adducts (Fig. 12a) the more favourable cyclic isomer is 
not always kinetically accessible, thus the less stable acyclic isomer is typically observed.7,10 In 
this chapter, it was thus hypothesized that carbohydrates react preferentially with the hydrazide 
end of linker 3 to form hydrazones, on account of ring-closure reactions (Fig. 9) which afford 
more thermodynamically stable cyclic forms of the carbohydrate. Although oxime bonds are 
typically more thermodynamically stable than hydrazones,8b the ring-closure of hydrazide-
carbohydrate adducts was hypothesized to bring additional stabilization of hydrazone-linked 
glycoconjugates which is simply not observed for the corresponding oxime conjugate. This 
hypothesis rationalizes why GM1os and D-Lactose reacted selectively with the hydrazide end 
of linker 3 to form hydrazone-linked glycoconjugates, leaving alkoxyamine end of 3 completely 
untouched. These observations have important consequences on the proposed synthesis of 
GM1-SCPNs, which will be later discussed on pages 162 – 163. 
Figure 12: Adducts obtained from reactions of carbohydrates with (a) 




4.2.8. Functionalization of Aldehyde Polymer Scaffold with GM1-Linker 
Glycoconjugate 
The ‘free’ alkoxyamine end of hydrazone-linked GM1 glycoconjugates 13/14 were grafted onto 
aldehyde-functionalized copolymer P3 (Fig. 13a) to afford carbohydrate-decorated scaffold 
GM1-P3. 1H NMR spectroscopy (Fig. 13b-d) showed total disappearance of the ‘diagnostic’ P3 
aldehyde (δ 9.80 ppm) and alkoxyamine 3 (δ 4.60 ppm) signals, indicating complete 
functionalization of P3 to afford GM1-grafted scaffold GM1-P3. GM1-P3 was purified by 
aqueous dialysis to remove small molecule impurities including any unbound GM1 conjugates 
13/14. After dialysis, the 1H NMR spectrum of GM1-P3  (Fig. 13d) revealed that GM1 
carbohydrate signals are still present, indicating that GM1 was successfully immobilized onto 
the polymer scaffold. Although this strategy was successful in grafting GM1 to the polymer 
backbone, the precise order in which the dynamic covalent bonds were assembled upon the 
polymer scaffold was incompatible with the proposed synthesis of GM1-SCPNs, for reasons 
which will now be discussed. 
Figure 13: (a) GM1 ‘decorated’ glycopolymer GM1-P3 was prepared by grafting GM1 hydrazone 
conjugates 13/14 onto aldehyde-functionalized polymer scaffold P3. GM1-P3 is functionalized with 
oxime bonds (i), a covalent linkage which is not labile towards component exchange with hydrazide 
nucleophiles. (b-d) Partial 1H NMR spectra of (b) aldehyde polymer P3 (D2O, 300 MHz), (c) GM1




4.2.9.  Barriers to the Preparation of GM1-SCPNs  
The proposed synthesis (Fig. 14a-c) of GM1-SCPNs required the glycopolymer scaffold to be 
entirely functionalized with dynamic covalent acyl hydrazone linkages.§§ In the above case, 
however, GM1-P3 was functionalized through oxime bonds on account of grafting P3 with 
alkoxyamine-displaying GM1 conjugate 4 (Fig. 14d). Whilst oximes are sometimes considered 
a dynamic covalent bond,11 these linkages are generally not labile towards component 
exchange with hydrazide nucleophiles (Fig. 14e).8b Thus, it was expected that crosslinking of 
GM1-P3 with succinic dihydrazide would be unsuccessful and ‘dynamic’ GM1-SCPNs may not 
be isolated from this synthetic route. The exact rationalization as to why GM1-SCPNs could 
not be directly synthesized from hydrazone-linked GM1-conjugates 13/14 is summarized 
schematically within Figure 14.  
 
§§ This feature was a crucial requirement for obtaining GM1-SCPNs which are capable of ‘shrink-wrapping’, as this 
process depends upon the component exchange of ‘dynamic’ acyl hydrazone crosslinkers to facilitate ‘structural 
metamorphosis’ of SCPNs into intermolecularly crosslinked polymer films 
Figure 14: The precise order of connectivity of stable (oxime) and dynamic (acyl hydrazone) covalent 
bonds upon the glycopolymer scaffold determines whether GM1-SCPNs can be successfully 
synthesized. (a-c) Proposed synthetic strategy for the preparation of GM1-SCPNs. (d-f) An 




The precise order of connectivity of stable (oxime) and dynamic (acyl hydrazone) covalent 
bonds upon the glycopolymer scaffold predetermines whether GM1-SCPNs can be 
successfully synthesized or not by a given synthetic route.  Figure 14a-c shows the proposed 
synthetic route to GM1-SCPNs (Route A). Here, the GM1 sugar moiety is connected to linker 
molecule via a stable oxime linkage, leaving a pendant hydrazide group. The ‘free’ hydrazide 
of linker-GM1 conjugate 4 might then react with aldehyde polymer scaffold P3, affording a 
hydrazone-functionalized polymer scaffold that is grafted with pendant carbohydrate (GM1) 
residues. Intramolecular crosslinking of this glycopolymer is initiated by addition of crosslinker 
(SD), which is anticipated to attack the dynamic covalent acyl hydrazone linkage in preference 
to the thermodynamically stable oxime bond (Fig. 14b). As a result, the crosslinker residue is 
incorporated onto the glycopolymer scaffold, and a single GM1-linker molecule is displaced 
through the process of hydrazone exchange. Under high dilution, the embedded crosslinker 
residue (purple) will undergo further hydrazone exchange reactions to yield the desired GM1-
functionalized SCPNs (GM1-SCPNs) (Fig. 14c). 
Figure 14d-f shows a synthetic route to GM1-SCPNs (Route B), which was explored on account 
of linker 3 reacting with GM1os to form predominantly the hydrazone-linked glycoconjugates 
13/14. This route is very similar to Route A (Fig. 14a-c), except that GM1 is now attached to 
the linker via a dynamic covalent acyl hydrazone linkage (Fig. 14e), leaving a pendant 
alkoxyamine free to be grafted onto the aldehyde functionalized polymer scaffold P3. This 
subtle discrepancy between the two synthetic routes has a drastic knock-on effect, which 
results in the failure of Route B to yield structurally dynamic GM1-SCPNs. Briefly, grafting of 
the ‘free’ alkoxyamine of GM1 conjugates 13/14 (Fig. 14d) onto P3 was undertaken and is 
hypothesized to result in an oxime-functionalized glycopolymer scaffold (Fig. 14e). Addition of 
SD was then hypothesized to undergo nucleophilic attack at the dynamic covalent acyl 
hydrazone in preference to the stable oxime linkage (Fig. 14e). SD attacks the electrophilic 
carbohydrate (GM1) component of this hydrazone bond, thus hydrazone exchange results in 
the displacement of a single GM1-crosslinker conjugate from the glycopolymer scaffold. 
Although further hydrazone exchange reactions are possible, none of these processes lead to 
intramolecular crosslinking, and thus GM1-SCPNs cannot be synthesized by this route (Fig. 
14f). An alternative synthetic strategy (Fig. 15) will now be discussed, which was employed to 






4.2.10.  An Alternative Synthetic Route to GM1-SCPNs 
To address the observed issue with the chemoselectivity of linker 3, an alternative linker 18 
which features a Boc-protected hydrazide moiety was prepared (Fig. 15a). It was anticipated 
that Boc-protection would prevent the hydrazide end from reacting with carbohydrates, thus 
oxime-linked GM1 conjugate 4 (Fig. 16c) is expected in place of the previously observed 
hydrazone conjugates 13/14 (see Fig. 14b).  
Boc-linker 15 was prepared (Fig. 15a) in three steps. In step (i), nucleophilic attack upon acid 
chloride 15 by tert-butyl carbazate afforded intermediate 16. In step (ii) 16 was furnished with 
a pendant N-hydroxyphthalimide moiety to yield intermediate 17. Hydrazinolysis of 17 then 
afforded the final compound, Boc-linker 18, which was isolated as a white solid (43 % yield). 
1H NMR spectroscopic analysis of 18 (Fig. 15b) was consistent with the proposed structure. 
The 1H NMR (Fig. 15b) spectrum showed two secondary amide NH (br, s) signals and the 
characteristic Boc methyl peak (9H, s) at δ 1.45 ppm, thus confirming the presence of the Boc-
protected hydrazide group. The chemoselectivity of Boc-linker 18 towards carbonyl 
compounds (benzaldehyde and acetone) was verified 1H NMR studies, revealing identical 
results to those observed for linker 3. 
 
Figure 15: (a) Synthesis of Boc-linker 18. Step (i): tert-butyl carbazate, DIPEA, CH2Cl2, 18 h, rt. Step (ii): 
DMF, reflux, 18 h. Step (iii): N2H4.H2O/EtOH, 4 h, rt. (b) Partial 1H NMR spectrum (CDCl3, 300 MHz) of 





4.2.11.  Glycoconjugation of Boc-Linker 18 to D-Lactose 
Reaction of D-Lactose with Boc-linker 18 (Fig. 17a) was performed in 50 mM AcOH/d6-DMSO 
and monitored by 1H NMR spectroscopy (Fig. 17b-d). Integral analysis of 1H NMR spectra (Fig. 
17b-d) revealed that anomeric signals of D-Lactose starting material at δ 4.85 (●, H1α) and 
4.25 ppm (●, H1β) were not consumed and the ‘diagnostic’ alkoxyamine signal at δ 4.60 ppm 
(●) remained unchanged over the 72 h period during which reaction monitoring took place. It 
was thus concluded that although ‘free’ alkoxyamine end is the only available nucleophile, Boc-
linker 18 does not react with carbohydrate electrophiles, suggesting that either (i) formation of 
oxime conjugate 9 was not a thermodynamically favourable product, or (ii) there is a kinetic 
barrier preventing oxime formation between the alkoxyamine end of 18 and D-Lactose. It has 
been reported that the conjugation of primary alkoxyamines (such as linkers 3 and 18) to the 
reducing end of carbohydrates can be low yielding in the case of some carbohydrates.7 One 
study has demonstrated that reactions of carbohydrates with N-alkylated alkoxyamine groups 
(Fig. 12b) afford predominantly stable cyclic hemiaminal adducts, which are anticipated to 
improve the yield of oxime ligation. These studies suggest that oxime linked GM1 conjugates 
(Fig. 17a, 9) cannot be easily accessed by reactions of primary alkoxyamine linkers (3, 18) with 
GM1os. Although investigations towards the ‘shrink-wrapping’ of SV40 viral capsids were 
progressing well, issues with linker chemoselectivity and time constraints forced the premature 
termination of experimental work. 
Figure 16: An alternative synthetic route towards GM1-SCPNs. It was hypothesized that oxime ligation 
(a) of GM1os with Boc-linker 18 would permit the selective formation (b) of oxime-linked conjugates (i) 
and (ii). It was expected that Boc-deprotection (c) would yield oxime glycoconjugate 4 which possesses 
a ‘free’ hydrazide moiety for grafting onto aldehyde-functionalized polymer scaffolds, thus allowing 




In summary, three synthetic strategies for the preparation of GM1-SCPNs have been explored 
and good progress has been made towards this goal. GM1os was successfully functionalized 
with linker 3, and this glycoconjugate (13/14) was then grafted onto polymer scaffolds to afford 
GM1-decorated glycopolymers. Crucially, the ‘shrink-wrapping’ project required precise 
ordering of acyl hydrazone (dynamic) and stable oxime (non-dynamic) linkages within the 
SCPN architecture, and thus this synthetic route was ultimately not achieved within the time 
available. Alternative synthetic routes will be required to grant access to the desired GM1-
SCPN architecture, and these will now be proposed in the research outlook. 
  
Figure 17: (a) Glycoconjugation of Boc-linker 18 to D-Lactose. (b-d) Partial 1H NMR spectra (d6-DMSO, 
400 MHz) of D-Lactose (b), Boc-linker 18 (c) starting materials and their reaction after 72 h (d). The 




4.2.12.  Future Work  
Thorough review of the literature in conjunction with results reported in this chapter has 
revealed two alternative synthetic strategies from which GM1-SCPNs may be constructed, and 
these will now be discussed. 
 
1. Oxime ligation with a Secondary Alkoxyamine Linker 
The N-alkyl (R) group of 19 is anticipated to significantly increase the yield of oxime ligation by 
facilitating formation of the stable cyclic isomer.7 It is thus hypothesized that linker 19 will 
undergo more efficient oxime ligation than did linker 18, thereby allowing GM1 conjugate 20 
to be isolated.  In this strategy, the hydrazide end should remain Boc-protected to prevent 
unwanted competing reactions that lead to hydrazide-carbohydrate adducts.  
2. Thioglycoside Formation 
The synthetic strategies discussed in this chapter utilized bis-functional alkoxyamine/hydrazide 
and relied on oxime formation to attach GM1 onto linker molecules. Oxime ligation was 
surprisingly low yielding, and thus an alternative covalent linkage should be considered 
between the linker and GM1 carbohydrate molecules. Thioglycoside formation (Fig. 19) at the 
reducing end of carbohydrates has become a popular glycoconjugation strategy, as this 
chemistry can be performed on unmodified carbohydrates in aqueous solution under mild 
conditions, and this would be an ideal approach to derivatize GM1 with the required acyl 
hydrazide. 
 
Figure 18: Proposed synthesis of oxime-linked GM1 conjugate 20 from which GM1-SCPNs can be 
prepared. Oxime ligation of secondary alkoxyamine nucleophiles, such as linker 3 are known10 to afford 
carbohydrate conjugates with reasonable yields. The presence of an alkyl substituent (R) upon 
nucleophilic nitrogen N1 favours the formation of the thermodynamically favourable cyclic form of the 
oxime-linked glycoconjugate.7 It is thus anticipated that secondary alkoxyamine linker 19 affords GM1
conjugate 20 with improved yields (relative to linker 3), such that GM1-SCPNs can successfully be 
prepared. 
Figure 19: Proposed synthesis of GM1-thioglycoconjugate 24. Step (i): Disulfide cleavage of 22 to yield 
the thiol-containing linker 23. Conditions: Tris(2-carboxyethyl)phosphine (TCEP), 4.5:1.0 H2O/MeCN, rt, 
4 h. Step (ii): Thioglycoside formation. Conditions: GM1os, 2-chloroimidazolinium chloride (DMC), 





The ‘shrink-wrapping’ of SV40 capsid through complementary recognition events requires 
SCPNs that are decorated with complex carbohydrate appendages of GM1, the native ligand 
which binds selectively to sialic acid receptors located upon the virus surface. This chapter 
explored three synthetic routes to GM1-SCPNs in which the reducing end of GM1os was 
functionalized with a linker molecule (3) and then grafted onto aldehyde polymer scaffolds via 
oxime or hydrazone linkages. The synthesis of a bis-functional alkoxyamine / hydrazide linker 
(3) was reported and its chemoselectivity towards both carbonyl and carbohydrate 
electrophiles was interrogated by 1H NMR spectroscopy. As anticipated, carbonyls such as 
acetone and benzaldehyde reacted with a strong preference for the alkoxyamine end of linker 
3 and formation of the corresponding oxime products was essentially quantitative within 
several hours. Surprisingly, linker 3 displayed the opposite chemoselectivity with carbohydrate 
electrophiles D-Lactose and GM1os, preferring to react through its hydrazide end to form the 
corresponding carbohydrate-hydrazide adducts. Upon exposure to GM1os, linker 3 afforded 
acyl hydrazone (13) and hemiaminal (14) adducts, but not the anticipated oxime conjugate (4).  
A rationale for these intriguing observations was proposed by comparison of experimental 
results to existing literature reports.7,10 Although oximes are widely accepted to be more 
thermodynamically stable than hydrazones,8 the results in this chapter demonstrate that such 
predictions do not always hold true and cannot be applied when considering reactions upon 
complex carbohydrate electrophiles such as GM1os. Carbohydrate-hydrazide adducts are 
known to undergo ring-closure reactions to afford cyclic hemiaminal species which are more 
thermodynamically stable than the corresponding acyclic hydrazone form.7 In contrast, 
carbohydrate-alkoxyamine adducts are reported to exist predominantly as the acyclic oxime 
form, with the trace quantities of the cyclic hemiaminal form.10 It was thus hypothesized that 
carbohydrate-hydrazide (predominantly cyclic) adducts are more energetically stable than the 
corresponding oxime (predominantly acyclic) glycoconjugates, on account of the additional 
thermodynamic stability which is introduced by the ring-closure reaction that may occur for 
carbohydrate-hydrazide adducts. This hypothesis was consistent with the observation that 
linker 3 prefers to react with carbohydrate electrophiles through its hydrazide end to yield the 
corresponding hemiaminal (cyclic) and acyl hydrazone (acyclic) products in preference to 
forming the oxime (acyclic) glycoconjugate. Although functionalization of GM1os with linker 3 
afforded predominantly acyl hydrazone (13) and hemiaminal (14) adducts, the decision was 
made to persist with the preparation of GM1-SCPNs by grafting these glycoconjugates onto 
the aldehyde-functionalized polymer scaffold (P3). 1H NMR spectroscopy revealed that grafting 




purification by dialysis. Attempts to intramolecularly crosslink these polymer scaffolds were, 
however, unsuccessful on account of the dihydrazide crosslinker (SD) being unable to displace 
the stable oxime linkages by which the GM1 glycoconjugates were connected to the polymer 
scaffold. 
An alternative synthetic route to GM1-SCPNs was explored to assess if carbohydrates can be 
selectively conjugated to linker molecule through oxime linkages. Judicious attempts were 
made to isolate the model oxime glycoconjugate (9) by functionalizing D-Lactose with linker 
18, where the hydrazide end is Boc-protected to prevent formation of carbohydrate-hydrazide 
adducts. However, attempts to isolate oxime 9 were unsuccessful, despite linker 18 
alkoxyamine end being the only nucleophilic site available to react with GM1os. These 
observations were consistent with literature reports7,10 that oxime ligation of primary 
alkoxyamines to carbohydrate electrophiles are occasionally low-yielding and can be highly 
dependent on the nature of the carbohydrate employed. Future work looks to build upon this 






4.4.1. General Experimental 
All chemicals were purchased from Sigma-Aldrich, Alfa Aesar, Fisher Scientific or Carbosynth 
UK (GM1 ganglioside) and were used as received without further purification. All solvents 
were dried prior to use according to standard methods. All solvents used for flash 
chromatography were GPR grade, except hexane and ethyl acetate, when HPLC grade was 
used. Unless state otherwise, all synthetic procedures were performed in oven-dried glassware 
under a N2 (g) atmosphere. Simian virus 40 (SV40) major capsid protein VP1 and the enzyme 
EGCase II were produced by recombinant expression from E. Coli and purified by the 
laboratory of Prof. Bruce Turnbull, University of Leeds. Assembly of the SV40 capsid was 
achieved by dialysis against ammonium sulfate to induce molecular crowding of VP1 
pentamers. 1H and 13C NMR spectra of synthesised compounds were recorded on a Bruker 
Avance 300 spectrometer (at 300 and 75 MHz respectively), Bruker Avance 400 spectrometer 
(at 400 MHz and 100 MHz, respectively), Bruker Avance III HD spectrometer (at 500 MHz and 
125 MHz, respectively), or Bruker 700 Avance III HD spectrometer (at 700 MHz and 175 MHz, 
respectively). High-resolution mass spectrometry was performed on a Waters LCT Premier 
mass spectrometerα 
4.4.2. Preparation of GM1os 
GM1os was prepared with slight modification of the published literature protocol.9 GM1 
ganglioside (500 mg, 319 µmol) and BSA (10 mg) were dissolved in 25 mM NH4OAc, pH 5.0, 
0.2 % Triton X (45 mL). ECGase II (1.3 mL at 67 µM in 20 mM Na2HPO4, pH 7.0, 500 mM NaCl) 
was added. The solution was split into 450 µL aliquots and incubated at 37 °C for 25 days, after 
which the reaction was judged complete by TLC (product spot Rf = 0.1 in 6:2:1 
CHCl3:MeOH:H2O, with H2SO4/MeOH TLC stain). The solutions were combined and washed 
with Et2O (4 x 15 mL). The combined aqueous fraction was diluted with H2O (10 mL), passed 
through a 0.45 µm syringe filter, then loaded onto a C18 solid phase extraction cartridge and 
eluted with H2O. Fractions containing GM1os were combined and twice lyophilised from H2O, 
yielding GM1os as a white solid (253.5 mg, 249 µmol, 78% yield). The product was used 
without further purification. 1H NMR (D2O, 700 MHz) 𝛿 (ppm): 5.22 (d, 1H, α-anomer, J3 = 3.78 
Hz), 4.66 (d, 1H, β-anomer, J3 = 7.98 Hz), 4.54 (t, 1H, J3 = 7.49 Hz), 4.12-4.18 (m, 2H) 4.04 (t, 
1H, J3 = 14.0 Hz), 3.55-4.00 (complex m, carbohydrate ring H’s, 25H), 3.47-3.54 (2 x d, 2H), 






4.4.3. Preparation of Linker 3 
 
Scheme 1: Synthesis of linker (3). (i) N-hydroxypthalimide, DIPEA, CH2Cl2, 18 h, rt. (ii) N2H4.H2O/EtOH, 
4 h, rt.  
Synthesis of Methyl 4-(((1,3-dioxoisoindolin-2-yl)oxy)methyl)benzoate (2): 
Methyl 4-(bromomethyl)benzoate 1 (4.85 g, 21.2 mmol) was dissolved in CH2Cl2 (90 mL) and 
DIPEA (5.44 g, 42.1 mmol) added afford a clear red solution. N-hydroxyphthalimide (4.50 g, 
27.7 mmol) was added and the suspension was stirred under nitrogen for 18 h. The reaction 
was judged complete by TLC (product Rf ≈ 0.4, CH2Cl2), then washed with H2O (4 x 50 mL) and 
the organic phase was dried over MgSO4, filtered, and then evaporated to dryness. The product 
was obtained as a white solid (4.23 g, 65 % yield) and used without further purification. 1H NMR 
(CDCl3, 300 MHz) 𝛿 (ppm): 8.03 (d, 2H, aromatic, J3 = 8.13 Hz), 7.79 (m, 2H, aromatic), 7.73 
(m, 2H, aromatic), 7.61 (d, 2H, aromatic, J3 = 8.13 Hz), 5.25 (s, 2H, -HN-O-CH2-Ar), 3.90 (s, 3H, 
-O-CH3), 13C NMR (75 MHz, CDCl3) 𝛿 (ppm): 166.65, 163.39, 138.59, 134.55, 130.87, 129.79, 
129.46, 128.78, 123.59, 79.04, 52.21. 
Synthesis of 4-((Aminooxy)methyl)benzohydrazide (3): 
Methyl 4-(((1,3-dioxoisoindolin-2-yl)oxy)methyl)benzoate 2 (713 mg, 2.35 mmol) was dissolved 
in EtOH (5 mL) and hydrazine monohydrate (1.0 mL, 20 mmol) was added. The solution was 
stirred at rt for 18 h, and the reaction was judged complete by TLC (product Rf ≈ 0.65, 1:1 
MeOH/CH2Cl2, red by ninhydrin stain). The phthalhydrazide by-product formed a white 
precipitate from EtOH and was removed by filtration. Residual hydrazine was removed by 
exhaustively drying the sample for 12 h under high vacuum. The product was judged pure by 
TLC and 1H NMR spectroscopy, then twice lyophilized to afford the pure product as a white 
solid (405 mg, 95 % yield). 1H NMR (d6-DMSO, 300 MHz) 𝛿 (ppm): 9.74 (broad s, 1H, NH), 7.80 
(d, 2H, aromatic, J3 = 8.40 Hz), 7.38 (d, 2H, aromatic, J3 = 8.40 Hz), 4.61 (s, 2H, H2N-O-CH2-





4.4.4. Preparation of Boc-Hydrazide Linker 18 
 
Scheme 1: Synthesis of Boc-linker (18). Step (i): tert-Butyl carbazate, DIPEA, CH2Cl2, 18 h, rt. Step (ii) 
DMF, reflux, 18 h. Step (iii): N2H4.H2O/EtOH, 4 h, rt. 
Synthesis of tert-butyl 2-(4-(chloromethyl)benzoyl)hydrazine-1-carboxylate (16): 
tert-Butyl carbazate (4.80 g, 36.3 mmol) and Et3N (3.93 g, 30.3 mmol) were dissolved in CH2Cl2 
(100 mL) and stirred under N2 atmosphere at 0 °C for 10 min. 4-(chloromethyl)benzoyl chloride 
15 (5.72 g, 30.27 mmol)  was dissolved in CH2Cl2 (50 mL), then added dropwise to the ice-cold 
mixture over 2 h. The reaction was then allowed to gently warm to rt, with overnight stirring. 
Product formation was confirmed by TLC (product Rf = 0.42, 20 : 1 CH2Cl2 / MeOH). The 
reaction mixture was washed with water (3 x 75 mL) and the organic extract dried over MgSO4, 
filtered, and evaporated to afford the crude product as a white solid. The product was further 
purified by precipitation, by dissolving the crude in a minimum volume of hot EtOAc and adding 
dropwise to ice-cold hexane (400 mL). The product was isolated by filtration as a white solid 
(6.57 g, 76 % yield). 1H NMR (CDCl3, 300 MHz) 𝛿 (ppm): 8.50 (br s, 1H, NH), 7.72 (d, 2H, 
aromatic, J3 = 8.1 Hz), 7.34 (d, 2H, aromatic, J3 = 8.1 Hz), 6.77 (br s, 1H, NH), 4.51 (s, 2H, -HN-
O-CH2-Ar), 1.42 (s, 9H, O-C(CH3)3). 13C NMR (75 MHz, CDCl3) 𝛿 (ppm): 166.22, 155.94, 146.19, 
141.54, 128.75, 127.75, 82.18, 45.28, 28.17 
Synthesis of tert-butyl 2-(4-(((1,3-dioxoisoindolin-2-yl)oxy)methyl)benzoyl)hydrazine-1-
carboxylate (17): 
tert-Butyl 2-(4-(chloromethyl)benzoyl)hydrazine-1-carboxylate 16 (1.30 g, 4.55 mmol), N-
hydroxyphthalimide (840.5 mg, 5.15 mmol), Na2CO3 (766.5 mg, 5.55 mmol) and NaI (78.5 mg, 
0.50 mmol) were dissolved in DMF (40 mL) and heated at 80 °C for 48 h. Product formation 
was confirmed by TLC (product Rf  = 0.75, 12 : 1 CH2Cl2 / MeOH). The reaction mixture was 
diluted with EtOAc (100 mL) and the organic layer was washed with distilled H2O (5 x 75 mL) 
to ensure all residual DMF and N-hydroxyphthalimide was removed. The organic extract was 
dried over MgSO4, filtered, and then evaporated to afford the crude product as a clearly 
colourless oil, which quickly crystallized into a white solid (819 mg, 64 % yield). 1H NMR (CDCl3, 
300 MHz) 𝛿 (ppm): 8.10 (br s, 1H, NH), 7.85 – 7.69 (m, 6H, Ar), 7.60 (d, 2H, Ar, J3 = 7.8 Hz), 
6.76 (br s, 1H, NH), 5.25 (s, 2H, R2N-O-CH2-Ar), 1.49 (s, 9H, O-C(CH3)3). 13C NMR (75 MHz, 
CDCl3) 𝛿 (ppm): 165.36, 164.98, 150.18, 143.54, 138.01, 134.56, 129.85, 128.79, 127.48, 




tert-Butyl 2-(4-((aminooxy)methyl)benzoyl)hydrazine-1-carboxylate (18): 
tert-Butyl 2-(4-(((1,3-dioxoisoindolin-2-yl)oxy)methyl)benzoyl)hydrazine-1-carboxylate 17 
(521.0 mg, 1.27 mmol) and hydrazine monohydrate (126.9 mg, 2.53 mmol) were dissolved in 
EtOH (7.5 mL) and stirred at rt overnight. Product formation was confirmed by TLC (product Rf 
= 0.60, 16 : 1 CH2Cl2 / MeOH), white precipitate (phthalhydrazide) was removed by filtration 
and reaction was evaporated to dryness. The crude residue was evaporated under high 
vacuum to ensure residual hydrazine was removed. The product was further purified to remove 
residual phthalhydrazide by precipitation from EtOH. The product was isolated by as a white 
solid (356.4 g, 91 % yield). 1H NMR (CDCl3, 300 MHz) 𝛿 (ppm): 8.00 (br s, 1H, NH), 7.78 (d, 2H, 
Ar, J3 = 8.0 Hz), 7.41 (d, 2H, Ar, J3 = 8.0 Hz), 6.77 (br s, 1H, NH), 5.09 (s, 2H, H2N-O-CH2-Ar), 
1.49 (s, 9H, O-C(CH3)3). 13C NMR (75 MHz, CDCl3) 𝛿 (ppm): 168.40, 155.69, 144.62, 139.79, 
127.90, 127.43, 82.17, 74.53, 28.31. 
4.4.5. Synthesis of Aldehyde Polymer Scaffold P3 
Synthesis and characterization of aldehyde-functionalized copolymer scaffold P3 is reported in 
Chapter 3, pages 97 – 98, whilst the experimental procedure for synthesis of P3 is given in 
Chapter 2, pages 80 – 81. 
 
4.4.6. Preparation of GM1-Scaffold P3 
The crude reaction mixture of GM1 conjugates 13/14 (42 µmol, 500 µL) was added directly to 
aldehyde scaffold P3. Complete disappearance of the aldehyde 1H NMR signal was observed 
within 10 minutes of mixing the components. The GM1-functionalized scaffold (GM1-P3) was 
purified by dialysis (Spectra Por, 3 kDa MWCO) against distilled water (3 x 600 mL) and then 
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This thesis has described the successful ‘wrapping’ of micron-sized objects within crosslinked 
polymer films. Results demonstrated that ‘wrapping’ occurs only when: (i) There are 
complementary recognition events between polymer and object, and (ii) crosslinks located 
within the polymer ‘wrapping agents’ are dynamic covalent in nature and may freely undergo 
processes of component exchange. Fluorescence microscopy experiments have provided 
strong evidence of the ‘wrapping’ process, and the development of a highly hydrophilic 
poly(ethylene glycol)-based ‘wrapping agent’ has permitted ‘wrapping’ to be successfully 
accomplished in aqueous media. These research outcomes have motivated progress towards 
the ‘wrapping’ of smaller, biologically relevant objects such as virus-like particles (VLPs) and 
bacteria. One remaining challenge, however, is the requirement of the ‘wrapping’ process to 
operate under mildly acidic (pH 4.5) conditions, which are necessary to catalyze the structural 
rearrangement of dynamic covalent acyl hydrazone crosslinkages located within the polymer 
‘wrapping agents’. Kinetics of hydrazone exchange are optimal at pH 4.5, yet exceptionally 
slow at pH 7.4, where most biological targets are stable. This discrepancy presents a bottleneck 
in the biocompatibility of the ‘wrapping’ approach, as relatively few biomacromolecules will 
tolerate acidic conditions for prolonged timescales. To address that limitation, improve 
biocompatibility and maximize biological utility of the ‘shrink-wrapping’ approach, this chapter 
reports a combined computational and experimental study, which was conducted to identify a 
palette of hydrazone linkages that undergo rapid component exchange at neutral pH. In these 
studies, judiciously placed N- or O-hydrogen bond acceptors within the carbonyl-derived 
moiety of the hydrazone were shown to stabilize transition states via hydrogen bonding 
interactions, providing a valuable boost to exchange kinetics at neutral pH. Incorporation of 
these rate-enhancing structural features onto polymer scaffolds was thus hypothesized to 
afford a second generation of ‘wrapping agents’, which could be engineered for their capacity 






The field of dynamic covalent chemistry1 requires chemical bonds that readily undergo 
component exchange processes. One of the most utilized is the hydrazone bond, (Fig. 1) which 
has optimal exchange kinetics at pH 4.5, being considerably slower at neutral pH.1b, 2 The 
requirement to operate at lower pH limits significantly the scope and application of hydrazone-
based dynamic covalent chemistry as many interesting biological targets are only stable at 
near neutral pH values, and thus it would be advantageous if hydrazone exchange were able 
to operate on an experimentally useful timescale at pH values closer to neutral. Inspired by the 
work3 of Jencks in the 1960s, Dawson and co-workers demonstrated4 that aniline can 
successfully catalyze exchange processes at neutral pH, and aniline catalysis was applied5 
successfully in a hydrazone-based dynamic combinatorial library for the discovery of inhibitors 
of glutathione S-transferase. The relatively high concentrations of aniline required (100 mM) to 
enhance the rate of component exchange can limit significantly the wider biocompatibility of 
the organocatalyst approach, and to this end Kool et al. have developed6 improved catalysts 
which can provide rate enhancements of up to eight times that of aniline catalysis at lower 
concentrations of catalyst. 
While investigating hydrazone and oxime formation at neutral pH, Kool and co-workers also 
studied6a an alternative approach to organocatalysis in which structural modifications of 
aldehyde components can increase the rate of hydrazone or oxime formation at neutral pH.  
These structural modifications involve the inclusion of neighbouring acidic or basic functional 
groups or atoms within the carbonyl-derived moiety of the hydrazone that assist proton transfer 
within the rate limiting step, thereby lowering transition state energies and enhancing the rate 
of hydrazone formation. It was anticipated that these structural modifications would also 
enhance the rate of hydrazone exchange processes at neutral pH, which are typically slow 
under basic conditions. The exchange kinetics were thus investigated for a small pool of 
hydrazones containing acidic or basic functional groups/atoms and their observed order of 
reactivity was rationalized by computational studies. Computational modelling indicated that 
the observed rate enhancements most likely arise on account of the abilities of ‘neighbouring’ 
functional groups/atoms to form stabilizing hydrogen bond interactions within the transition 
state structure. Furthermore, this model correctly identified benzodihydropyran (benzoDHP) 
Figure 4: Hydrazones undergo reversible component exchange through transimination 




as a candidate rate-enhancing group. Although this prediction was initially surprising given the 
absence of any acidic or basic moieties within benzoDHP, the expected rate-enhancement was 
subsequently verified by experiment to be the fastest performing substrate, demonstrating that 
useful enhancements in rate can be obtained.  
5.2.1. Mechanism of Hydrazone Exchange 
Although hydrazone formation and hydrazone exchange reactions proceed via similar 
condensation mechanisms (Fig. 2), there exist several key differences between these two 
processes: (i) At neutral pH, the rate-determining step in hydrazone formation is collapse of 
the tetrahedral carbinolamine intermediate (Fig. 2a), whereas in hydrazone exchange the rate-
limiting step is nucleophilic attack upon the hydrazone (Fig. 2b), which was entirely consistent 
with the results from computational studies (see Fig. 6). (ii) In hydrazone formation, a single 
water molecule – a poor leaving group – is ejected from the carbinolamine intermediate, whilst 
in hydrazone exchange the departing hydrazine/hydrazide constitutes a much better leaving 
group. (iii) In hydrazone exchange, nucleophilic attack by the incoming hydrazide requires 
protonation at the hydrazone nitrogen (N1) to increase the electrophilicity at the hydrazone C1 
position. Yet, in hydrazone formation nucleophilic attack is rapid, and does not require 
protonation of the carbonyl oxygen. Although there are substantial mechanistic similarities 
between hydrazone formation (Fig. 2a) and hydrazone exchange (Fig. 2b), the above 
discrepancies (i-iii) between the two reactions mean that it should not take for granted that 
structural features which enhance the rate of hydrazone formation would also enhance the 
kinetics of hydrazone exchange.  
 
Figure 2: Proposed mechanisms of hydrazone formation (a) and hydrazone exchange (b), which was 
consistent with the computational studies. The rate-determining step in hydrazone formation (a) is 
ejection of water from the carbinolamine intermediate, whereas in hydrazone exchange (b) the rate-




5.3. Results and Discussion 
5.3.1. Experimental Hydrazone Exchange Studies 
When considering the application of hydrazone bonds in dynamic combinatorial chemistry, one 
must take account of several important requirements.  It is crucial that equilibria lie very much 
on the side of product hydrazone, and thus aromatic aldehyde partners are often used as the 
extended conjugation of the resultant hydrazone ensures product stability, especially important 
when operating in aqueous solutions.  Aliphatic aldehydes, on the other hand, tend to form 
hydrazones where the equilibrium is less towards the desired hydrazone. Furthermore, acyl 
hydrazide reaction partners are used to ensure reasonable rates of component exchange as 
other classes of hydrazides/hydrazines often form hydrazones which undergo component 
exchange on a timescale too slow to be practically useful. With these considerations in mind, 
investigations focused upon a small pool of hydrazones 1a-f (Fig. 3) (for synthetic procedures 
see experimental). Hydrazones 1a-c and 1e-f contain a basic nitrogen or acidic group either 
upon or within the aromatic moiety of the carbonyl components which it was postulated would 
likely influence the kinetics of exchange. These specific substrates were chosen based upon 
the work6a of Kool et al., where they exhibited relatively high rate enhancements for hydrazone 
formation and thus were sensible starting points to investigate their influence on hydrazone 
exchange.  Hydrazone 1d, however, is an exception in that it contains no potential rate-
enhancing structural features, and thus serves as a control.  
Figure 3: Component exchange of hydrazones 1a-f with acyl hydrazide 3 to form hydrazones 2a-f 
and acyl hydrazide 4, a process which was studied by 1H NMR spectroscopy. (a) Exchange of 1a-f
was studied both experimentally and modelled computationally as a symmetrical exchange process, 
where AcNHNH2 is both the attacking nucleophile, and hydrazide component of the hydrazone. (b) 
Substrates h-j were only studied computationally, and based upon the outcomes of this work, g was 




Component exchange to form hydrazones 2a-f was accomplished by reaction of hydrazones 
1a-f with an excess of acyl hydrazide 3 (see experimental for details). Acyl hydrazides 3 and 4 
possess hydroxyl and quaternary ammonium groups, respectively, which ensure water 
solubility of their associated hydrazones. Exchange reactions (see experimental for details) 
were monitored by 1H NMR spectroscopy at room temperature over a range of pD values (5.8-
7.8).* The mole fraction of each species in solution was determined at each time point from the 
normalized integrals of ‘diagnostic’ protons. Although it was found that any ‘diagnostic’ signal 
could be used as a spectral ‘handle’ to quantify the rate of hydrazone exchange, for reasons 
of experimental simplicity, the trimethylammonium (-NMe3+) signals associated with 
hydrazones 1a-f (●) and exchange product 4 (●) (Fig. 4a) were chosen. Integral analysis of 
time-resolved 1H NMR spectra (Fig. 4a) afforded kinetics traces (Fig. 4b) (see page 199, Fig. 
10) from which the second order rate constants (kf and kr) (page 200, Table 1) were obtained 
 
* All experimental studies are performed in D2O and thus acidities were measured in pD. Computational studies 
which were modelled in H2O with acidity measured in pH. pD can be related to pH by the simple calculation pD = 
pH + 0.42.21 
Figure 4: Hydrazone exchange reactions were monitored by 1H NMR spectroscopy. (a) A series of time-
resolved 1H NMR spectra are shown for a representative exchange process (1d, pD 7.8). Integration of 
‘diagnostic’ quaternary ammonium (-NMe3+) signals associated with the starting hydrazone (●) and 
exchange product 4 (●) allowed for the kinetics traces (b) to be deduced. (b) Kinetics traces of 




(see experimental for details). Division of each of the forward rate constants (kf) by the that of 
the slowest exchange process (with the smallest kf value), allowed for the relative rates (krel) of 
hydrazone exchange to be deduced (Fig. 5). As anticipated, the exchange kinetics (Fig. 5) of 
all examples were faster as the pD decreased.  The rates of exchange are 2-8 times faster at 
the lowest pD investigated (5.4) compared to the highest pD (7.8), observations consistent with 
component exchange being accelerated by protonation.  
Component exchange was fastest with hydrazone 1a, being approximately 5 times faster than 
control hydrazone 1d at all pD values investigated, suggesting that the inclusion of a proximal 
basic nitrogen may catalyze hydrazone exchange.  Surprisingly, hydrazones 1e and 1f – both 
of which possess proximal acid/basic groups – were observed to undergo slower component 
exchange processes (at all pD values) than the control hydrazone 1d. This result was initially 
surprising, as it had been anticipated that the hydrazone containing the most basic group would 
best catalyze the hydrazone exchange process as it would exhibit the greatest likelihood of 
being protonated and so be able to transfer a proton in the rate limiting step; the pKa of the 
pyridyl nitrogen is estimated to be 5.14,7 which is higher than that of the quinoline (pKa = 4.85)7  
and the benzoic acid (pKa = 4.20)7 suggesting that pyridine 1e should undergo the fastest 
hydrazone exchange. The observed order of reactivity (quinoline > phenol > phenyl > pyridine 
≈ carboxylate) does not correlate with the pKa value of the proximal acid/basic groups, an 
observation which suggests that the rate enhancement is not caused by protonation of this 
group. 
Figure 5: Relative rates of component exchange for hydrazones 1a-f, which were obtained from the 




5.3.2. Computational Hydrazone Exchange Studies 
In order to better understand the experimental observations, computational studies were 
undertaken. All computational work was conducted by Dr Andrew Leach at Liverpool John 
Moores University. Three possible hydrazone exchange mechanisms were considered and 
studied at the M06-2X/6-31G* level8 of theory, a level that is expected to produce reasonable 
agreement with barrier heights. All calculations were performed in Gaussian099 and included 
implicit solvation using the PCM protocol.† To simplify calculations, the hydrazide employed in 
modelling the exchange processes was AcNHNH2, which was also used as the hydrazide 








Firstly, process (1) (Fig. 6a) was considered, in which no protons were added into the system. 
In the calculated transition state (P1TS), proton shuttling between the incoming nucleophile 
and the hydrazone was required, and a single water molecule can fulfil this role by 
simultaneously removing a proton from the incoming hydrazide and protonating the hydrazone. 
This proton shuttling leads to a neutral tetrahedral intermediate (P1Int) that would be expected 
to collapse either to reactants or products through similar barriers. In process (2) (Fig. 6b), 
groups located within the aldehyde derived moiety of the hydrazone were protonated to give 
reaction precursors (P2Prot) before nucleophilic attack by the hydrazide, a process that 
proceeds through a similar transition state (P2TS) to process (1). This mechanism leads to a 
protonated intermediate (P2PI) that can either rearrange (intramolecular proton transfer) or 
return a proton to the surrounding environment. The computed energetics (see ΔG† values in 
Fig. 6) are those calculated for pH 7, while those for pH 5 (where different) are in brackets. The 
calculated values reveal that process (2) features a high energy barrier, with ΔG† values 
exceeding 30 kcal/mol, indicating that protonation of the functional group/atom within the 
aldehyde-derived moiety likely impedes the exchange process. Next, process (3) (Fig. 6c) was 
considered, which represents a specific acid-catalysed reaction where the hydrazone nitrogen 
(N1) is protonated prior to nucleophilic attack by the hydrazide. This protonation gives 
protonated hydrazone (P3PH) that is attacked by hydrazide through transition state P3TS to 
Figure 6: Three mechanisms of hydrazone exchange which were explored computationally. (a) Process 
(1): No protonation of hydrazone prior to hydrazide attack (uncatalyzed reaction). (b) Process (2): 
Protonation of proximal acid/base group within aldehyde component of hydrazone. (c) Process (3): 
Protonation of hydrazone nitrogen (N1) prior to attack. Energetics (ΔG† values, kcal/mol) were calculated 
at pH 7, whilst values for pH 5 are in brackets. Process (3) represents the most likely mechanism for 
hydrazone exchange, on account of having low energy barriers, relative to Processes (1) and (2). (d-f) 




give a protonated tetrahedral intermediate P3PTI. For process (3) the calculated free energy 
barrier (see ΔG† values, Fig. 6) is significantly lower than those obtained for processes (1) and 
(2), indicating that process (3) constitutes the most likely mechanism for hydrazone exchange. 
Although the pathway with the lowest free energy barrier is likely to be the one that is 
operational there are significant uncertainties in these comparisons and therefore the ability of 
each process to explain the relative reactivity of the different hydrazones was also considered. 
For process (1), the lowest computed free energy barrier (and therefore fastest reaction) is for 
carboxylate 1f‡ (see page 207, Table 4) whilst the highest energy barrier (and therefore slowest 
process) involves quinoline 1a, observations that are not consistent with experiment and 
therefore process (1) was discounted. The energetics calculated for process (2) (page 207, 
Table 5) predict that: (i) the most reactive substrate is control compound 1d – which is absent 
of any acid/basic groups to catalyze the reaction; and (ii) the least reactive substrate is 1a – 
which was experimentally observed to have the fastest hydrazone exchange kinetics. Process 
(2) was not consistent with the observed order of reactivity and was discounted. The computed 
barrier heights for process (3) (page 207, Table 6) however, predict an order of reactivity (pH 
 
‡ Further modelling of 1f revealed that the carboxylate moiety may ring-close upon the aminal-like intermediate to 
form a meta-stable 5-membered cyclic structure (see page 209, Fig. 16), although no evidence of this species was 
observed during 1H NMR experiments. This meta-stable presented a local minimum on the potential energy surface, 
making it challenging to reliably compute energetics that were consistent with a single exchange mechanism. 
Energetics of all other substrates however, were in close agreement with process (3). 
Figure 7: Hydrogen bonding interactions stabilise the transition states for hydrazone exchange. The 
energy barriers (ΔG†) corresponding to each TS structure were calculated at pH 7.4 and pH 5.4 
[brackets]. (a) 6-membered cyclic TS (benzoDHP 1g, quinoline 1a, phenol 1b) have the lowest energies 
and exhibit the fastest hydrazone exchange. (b) 5-membered cyclic TS (pyridine 1c, thiophenol 1j), 




7.4: 1a > 1b > 1d ≈ 1e > 1f; pH 5.4: 1a ≈ 1b > 1d ≈ 1e > 1f) that was consistent with the 
observed relative rates (Fig. 3), further supporting the idea that process (3) constitutes the 
most likely mechanism of hydrazone exchange. 
In process (3), the key species that governs the reactivity was the transition state for hydrazide 
attack (P3TS). The origin of the high reactivity of 1a was revealed in the corresponding 
transition state structure (Fig. 7a), which features two hydrogen bonds from the quinoline 
nitrogen to both the incoming hydrazide (N-H distance: 3.18 Å) and the protonated hydrazone 
(N-H: 1.96 Å), that stabilize the transition state.10 Crucially, these stabilizing interactions help to 
lower the energy barrier for hydrazone exchange, thus providing a boost in the exchange 
kinetics. In the analogous transition states for pyridine 1e (N-H: 2.93 Å, 2.25 Å) (Fig. 7b) and 
carboxylate 1f (O-H: 2.23 Å, 2.21 Å) (Fig. 7c) these distances are longer, suggesting that of the 
two interactions it is the hydrogen bond to the protonated hydrazone that governs reactivity. It 
has been noted previously11 that 6-membered ring intramolecular hydrogen bonding 
interactions (such as those that operate for quinoline 1a) are slightly favoured over their 5-
membered equivalent (as for pyridine 1e) and much favoured compared to their 7-membered 
equivalent (carboxylate 1f). Thus, it is the ideal spatial positioning and orientation of hydrogen 
bond acceptor atoms/groups within the transition state, rather than simply the presence of 
acidic or basic moieties, that leads to increased reactivity in hydrazone exchange. With this 
thought in mind, alternative oxygen-containing substrates 1g-i, and thiophenol 1j (Fig. 7) were 
considered computationally as a test of this model, as such substrates contain hydrogen bond 
acceptors, but lack the suitably acidic/basic groups required to catalyze the reaction via 
intramolecular proton transfer. Amongst these examples, benzoDHP 1g was predicted to be 
faster than all other compounds studied experimentally and was therefore selected for 
synthesis. The origin of this predicted rate enhancement was clear in the structure of the 
relevant transition state for 1g (Fig. 7a). The heterocyclic oxygen atom in this species is 
positioned in such a way that it can form two stabilizing interactions through a favoured 6-
membered ring: one with the protonated hydrazone (2.04 Å, O-H) and a second with the 
incoming nucleophile (2.73 Å, O-H). Short hydrogen bonding interactions within the transition 
state indicate stronger stabilizing interactions, the likes of which lower the transition state 
energy to a greater extent, thus resulting in faster hydrazone exchange. The transition state of 
benzoDHP 1g features two such short hydrogen bonds, which are considerably shorter (and 
therefore presumably stronger) than analogous bond lengths calculated for quinoline 1a (N-H: 
1.96 Å, 3.18 Å) and phenol 1b (O-H: 2.03 Å, 2.93 Å). This observation suggests that 1g would 
offer significantly improved exchange kinetics over quinoline 1a, an already fast exchanging 
hydrazone. This hypothesis was then experimentally validated by determining the hydrazone 




5.3.3. Exchange Kinetics of BenzoDHP (1g) 
Hydrazones 1a, 1d and 1g were exchanged with hydrazide 5 (Fig. 8a), and the kinetics were 
monitored by 1H NMR spectroscopy and the relative rates of exchange were deduced (see 
page 203, Table 2). It was necessary to study this exchange process with morpholine hydrazide 
(5) instead of glycol hydrazide 3, as exchange of 1g with 3 resulted in product precipitation 
that convoluted the exchange kinetics (see page 201, Fig. 11).  Gratifyingly, 1g displayed a 2-
fold rate enhancement with respect to quinoline 1a (Fig. 8b), highlighting the predictive power 
of the deduced computational model for hydrazone exchange.  
Figure 8: Hydrazone exchange kinetics of 1a, 1d and 1g were studied at pD 7.8 by 1H NMR 
spectroscopy. (a) Exchange of hydrazones 1a,d,g with hydrazide 5. (b) Kinetic traces of 1a, 1d, 1g. 
Experimental data and theoretical fit are shown as circles and solid lines, respectively. Inset: derived 




Despite mechanistic differences between hydrazone exchange and formation processes, it was 
hypothesized that the rate-enhancing effects observed for proximal acid/base groups upon 
hydrazone formation may also arise on account of hydrogen bonding interactions which lower 
the activation energies (by stabilising the transition states). The ability of those groups to 
facilitate intramolecular proton transfer, as postulated by Kool et al.6a-d, will also be a 
contributing factor. Preliminary experiments (Fig. 9a) revealed that chroman-8-carbaldehyde 
(the aldehyde from which benzoDHP 1g was derived) exhibited rapid hydrazone formation, 
reacting 15-fold faster than quinoline-8-carbaldehyde, and 26-fold faster than benzaldehyde, 
which lacks any rate-enhancing features. The intriguing observation that the benzoDHP moiety 
catalyses rapid hydrazone formation despite its lack of a significantly acidic or basic group to 
facilitate intramolecular proton transfer processes, supports the hypothesis that hydrogen-
bonding interactions play an important role in organocatalysed hydrazone formation, and most 
likely also the mechanistically similar processes of imine and oxime formation.  
Figure 9: (a) Hydrazone formation of aromatic aldehydes 6a, 6d, 6g with Girard’s Reagent T (5) to form 
hydrazone products 1a, 1d and 1g, respectively. 1H NMR monitored the reaction kinetics at pD 7.8. (b) 
Kinetics traces of hydrazone formation of aldehydes 6a, 6d, 6g. Inset: Relative rates of hydrazone 





The results in this chapter demonstrated that the judicial placement of neighbouring hydrogen-
bond acceptors within the carbonyl-derived fragment of a hydrazone compound leads to 
significant enhancements in rates of hydrazone exchange. Computational modelling identified 
the most likely reaction pathway for this process, the energetics of which were entirely 
consistent with experimentally determined exchange rates.  Furthermore, modelling supported 
the hypothesis that the rate-determining step in hydrazone exchange is nucleophilic attack on 
the protonated hydrazone, which is an important distinction between hydrazone exchange and 
hydrazone formation, where the rate-limiting step is collapse of the carbinolamine tetrahedral 
intermediate. Crucially, modelling revealed that the origin of the observed rate enhancements 
lies in the ability of neighbouring functional groups to form a stabilizing hydrogen bonds within 
the transition state, and that geometries where 6-membered ring intramolecular hydrogen 
bonding interactions can be adopted are particularly important. The reliability of this model was 
demonstrated by its prediction that a benzoDHP group – containing a very weakly basic but 
optimally placed oxygen atom that acts as a hydrogen-bond acceptor – displayed fast 
exchange kinetics, which was gratifyingly supported by experimental observation. Preliminary 
experiments revealed that chroman-8-carbaldehyde (from which BenzoDHP 1g was derived) 
also catalyses rapid hydrazone formation. Remarkably, chroman-8-carbaldehyde was found to 
react 15-fold faster than previously reported quinoline-8-carbaldehyde,6a despite its lack of an 
acidic/basic group. These observations suggest that the inclusion of hydrogen-bond acceptor 
moieties within the aldehyde component may also play an important role in catalysing 
hydrazone formation, alongside the previously reported6a-d catalytic effect of proximal acid/base 
groups. At neutral pD, benzoDHP 1g was observed to afford a 2-fold enhancement in the rate 
of hydrazone exchange, relative to the kinetics of quinoline 1a, and was observed to be 10-fold 
faster than control hydrazone 1d. With regards to the DAF groups interest in dynamic 
combinatorial chemistry, this work suggests that valuable gains in rate of exchange can be 
made, which in turn would permit the design and fabrication of a polymer-scaffolded DCLs12 
operating with reasonable kinetics at near-neutral pH – a crucial requirement for interfacing 
DCLs with biomacromolecules.13 Furthermore, given the importance of hydrazone exchange 
within dynamic covalent polymers,14 materials,15 surfaces,16 molecular machines,17 interlocked 
molecules,18 cages19 and functionalized nanoparticles,20 where component exchange 
processes endow structural adaptivity, thus these findings may offer insight to the design and 
optimization of new systems. It was also anticipated that this work would benefit the 
development of new organocatalyst for hydrazone/oxime formation and exchange processes, 
indicating that computational studies, on account of their ability to ‘pick winners’, might 





5.5.1. General Experimental 
All chemicals, including Girard’s reagent T (R1) were purchased from Sigma-Aldrich or Alfa 
Aesar and were used as received without further purification. 1H and 13C NMR spectra of 
synthesised compounds were recorded on a Bruker Avance 300 spectrometer (at 300 and 75 
MHz respectively), Bruker Avance 400 spectrometer (at 400 MHz and 100 MHz, respectively), 
or a Bruker Avance III HD spectrometer (at 500 MHz and 125 MHz, respectively). High-
resolution mass spectrometry was performed on a Waters LCT Premier mass spectrometerα 
or an Agilent 6550 iFunnel Q-TOF LC/MSβ. The synthesis and characterization of morpholine 
hydrazide 5 was reported in Chapter 2 (see pages 39 and 86). 
 
Synthetic Procedures: 
5.5.2. General Procedure for Preparation of Hydrazone Compounds (1a-1g)  
Aromatic aldehyde (1.00 eqv.) was dissolved in MeOH (2.5 mL) and stirred at room 
temperature. Girard’s Reagent T (0.9 eqv) was dissolved in MeOH (2.5 mL), then added in one 
portion to the aldehyde solution. Reactions were judged complete by TLC (7:2 MeOH/2M 
H4NCl), evaporated to dryness and the crude residue washed with dichloromethane (7 mL) 
and sonicated for 5 min. The final products were isolated by filtration and dried for 30 min 
under high vacuum.  
 
5.5.3. Characterization of Hydrazones 1a-1g 
1H and 13C NMR spectra of compounds 1a-1g appear complex on account of syn/anti 
isomerization about the C-N amide bond that exhibits hindered rotation, consistent with 
previous literature reports.22 The syn/anti ratio was typically in the range 50:50 to 30:70, with 
the anti-isomer being the preferred conformer in most cases.  
 
N,N,N-Trimethyl-2-oxo-2-(2-(quinolin-8-ylmethylene)hydrazineyl)ethan-1-aminium (1a) 1H 
NMR (D2O, 400 MHz) δ (ppm): 8.81(anti) + 8.64(syn) (1H, s, Ar-HC=N-), 8.75(anti) + 8.68(syn) 
(1H, d, Ar), 8.36(anti) + 8.25(syn) (1H, d, Ar), 8.10 (1H, d, Ar), 7.96(anti) + 7.87(syn) (1H, d, Ar), 
7.55 (2H, m, Ar), 4.74(syn) + 4.31(anti) (2H, s, -C=N-N-CH2-), 3.43 (9H, s, -N(Me)3). 13C NMR 
(101 MHz, D2O) δ (ppm): 160.91, 150.23, 149.58, 149.30, 147.38, 144.24, 131.94, 131.15, 
128.40, 127.05, 126.55, 122.05, 121.87, 63.98, 62.90, 54.49, 54.40. HRMS+ C15H19N4O+, 





2-(2-(2-Hydroxybenzylidene)hydrazineyl)-N,N,N-trimethyl-2-oxoethan-1-aminium (1b) 1H NMR 
(D2O, 400 MHz) δ (ppm): 8.12(anti) + 7.95(syn) (1H, s, Ar-HC=N-), 7.35 (2H, m, Ar), 6.89 (2H, 
m, Ar) 4.54(syn) + 4.12(anti) (2H, s, -C=N-N-CH2), 3.30 (9H, s, -N(Me)3). 13C NMR (101 MHz, 
D2O) δ (ppm): 164.70, 160.08, 156.67, 155.87, 152.76, 148.08, 132.91, 132.53, 131.07, 129.93, 
120.64, 120.47, 118.24, 117.48, 116.46, 116.33, 63.88, 62.58, 54.47. HRMS+ C12H18N3O2+, 




(1c) 1H NMR (D2O, 400 MHz) δ (ppm): 8.35(anti) + 8.10(syn) (1H, s, Ar-HC=N-), 8.25(anti) + 
8.20(syn) (1H, d, Ar) 7.71(anti) + 7.65(syn) (1H, d, Ar), 6.65 (1H, m, Ar), 4.74(syn) + 4.26(anti) 
(2H, s, -CH2-N(Me)3) 3.40 (9H, -CH2-N(CH3)3. 13C NMR (75 MHz, D2O) δ (ppm): 165.59, 162.75, 
162.70, 160.84, 147.22, 142.60, 141.24, 140.58, 138.26, 137.44, 122.79, 122.24, 108.96, 63.99, 




2-(2-Benzylidenehydrazineyl)-N,N,N-trimethyl-2-oxoethan-1-aminium (1d) 1H NMR (D2O, 400 
MHz) δ (ppm): 8.18(anti) + 7.95(syn) (1H, s, Ar-HC=N-), 7.70(anti) + 7.67(syn) (2H, d, Ar), 7.43 
(3H, m, Ar), 4.65(syn) + 4.15(anti) (2H, s, -C=N-N-CH2-), 3.30 (9H, s, -N(CH3)3). 13C NMR (101 
MHz, D2O) δ (ppm): 165.61, 160.81, 153.19, 148.32, 133.08, 132.47, 131.74, 131.06, 129.09, 
128.99, 127.95, 127.44, 64.06, 62.88, 54.45. HRMS+ C12H18N3O+, Theoretical: 220.1432, Actual: 







N,N,N-Trimethyl-2-oxo-2-(2-(pyridin-2-ylmethylene)hydrazineyl)ethan-1-aminium (1e) 1H NMR 
(D2O, 400 MHz) δ (ppm): 8.57 (1H, dd, Ar), 8.23(anti) + 8.04(syn) (1H, s, Ar-CH=N-N), 7.95 (2H, 
m, Ar) 7.51 (1H, dd, Ar), 4.29 (2H, s, -C=N-N-CH2-), 3.39 (9H, s, -N(CH3)3).
 
13C NMR (101 MHz, 
D2O) δ (ppm): 166.11, 161.38, 150.80, 150.65, 150.60, 149.22, 149.11, 146.17, 138.39, 126.02, 
125.63, 122.85, 122.55, 63.87, 62.85, 54.47, 54.34. HRMS+ C11H17N4O+, Theoretical: 221.1402, 
Actual: 221.1393.α mp. 190 °C. 
 
2-(2-(2-Carboxybenzylidene)hydrazineyl)-N,N,N-trimethyl-2-oxoethan-1-aminium (1f) 1H NMR 
(D2O, 400 MHz) δ (ppm): 8.34(anti) + 8.28(syn) (1H, s, br, Ar-HC=N-), 7.90-7.42 (4H, m, Ar), 
4.66(syn) + 4.13(anti) (2H, s, -C=N-N-CH2-), 3.28 (9H, s, -N(CH3)3). 13C NMR (101 MHz, D2O) δ 
(ppm): 171.26, 161.57, 146.74, 135.37, 133.19, 131.82, 131.07, 130.56, 129.38, 126.67, 63.94, 
62.80, 54.33. HRMS+ C13H18N3O3+, Theoretical: 264.1348, Actual: 264.1355.β mp. 162 °C. 
 
 
2-(2-(Chroman-8-ylmethylene)hydrazineyl)-N,N,N-trimethyl-2-oxoethan-1-aminium (1g) 1H 
NMR (D2O, 300 MHz) δ (ppm): 8.48(anti) + 8.21(syn) (1H, s Ar-HC=N-), 7.64 (1H, d, Ar), 7.23 
(1H, d, Ar), 6.94 (1H, dd, Ar), 4.67(syn) + 4.21(anti) (2H, s, -CH2-N(Me)3), 4.24 (2H, t, -OCH2-), 
3.29 (9H, s, -N(CH3)3), 2.77 (2H, t, -OCH2-CH2-CH2-), 1.98 (2H, t, -OCH2-CH2-CH2-). 13C NMR 
(75 MHz, D2O) δ (ppm): 165.28, 160.41, 153.99, 153.54, 148.98, 144.14, 133.58, 132.86, 
124.62, 124.20, 120.48, 120.38, 119.87, 67.23, 64.06, 62.82, 54.41, 54.33, 24.05, 21.41, 21.34. 







Preparation of Kinetics Experiments 
5.5.4. Study 1 + Study 2 (See Appendix A, pages 198 and 202, respectively) 
Hydrazones 1a-1g were dissolved in 500 µL deuterated buffer solution (pD = 5.8-7.8), and 
hydrazide residue 3 (or 5 for Study 2) (5.0 eqv. dissolved in 500 µL buffer) was added, and 
solution mixed thoroughly by rapidly pipetting up and down 10 times. The sample was loaded 
into the NMR spectrometer to monitor the exchange kinetics over a minimum of 16 h at 25 o C. 
The kinetics traces were corrected for the time delay between initial mixing of reagents, and 
the time at which the first spectrum was acquired. The absolute rate constants were obtained 
according to the method described on page 194. 
 
Final prepared sample contains: 23.4 mM hydrazone (1a-1g), 117 mM (5.0 eqv.) hydrazide 
residue 3 (or 5 for Study 2) dissolved in a total volume of 1.00 mL phosphate/D2O buffer, pD 
7.8. 
 
5.5.5. Study 3 (See Appendix A, page 204)  
Stock solutions of aldehydes 6a, 6d and 6g were prepared by dissolving in d6-DMSO. 
Concentrations were as follows: 6g (87 mg/mL, 536.4 mM), 6a (67.5 mg/mL, 429.5 mM), 6d 
(84 mg/mL, 791.6 mM). A 304.8 mg/mL, 1.82 M stock solution of Girard’s Reagent T (4) in 100 
mM phosphate/D2O buffer, pD 7.8.  
 
A typical 1H NMR experiment was prepared by adding aldehyde stock (29.5 – 54.4 µL) and d6-
DMSO (345.6 – 370.5 µL) to a clean NMR tube, then diluting with 100 mM phosphate/D2O, pD 
7.8 (389.3 µL). The reaction was initiated by addition of the Girard’s Reagent T stock solution 
(128.4 µL), the sample was rapidly mixed by pipetting up and down 10 times, then loaded into 
the NMR instrument for analysis. The kinetics traces were corrected for the time delay between 
initial mixing of reagents, and the time at which the first spectrum was acquired. The absolute 
rate constants were obtained according to the method described on page 195.  
 
Final prepared sample contains: 25.5 mM aldehyde (6a, 6d, or 6g), 254.4 mM Girard’s Reagent 
dissolved in a total volume of 400 µL d6-DMSO + 517.7 µL phosphate/D2O buffer, pD 7.8. d6-





5.5.6. Determination of Second Order Reversible Rate Constants 
The kinetic data for hydrazone exchange reactions (Study 1 and Study 2) were analyzed 
according to a second order reversible reaction mechanism: 
𝐴 + 𝐵 ↔ 𝐶 + 𝐷   (1)  
 
Where A is the starting hydrazone (1a-g), B is glycol hydrazide 3 (Study 1) or morpholine 
hydrazide 5 (see Study 2), C is product hydrazone (2a-g) and D is the free hydrazide (Girard’s 
Reagent T, 4) liberated by the exchange process. 
 
Differential rate law:  
[ ]
=  −𝑘  [𝐴][𝐵] + 𝑘 [𝐶][𝐷]  (2) 
 
Where kf is the second order rate constant of the forward process and kr is the second order 
rate constant for the reverse process. The differential rate law (2) was integrated numerically 
by explicit finite difference using the experimental time data, the initial values of the 
concentrations and trial values of kf and kr. The values of the two rate constants and the initial 
mole fraction of A (χA) were then optimized by least square fitting of the integrated rate law to 
the experimental data for [A] obtained by integration of the trimethylammonium (-NMe3+) 
signals associated with the starting hydrazone (1a-g) and exchange product 4 (Girard’s 
Reagent T) in the 1H NMR spectra recorded during the reaction. Each spectrum required about 
2 minutes to collect, which is a much shorter time than the half-life of the reactions at the 
concentrations employed.  
 
Statistical errors on the fitted values of rate constant are reported as ±1 σ confidence intervals 
estimated under the usual assumption of independent and identically distributed (i. i. d.) 





The kinetics of hydrazone formation (Study 3) were analyzed according to a second order 
irreversible reaction mechanism: 
𝐴 + 𝐵 →  𝐶 + 𝐷    (3) 
 
Where A is the starting aldehyde (a, d, g), B is Girard’s Reagent T 4, C is the product hydrazone 
(2a-g) and D is the water molecule liberated by the condensation reaction. 
 
Differential rate law:  
[ ]
=  −𝑘[𝐴][𝐵]   (4) 
Where k is the second order rate constant. The differential rate law (4) was integrated 
numerically in Microsoft Excel by explicit finite difference method, using the experimental time 
data, the initial values of the concentrations and trial values of k. The values of rate constant k 
and the initial mole fraction of A (χA) were then optimized by least square fitting (using Excel 
Solver Function) of the integrated rate law to the experimental data for [A] obtained by 
integration of the aldehyde (-CHO) signal and signals (syn- and anti-) associated with the 
hydrazone (-HC=N-N-) product in the 1H NMR spectra recorded during the reaction. 
Acquisition of each 1H NMR spectrum took approximately 2 minutes, a timescale which (at the 
concentration of reagents employed) was significantly shorter than the half-lives of the 
reactions being monitored. 
 
Statistical errors on the fitted values of rate constant are reported as ±1 σ confidence intervals 
estimated under the usual assumption of independent and identically distributed (i. i. d.) 
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5.7. Appendix A 
Kinetics Traces, Absolute Rate Constants and Preliminary NMR Spectra 
5.7.1. Study 1  
Hydrazones 1a-f (23.4 mM) were exchanged with hydrazide 3 (117 mM) in buffered D2O at pD 
7.8, pD 6.8 and pD 5.8. See Fig. 10 for kinetics traces. 
 
 







Figure 10: Kinetics traces of hydrazones 1a-1f reacting with hydrazide 3 at pD 7.8 (Study 1) (a), pD 
6.8 (b) and pD 5.4 (c). Experimental data and theoretical fit are shown as circles and solid lines, 




Second Order Rate Constants: 
 
 kf (M-1 s-1) kr (M-1 s-1) 
krel pD 7.8 pD 6.8 pD 5.8 pD 7.8 pD 6.8 pD 5.8 
1a 30.3 
0.159 
(± 2.9 %) 
0.344 
(± 0.6 %) 
0.852 
(± 0.5 %) 
0.107 
(± 10.6 %) 
0.154 
(± 4.3 %) 
0.858 
(± 2.2 %) 
1b 26.5 
0.087 
(± 1.9 %) 
0.156 
(± 0.4 %) 
0.744 
(± 0.1 %) 
0.055 
(± 0.6 %) 
0.116 
(± 2.6 %) 
0.368 
(± 0.7 %) 
1c 5.7 
0.076 
(± 0.9 %) 
0.162 
(± 0.5 %) 
0.162 
(± 1.6 %) 
0.071 
(± 3.3 %) 
0.128 
(± 1.0 %) 
0.776 
(± 1.3 %) 
1d 7.4 
0.030 
(± 2.4 %) 
0.052 
(± 0.4 %) 
0.207 
(± 0.2 %) 
0.030 
(± 9.3 %) 
0.043 
(± 2.7 %) 
0.206 
(± 0.6 %) 
1e 3.8 
0.018 
(± 2.1 %) 
0.036 
(± 0.3 %) 
0.107 
(± 0.1 %) 
0.067 
(± 12.3 %) 
0.220 
(± 5.9 %) 
0.090 
(± 1.4 %) 
1f 4.4 
0.020 
(± 1.1 %) 
0.028 
(± 0.2 %) 
0.122 
(± 0.1 %) 
0.121 
(± 4.9 %) 
0.035 
(± 1.1 %) 
0.157 
(± 0.3 %) 
 
Table 1: Second order rate constants (kf, kr) for hydrazone exchange of 1a-1f with glycol hydrazide 3 
(Study 1). Where, kf is the rate constant for the forward reaction and kr is that of the reverse process. 
The statistical errors are reported as percentages. They correspond to 68 % (1 σ) confidence intervals 





5.7.2. Preliminary Kinetics Experiment 
Hydrazone 1g was exchanged with hydrazide 2 (Fig. 11a) to form product hydrazone 2g, which 
precipitated from aqueous solution and thus disappeared from the 1H NMR specta (Fig. 11b) 
which made it impossible to monitor reaction progress using 1H NMR as the analytical method. 
It was therefore necessary to study an alternative exchange process (Study 2) involving 
morpholine hydrazide 5 (Scheme 2). 
 
 
Figure 11: A preliminary experiment revealed that hydrazone exchange of 1g with hydrazide 3 (a) 
resulted in precipitation of the product hydrazone (2g), which led to signal broadening in the 1H NMR 
spectra. (b). Convolution of the NMR spectra ultimately prevented accurate monitoring of the hydrazone 







5.7.3. Study 2 
Hydrazones 1a, 1d and 1f (23.4 mM) were exchanged with hydrazide 4 (117 mM) in buffered 
D2O at pD 7.8. See Fig. 12 for kinetics traces. 
  
Figure 12: Kinetics traces of BenzoDHP 1g, Quinoline 1a and Phenyl 1d reacting with hydrazide 5 at pD 
7.8. Inset shows relative rates of hydrazone exchange. Experimental and fitted data are shown as circles 
and solid lines, respectively. See page 194 for details of fitting the kinetics data.  
Scheme 2: Hydrazones 1a, 1d and 1g undergo component exchange with 




Second Order Rate Constants: 
 
 kf (M-1 s-1) kr (M-1 s-1) 
krel pD 7.8 pD 7.8 
1a 10.3 0.078 (± 9.9 %) 
0.037 
(± 30.4 %) 
1d 6.0 0.046 (± 9.3 %) 
0.032 
(± 22.2 %) 
1g 1.0 0.008 (± 2.5 %) 
0.021 
(± 10.1 %) 
 
Table 2: Second order rate constants (kf, kr) for hydrazone exchange of 1a,d,g with morpholine 
hydrazide 5 (Study 2). Where, kf is the rate constant for the forward reaction, kr is that of the reverse 
process and krel is the relative rate as deduced from kf. The statistical errors are reported as percentages. 





5.7.4. Study 3  
Hydrazone formation kinetics of aldehydes 6-8 with Girard’s Reagent T was studied by 1H NMR 
spectroscopy. Hydrazone formation was observed to be significantly faster than hydrazone 
exchange under similar conditions. See page 193 for details on sample preparation. 
  
Figure 13: Hydrazone formation kinetics obtained for aldehydes 6a,d,g in their condensation reaction 
with hydrazide 1. Inset shows the relative rates of hydrazone formation. 
Scheme 3: Aldehydes 6a, 6d and 6g undergo condensation reactions with hydrazide 1 to afford product 





Second Order Rate Constants: 
 
 
 k2 (M-1 s-1) 








(± 13.8 %) 
Benzaldehyde, 6d 1.0 0.002 
(± 6.9 %) 
 
Table 3: Second order rate constants (k) for hydrazone formation of 6a, 6d and 6g with Girard’s reagent 
T (4) (Study 3). The statistical errors are reported as percentages. They correspond to 68 % (1 σ) 




5.7.5. Computational Studies 
Hydrazone Exchange Studies: In order to gain insights to our experimental observations, 
computational studies were undertaken.  Reaction mechanisms were studied at the M06-2X/6-
31G* level of theory. To simplify the calculations, the hydrazide employed in modelling the 
exchange processes was AcNHNH2, which was also used as the hydrazide component within 
the hydrazone. The process modelled is therefore a symmetrical exchange but provided the 
mechanistic insight required. Protonation free energies were computed using H3O+ as the 
proton source and corrected by adding the difference between the computed and 
experimental values of Kw. Corrections to 1 M concentrations were applied using an ideal gas 
approximation.  Concentrations of H+ and –OH that are appropriate to the pH were applied and 
water was assumed to be present at 55.5 M. 
  
Figure 14: Three mechanisms of hydrazone exchange which were explored computationally. (a) 
Process (1): No protonation of hydrazone prior to hydrazide attack (uncatalysed reaction). (b) Process 
(2): Protonation of proximal acid/base group within aldehyde component of hydrazone. (c) Process (3): 






Substrate P1TS P1Int 
quinoline 1a +28.9 +4.0 
phenyl 1d +27.1 +3.0 
pyridine 1e +26.2 +3.7 
carboxylate 1f +23.0 +3.0 
Table 4: Free energies (ΔG†) computed for intermediates and transition states of 1a-f at pH 7.4. Values 
computed at pH 5.4 are in brackets (where given). 
 
Process 2: 
Substrate P2Prot P2TS P2PI ΔG† 
quinoline 1a -0.5 [-3.2] +33.3 [+30.6] +3.3 [+0.6] +33.8 [+33.8] 
phenyl 1d 0.0 +27.1 +3.0 +27.1 
pyridine 1e +3.4 [+0.7] +33.2 [+30.5] +3.2 [+0.5] +33.2 [+30.5] 
carboxylate 1f -16.2 [-19.0] +15.3 [+12.7] -14.4 [-17.1] +31.6 [+31.6] 
Table 5: Free energies (ΔG†) computed for intermediates and transition states of 1a-f at pH 7.4. Values 
computed at pH 5.4 are in brackets (where given). 
 
Process 3: 
Substrate P3PH P3TS P3PTI ΔG† 
quinoline 1a +6.8 [+4.1] +16.2 [+13.5] +4.6 [+1.9] +16.7 [+16.7] 
phenol 1b +11.1 [+8.3] +19.4 [+16.7] +23.2 [+20.4] +19.4 [+16.7] 
phenyl 1d +15.0 [+12.2] +20.3 [+17.6] +7.9 [+5.2] +20.3 [+17.6] 
pyridine 1e +13.4 [+10.6] +20.2 [+17.5] +6.7 [+3.9] +20.2 [+17.5] 
carboxylate 1f -4.3 [-9.8] +10.8 [+5.3] +4.3 [-1.1] +27.0a [+24.3] 
a this is the free energy relative the lowest free energy state available pre-rate-limiting transition state, P2Prot 
 
Table 6: Free energies (ΔG†) computed for intermediates and transition states of 1a-f at pH 7.4. Values 





Hydrazone Formation versus Hydrazone Exchange  
In order to gain insight to the mechanistic differences between hydrazone exchange and 
hydrazide, both reactions were studied in an identical way, with three possible mechanisms 
being considered: Process (1) hydrazide directly attacks the unprotonated aldehyde (Fig. 15a); 
process (2) protonation of acid/base groups within the aldehyde, followed by hydrazide attack 
(Fig. 15b); process (3) protonation of the aldehyde, followed by hydrazide attack (Fig. 15c). 
 
Figure 15: Three potential mechanisms of hydrazone formation were explored computationally for 
quinoline-8-carbaldehyde (Ar = quinoline). Free energy barriers (kcal/mol) were calculated relative to 
the lowest energy species. (a) No protonation prior to hydrazide attack on aldehyde (uncatalysed 
reaction). (b) Protonation of proximal acid/base group within the aromatic aldehyde, and subsequent 
hydrazide attack to form the hemiaminal intermediate. (c) Protonation of aldehyde oxygen prior to 






Figure 16: Computational modelling revealed that hydrazone 1f forms a meta-stable cyclic intermediate, 
formed by carboxylate ring-closing upon tetrahedral (aminal) intermediate to form a 5-membered ring 
(a). Annotations indicate key bond lengths: 1.45 Å (O-C), 1.43 Å (C-N) are shown for the computed 
















This thesis set out to explore the ‘shrink-wrapping’ of nano- and microscale objects – a 
process which is thought to occur through the adsorption of discrete polymer chains onto object 
surfaces followed by their ‘structural metamorphosis’ into covalently crosslinked polymer films. 
It was hypothesized that ‘structural metamorphosis’ could be exploited to achieve the 
‘wrapping’ complex biological targets such as virus-like particles or bacteria, which may 
improve their stabilities and permit engineering of their surface properties. Chapter 1 proposed 
an incremental approach towards this ambitious goal (Fig. 1), beginning with the ‘wrapping’ of 
readily available model systems (Fig. 1a-b). Whilst it was initially envisaged that ‘simple’ nano-
objects (Model System I and II) (Fig. 1a-b) would be straightforward to ‘wrap’ compared to 
complex biological targets (Fig. 1c-d), results later demonstrated that the ‘wrapping’ of 
nanoscale objects is often more challenging to investigate than microscale objects, as nano-
objects often prone to unwanted processes of particle-particle aggregation and may suffer 
irreversible polymer-object binding on account of their large surface areas and high surface 
energies. Considering these challenges, a top-down approach for investigating the ‘shrink-
wrapping’ of biological targets is now proposed. Studies should first explore the ‘wrapping’ of 
large objects, such as micron-sized bacteria, the surface-coating of which can be readily 
monitored by the fluorescence microscopy protocol established in Chapter 3. 
Figure 1: Proposed research strategy for progressing the ‘shrink-wrapping’ concept towards biological 
targets of increasing complexity. (a) Model System I: Electrostatically charged SCPNs were adsorbed 
onto oppositely charged polystyrene nano- or microsparticles. Electrostatic interactions drive the ‘shrink-
wrapping’ process. (b) Model System II: Protein-functionalized silica nano- and microspheres displaying 
mannose-binding receptors were ‘shrink-wrapped’ with mannose decorated glyco-SCPNs. (c) Virus-
Like Particles: Investigations towards the ‘shrink-wrapping’ Simian virus 40 viral capsid. (d) ‘Shrink-
wrapping’ of ‘native’ viruses such as influenza, or pathogenic bacteria such as E. Coli. (e) Rate-enhancing 
structural features (A) facilitate rapid hydrazine exchange at neutral pH, and thus their inclusion upon 




6.2. The Challenges of ‘Wrapping’ Nano-Objects 
The ‘metamorphosis’ of polymer chains upon object surfaces was found to be a subtle and 
thus difficult to interrogate process. The ‘shrink-wrapping’ of 3D nanoscale objects proved 
particularly difficult to investigate for two key reasons: (i) Nano-dimensional objects have high 
surface areas, and thus may exhibit unwanted processes of non-specific binding and particle-
particle aggregation. These processes both can inhibit objects from being ‘wrapped’ within a 
homogeneous layer of polymer film. (ii) DLS is one of the few readily available analytical 
techniques that can monitor the ‘shrink-wrapping’ of nanoscale objects within nanometer-thick 
polymer films in real-time and in aqueous solution. However, the process of attaching or 
removing polymer chains from the particle surface was observed to modulate the colloidal 
stability of nano-objects, which can trigger their aggregation and may have a drastic impact on 
the accuracy with which DLS analysis can characterize the thickness of object-bound polymer 
films. In only the most well-behaved systems does DLS provide truly informative data from 
which judgements can be made to optimize the ‘shrink-wrapping’ chemistry. Because of the 
significant analytical challenges associated with monitoring the formation of thin polymer films 
upon nanoscale objects, future work should first explore the ‘wrapping’ of microscale objects, 
which can be readily interrogated via the established fluorescence microscopy protocol, and 
thus may serve as a reliable model for the ‘wrapping’ of nanoscale objects. 
6.3. Success in ‘Wrapping’ Microscale Objects 
Whilst ‘wrapping’ of nanoscale objects proved difficult to investigate, excellent progress 
has been made in the ‘shrink-wrapping’ of microscale objects. In Chapter 3, fluorescence 
microscopy experiments granted direct access to monitor the formation of polymer films upon 
microparticle surfaces, and thus provided a strong characterization handle with which to 
investigate the ‘shrink-wrapping’ phenomenon. Successful ‘wrapping’ was observed only for 
polymer ‘wrapping-agents’ which contain dynamic covalent acyl hydrazone crosslinks, thus 
highlighting that hydrazone exchange reactions are key to the ‘wrapping’ process. Specific 
ligand-receptor interactions were also observed to play a crucial role in concentrating polymer 
chains upon the particle periphery through complementary recognition events, which were 
hypothesized to drive the ‘shrink-wrapping’ process. Since ‘wrapping’ only occurs in the 
presence of complementary recognition between polymer ‘wrapping-agent’ and the object 
surface, it may be possible to selectively ‘wrap’ target objects within complex mixtures – a 
feature which could later be exploited to sequester biologically-relevant objects, such as 
viruses or pathogenic bacteria, from their local environment. ‘Wrapping’ may also stabilize 
these species, increase their shelf-lives, and improve their performance – in much the same 




Figure 2: Proposed synthesis of next-generation polymer ‘wrapping-agents’ which should be 
hydrophilic, highly water-soluble and capable of rapid hydrazone exchange at neutral pH. (a) Linear 
polymer chains (P1 - P5) produced by copolymerization of reactive aldehyde (BenzoDHP) and water-
soluble (N-Methyl Glycamine) monomers. A range of linear polymer chains (P1 - P5) should be 
produced, which contain varying densities of aldehyde ‘anchor-points’ which can be intramolecularly 
crosslinked (i) to form polymer ‘wrapping-agents’ (SCPNs) (b). SCPNs should be constructed with acyl 
hydrazone crosslinks (c), but varied crosslinker functionality can be achieved by employing a range 
of crosslinker types (d), including a disulfide-cleavable linker (DCD) which is anticipated to allow the 
triggered ‘un-wrapping’ of objects, by addition of reducing agents such as glutathione or DTT (e). 
6.4. Development of Next-Generation Polymer ‘Wrapping-Agents’ 
In future research, the ‘shrink-wrapping’ of sensitive biological targets will require 
hydrazone exchange processes which operate with reasonable kinetics at neutral pH. A 
combined computational-experimental study in Chapter 5 identified the key structural features 
of hydrazone bonds which undergo rapid component exchange at neutral pH (Fig. 1e). 
Incorporating the structures of these fast-exchanging hydrazones into polymer scaffolds (Fig. 
1f) is anticipated to provide a useful boost to the kinetics of ‘shrink-wrapping’ at neutral pH, 



















Figure 2 outlines the proposed synthesis of next-generation polymer ‘wrapping-agents’ 
which should be hydrophilic, highly water-soluble, and capable of rapid hydrazone exchange 
at neutral pH. Hydrophilic polymer scaffolds (Fig. 2a) bearing reactive aldehyde (BenzoDHP) 
‘anchor-points’ and highly water-soluble (N-Methyl Glycamine) moieties can be constructed 
by copolymerization of the corresponding acrylamide monomers. In Chapter 5, BenzoDHP 
was shown to established rapid hydrazone exchange at physiological pH, on account of its 
ability to stabilize the transition state through hydrogen-bonding interactions (Fig. 1e), and thus 
inclusion of these moieties upon polymer scaffolds (Fig. 2a) is anticipated to afford ‘wrapping-
agents’ capable of ‘shrink-wrapping’ at physiological pH. In order to facilitate ‘triggered’ object 
‘un-wrapping’, future work should incorporate alternative crosslinker types, such as disulfide-
cleavable linker DCD (Fig 2d) into polymer ‘wrapping agents’, as these linkages could be 




6.5. Beyond the ‘Wrapping’ of Nanoscale Objects 
Beyond the idea of ‘shrink-wrapping’ nano- and microscale objects, it was hypothesized 
that the ‘wrapping’ approach may also be applied to the capture individual water droplets 
suspended in air – an impressive feat which is achieved in nature by the bacterial hydrophobin 
BslA (Fig. 3a, iv).  
  
Figure 3: (a) ‘Structural metamorphosis’ of the bacterial hydrophobin BslA, a crucial protein component 
of bacterial biofilms. Wild-type BslA (i) migrates to the water/air interface and the protein spontaneously 
undergoes a conformational ‘switch’ (ii), which drives the irreversible formation of a polymer-like 
‘crosslinked’ protein film (iii) upon the droplet surface. Droplet compression experiments (iv) revealed 
that BslA films are elastic in nature, encapsulating the water droplet within plastic-like layer. (b) ‘Shrink-
wrapping’ of aqueous droplets by Amphiphilic SCPNs, which are ‘decorated’ with hydrophilic (green) 
and hydrophobic (yellow) appendages. In dilute solutions (i) with low interfacial areas, these SCNPs will 
be kinetically stable and they will not aggregate. However, after generation of an aerosol (ii), a dramatic 
increase in interfacial area is expected, which thus drives SCNPs to migrate and concentrate at the 
water/air interface (iii). This process brings the SCNPs into close spatial proximity with one another, thus 
allowing their ‘metamorphosis’ into crosslinked polymeric film (iv) which is anticipated to encapsulate 




BslA is a relatively hydrophobic protein component which plays a crucial role in biofilm 
formation. When dissolved in aqueous solution, BslA spontaneously migrates to the water/air 
interface (Fig. 3a, ii) on account of its amphiphilic nature. This process triggers a ‘switch’ in the 
protein conformation to ‘display’ a hydrophobic patch upon its periphery, which subsequently 
‘locks’ the proteins together (Fig. 3a, iii) in a plastic-like film (Fig. 3a, iv) at the droplet surface. 
Inspired by this elegant form of ‘structural metamorphosis’, it was hypothesized that 
amphiphilic polymer ‘wrapping agents’ (Fig. 4b) displaying an appropriate balance of 
hydrophilic (green) and hydrophobic (yellow) appendages may also migrate to the water/air 
interface, concentrate themselves at the droplet surface, and thus could trigger the 
‘metamorphosis’ of neighbouring polymer chains to form a crosslinked polymer film (Fig. 3b, i 
- iv) upon the droplet exterior. Future work should further develop this concept, as it presents 
scope to ‘capture’ aqueous droplets within polymer films, and thus an entirely new class of 
‘smart’ materials may be engineered. Polymer 'wrappings' are anticipated to (i) prevent 
unwanted droplet coalescence, (ii) protect and stabilize aerosol cargos in their environments, 
(iii) allow control over when cargos are released, and (iv) allow us to isolate and store droplets 
of tailored size, concentration and composition. Furthermore, the dynamic covalent nature of 
the crosslinks within polymer film permits scope to achieve triggered ‘un-wrapping’ of aqueous 
droplets, or even to perform component exchange of residues located within polymer films at 
the droplet interface.  
 
6.6. Research Outlook 
This chapter has proposed a basic research framework and outlined the key concepts which 
should be explored during future work. With firm evidence of the ‘wrapping’ of microscale 
objects now in hand, the outlook for this research program is very optimistic. Chapter 3 
established a robust fluorescence microscopy protocol by which the ‘wrapping’ of microscale 
objects can be monitored with confidence. Whilst the ‘wrapping’ of nanoscale objects has 
proven difficult to achieve – on account of nano-objects having a high propensity to exhibit 
irreversible and non-specific binding polymer-object binding – it is now anticipated that the 
highly hydrophilic poly(ethylene glycol) based ‘wrapping agents’ developed in Chapter 3 will 
circumnavigate these issues, and should thus permit successful ‘shrink-wrapping’ of nanoscale 
targets. Chapter 5 elucidated candidate hydrazone structures, which may undergo hydrazone 
exchange at neutral pH, and this constitutes the first step in preparing the next-generation of 
polymer ‘wrapping-agents’, capable of ‘wrapping’ biological targets under their ‘native’ 
physiological conditions. Finally, the novel concept of ‘wrapping’ aqueous droplets within 
polymer films was proposed – a process in which hydrophobic interactions could be exploited 
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Molecular Recognition-Mediated ‘Wrapping’ of Micron-Sized Spherical Objects  
We would like to present the above manuscript for your consideration as an Edge article in 
Chemical Science. 
There has been a growing interest in developing methods to isolate or stabilize nano- and micron-
sized objects through their inclusion within protective coatings.  Polymer films make particularly 
appealing protective coatings, but to the best of our knowledge, there are no reported methods to 
‘wrap’ tiny objects within polymer films. 
In this work we demonstrate how a molecular-recognition mediated ‘wrapping’ approach can be 
applied to successfully ‘wrap’ micron-sized particles within a layer of cross-linked polymer film.  
This involves the utilisation of polymer ‘wrapping’ agents that can concentrate upon the 
microparticle surface then cross-link with one another to form polymer films.  The concentration 
process is driven by specific molecular recognition between the polymer and the surface, and 
cross-linking is facilitated by intramolecular dynamic covalent bonds within the polymer that 
rearrange to intermolecularly cross-link the polymer chains.  This work is significant because it 
suggests that the approach will also be compatible with virus-like particles, which are of 
significant interest as next generation vaccines but which suffer from poor stability in warm or 
dehydrating conditions and would thus benefit from their inclusion within ‘wrappers’ that 
improve their stabilities.  This work will be of considerable general interest, especially in the field 
of ‘smart’ materials, stimulate discussion and inspire the development of new materials 
 
We hope that you will consider this manuscript for publication in Chemical Science, and we look 
forward to hearing from you shortly. 
Yours faithfully 
 
David A Fulton
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